Genetics and transcriptomics of host response to PRRS in nursery pigs by Dong, Qian
Graduate Theses and Dissertations Iowa State University Capstones, Theses and Dissertations 
2019 
Genetics and transcriptomics of host response to PRRS in nursery 
pigs 
Qian Dong 
Iowa State University 
Follow this and additional works at: https://lib.dr.iastate.edu/etd 
 Part of the Animal Diseases Commons, Bioinformatics Commons, and the Biostatistics Commons 
Recommended Citation 
Dong, Qian, "Genetics and transcriptomics of host response to PRRS in nursery pigs" (2019). Graduate 
Theses and Dissertations. 17441. 
https://lib.dr.iastate.edu/etd/17441 
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and 
Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and 
Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please 
contact digirep@iastate.edu. 
Genetics and transcriptomics of host response to PRRS in nursery pigs 
 
 
by 
 
Qian Dong 
 
 
A dissertation submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY  
 
Major: Animal Breeding and Genetics  
 
Program of Study Committee: 
Jack Dekkers, Major Professor 
Rohan Fernando 
Susan Lamont 
Dan Nettleton 
Christopher Tuggle 
 
 
 
The student author, whose presentation of the scholarship herein was approved by the program 
of study committee, is solely responsible for the content of this dissertation. The Graduate 
College will ensure this dissertation is globally accessible and will not permit alterations after a 
degree is conferred.  
 
 
 
Iowa State University 
Ames, Iowa 
2019 
 
Copyright © Qian Dong, 2019. All rights reserved. 
 
ii 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGMENTS ............................................................................................................. iv 
ABSTRACT ................................................................................................................................... ix 
CHAPTER 1. GENERAL INTRODUCTION ................................................................................1 
Organization of the Thesis ......................................................................................................... 4 
References ................................................................................................................................. 6 
CHAPTER 2. LITERATURE REVIEW .........................................................................................9 
Pig Immune Response to PRRSV infection, Vaccination or Co-infection ............................... 9 
Genetic Basis of Host Immune Response to PRRSV and Co-infection with PCV2 ............... 16 
Transcriptome Responses to PRRSV Infection ....................................................................... 19 
The Effect of PRRSV Infection on Cell Composition in Blood and Tonsil ............................ 22 
References ............................................................................................................................... 24 
CHAPTER 3. GENE EXPRESSION IN TONSILS IN SWINE FOLLOWING INFECTION 
WITH PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS .................32 
Abstract .................................................................................................................................... 32 
Background .............................................................................................................................. 34 
Results ..................................................................................................................................... 37 
Discussion ................................................................................................................................ 46 
Conclusions ............................................................................................................................. 59 
Methods ................................................................................................................................... 60 
Tables and Figures ................................................................................................................... 69 
References ............................................................................................................................... 83 
CHAPTER 4. BLOOD TRANSCRIPTOME RSPONSE TO VACCINATION AND CO-
INFECTION WITH PORCINE REPRODUCTIVE AND RESPIRATORY VIRUS AND 
PORCINE CIRCOVIRUS TYPE 2B IN NURSERY PIGS ..........................................................90 
Abstract .................................................................................................................................... 90 
Introduction ............................................................................................................................. 91 
Results ..................................................................................................................................... 95 
Discussion .............................................................................................................................. 103 
Conclusions ........................................................................................................................... 111 
Methods ................................................................................................................................. 112 
Tables and Figures ................................................................................................................. 121 
References ............................................................................................................................. 140 
Appendix: Justification of using xCell ........................................................................................146 
Tables and Figures ................................................................................................................. 148 
References ............................................................................................................................. 148 
 
 
iii 
CHAPTER 5. ASSOCIATIONS OF NATURAL VARIATION IN THE CD163, CD169,  
AND OTHER CANDIDATE GENES ON HOST RESPONSE OF NURSERY PIGS TO  
PRRSV INFECTION ...................................................................................................................150 
Abstract .................................................................................................................................. 150 
Introduction ........................................................................................................................... 151 
Materials and Methods .......................................................................................................... 156 
Results ................................................................................................................................... 162 
Discussion .............................................................................................................................. 166 
Conclusions ........................................................................................................................... 175 
Tables and Figures ................................................................................................................. 176 
References ............................................................................................................................. 193 
CHAPTER 6. GENERAL DISCUSSION ...................................................................................199 
Summary of Key Results and Implementation of the findings ............................................. 200 
Limitations of This Study and Future Directions .................................................................. 206 
References ............................................................................................................................. 209 
iv 
ACKNOWLEDGMENTS 
First and most importantly, I would like to thank my supervisor Dr. Jack Dekkers. He 
was the best supervisor in the world for me. In these four years, he has always instructed me, 
supported me, encouraged me, and guided me. When I derived the idea of creating a “network 
QTL” concept from reading a paper he shared with me, he supported me to join a short course 
about the network, write a proposal, collaborate with the author of that paper, and publish a 
poster about this idea. He encouraged us to apply for a departmental scholarship and offered to 
write a reference for us. No matter how busy he is, he always tries his best to support his 
graduate students and helps us to succeed. He even wrote the reference letter for me to apply for 
the scholarship while attending a conference, and gave me comments and edited my dissertation 
every night after a whole day biking during his vacation. He always replied to my emails 
promptly and gave me feedback so quickly on abstracts, slides, posters, and papers I sent to him. 
He recommended me to a professor who was looking for a postdoc during a conference when I 
was searching for a job. Because of his recommendation, I got my first chance for an on-site 
interview, which built my confidence for my whole job search. He encouraged me to go to the 
on-site interview when I almost had given up on it, from which I gained and learned a lot. I 
really appreciate his patience and time spent with me during these four years. No matter how 
many jobs I applied for, he always answered the phone calls from the interviewers to give a 
reference and wrote reference letters for me if necessary. He always had patience to teach me 
basic concepts if he noticed that I was not familiar with them without blaming or discouraging 
me. He inspired me to see the whole picture by connecting all the concepts of my study during 
my preparation for the PhD preliminary exam. He always asked “what do you think” to 
encourage me to think independently. He always trusted me and gave me the responsibility to 
v 
arrange the coffee breaks for the deparmental short courses and to coordinate weekly genomic 
selection meetings. He always reminded me of some details and steps that I forgot in doing 
research or processing some paper work. He gave me the chance to have weekly joint meetings 
with his postdoc, Kyu-Sang Lim, to learn from him for more than a year. He supported me to go 
back to China immediately for two months when my family had an emergency. We always had 
weekly meetings no matter where he was to update my research and help me move forward. He 
always pointed out where I should improve directly and honestly, in a way that I felt was 
comfortable and acceptable. Because of his compassionate heart, I could be myself in my PhD 
study. 
Besides my supervisor, I would like to thank two mentors in my PhD study. One is Dr. 
Susan Lamont, who was my mentor when I joined the future faculty program (PFF) in the fall 
semester, 2018, and who is also one of my committee members. During that semester, which was 
the most frustrating time because I did not know what I wanted to do in the future after 
graduation, she gave me positive energy and hope when I felt disappointed about myself. She 
shared her treasurable wisdom and experience with me in an open mind and heart, not only about 
career development but also about happiness in life. She also did a mock interview with me and 
gave me feedback and suggestions after that, which was the first time I knew what an interview 
was like. She helped me to know myself better and inspired me to use my strength as a good 
leader. She tried to join every presentation I gave and informed me if she could not come. She 
also helped me to connect with one of her previous students who works at the Children’s 
Hospital that I will join soon. This connection means a lot to me: like sowing a seed in my heart, 
which grows my willingness to work there. She also told me the top three considerations about a 
good job and gave me suggestions when I needed to choose from three opportunities. She also 
vi 
read my dissertation in detail, gave me many good comments and forgave my delay in sending 
her the revised version. As a woman, she is a model in my heart. 
The other mentor of mine is Kyu-Sang Lim. I feel I am so lucky to have had a chance to 
work with him and learn from him. He is very smart with very clear logic and always tries his 
best to help me. He gave me very good suggestions during our weekly meetings, especially at 
important points in my life, such as my oral presentation at the World Congress on Genetics 
Applied to Livestock Production and my final oral defense, for which we met before 8 AM to go 
through my slides one by one while Kyu-Sang gave me suggestions. He always pointed out the 
weakness of my slides with a sharp eye. He is also very professional and patient when answering 
my research questions and always shared his code or experience with me without any hesitation. 
I have always believed that he will be a very good professor in the near future. In life, he and his 
wife are also my best friends who support me and inspire me.  
I also would like to thank my other three committee members, who are all the best for me 
in the world. Firstly, I really appreciate Dr. Christopher Tuggle, who gave me a great question in 
my preliminary exam which led to the main creative part of my dissertation about considering 
cell enrichments in multicellular tissues when doing differential gene expression analyses. Every 
time after I had an individual meeting with him, I always felt I had learned and been inspired a 
lot, and I was impressed by his passion for molecular biology and doing research. I really 
appreciate that he read my dissertation very carefully and gave me many great comments and 
pointed out the logic issues with a sharp eye. Secondly, I would like to thank Dr. Rohan 
Fernando. Whenever I had questions related to quantitative genetics, he always tried his best to 
help me and taught me immediately with patience. His office door was always open for me to 
ask questions. Furthermore, I would like to thank to Dr. Dan Nettleton and his two PhD students, 
vii 
Yet Nguyen and Hyeongseon (Sammy) Jeon, who helped me to conduct the differential gene 
expression analyses professionally in statistics. They always tried their best to explain statistical 
concepts or methods to me and taught me how to do the analyses with patience. They also have 
become very good friends. 
There is another very important person I would like to thank: Dr. Joan Lunney, who is an 
expert on PRRS. She was always willing to help me interpret the results in the right way and 
supported me during my job search by giving me a reference letter. She always replied to my 
emails promptly to answer my questions. In addition, I would like to thank my masters 
supervisor, Dr. Shuhong Zhao. Without her reference and support, I could not have come to the 
U.S. for my PhD study. I want to also offer my appreciation to my family, especially my mum, 
Meirong Jiang. My mum taught me what love is through the way she loved me. 
Additionally, I would like to thank other faculty, including Dr. Nick Serao, Dr. James 
Reccey, Dr. James Koltes, and Dr. Anna Wolc; to my fellow graduate students, including Jenelle 
Dunkelberger, Melanie Hess, Lydia Hardie, Emily Mauch, Ziqing Weng, Anita Corredor, Leticia 
Sanglard, Yulu Chen, Amornrat Tunboonjit, Hailin Su, Muhammed Walugembe Simbwa, 
Melissa Monson, Andrew Hess, Hao Cheng, Jian Zeng, Luke Kramer, Jian Cheng, Austin Putz, 
and China Supakorn; to my friends, including Qingyun Li, Xi Lan, John Hsieh, Haibo Liu, Xi 
Feng, Don Boyle, Craig Mcclanahan, Nicole Mcclanahan, Sisi Liu, Jing Liu, Sijia He, Tianqi 
Wang, Jibin Zhang, Wei Liu, Honghu Quan, Shulan Xiao, Minhong Huang, Panfei Zhen, and 
Liqun Ma; to my classmates, including Zihao Zhen, Lijun Cao, Linkai Li, Qi Mu, and Jinyu 
Wang; to my roommates, including Miao Na, Eka Novita, Wei Dou, and Hongmei Zhao; and to 
my fellow members of the Toastmaster Club, the Center for Communication Excellence, the 
Writing and Media Center, and the staff in the Department of Animal Science, who are/were 
viii 
always supportive and friendly to me, which warmed my heart. We laughed together, celebrated 
together, discussed together, and studied together. All these people were the angels during my 
whole PhD study.  
And finally, I want to acknowledge project funding from USDA NIFA grant 2013-
68004-20362, Genome Canada, and National Pork Board grants #12-061 and #14-223, as well as 
funding from the China Scholarship Council. I also would like to acknowledge the lab groups of 
Dr. Bob Rowland and Dr. Joan Lunney for conducting the experiments, collecting samples and 
data, and running assays for the PHGC trials. 
ix 
ABSTRACT 
The overall objective of this dissertation was to investigate the genetic and molecular 
mechanisms of host response to porcine reproductive and respiratory syndrome (PRRS) virus 
(PRRSV), and to identify biomarkers in pigs to improve host response to PRRS and reduce 
PRRSV persistence in pigs. Because pigs that are only infected with PRRSV rarely exist in the 
industry, host transcriptome responses to vaccination with a PRRS modified-live virus (MLV) 
and to co-infection with PRRS and porcine circovirus type 2b (PCV2b), with or without prior, 
were also investigated. The first study reported in this dissertation was designed to investigate 
mechanisms of PRRSV persistence in nursery pigs by studying the tonsil transcriptome at 42 
days post infection (dpi) with one of two PRRSV isolates, NVSL-97-7895 (NVSL) and KS-
2006-72109 (KS06), along with the effect of PRRSV level in tonsil at 42 dpi and of genotype at 
a genetic marker (WUR) for the GBP5 resistance gene on the tonsil transcriptome at 42 dpi. 
Consistent with our hypotheses that (1) the more virulent NVSL PRRSV isolate inhibited host 
immunity in tonsil more, or activated it less, than the KS06 PRRSV isolate; (2) having a higher 
virus level in tonsil induces stronger immune response; and (3) pigs with the favorable AB 
genotype at the WUR genetic marker, which can putatively produce functional GBP5 protein, 
can induce a stronger innate immune response than AA pigs, the tonsil transcriptome results 
showed that genes related to immune response were expressed more in tonsils of KS06-infected 
pigs, in pigs with high tonsil viral level, and in pigs with the AB genotype at WUR, than in 
NVSL-infected pigs, in pigs with low tonsil viral level, and in pigs with the AA genotype at 
WUR, respectively. The second study was designed to investigate the effects of PRRS 
vaccination and WUR genotype on the blood transcriptome of nursery pigs following PRRS-
MLV vaccination and to co-infection with PRRSV and PCV2b with or without prior vaccination. 
x 
Consistent with our hypotheses, before co-infection, PRRS vaccination stimulated host immune 
response, especially innate immunity at the early stage of vaccination; after co-infection, 
vaccinated pigs had a stronger adaptive immunity than non-vaccinated pigs, based on higher 
expression levels of adaptive immunity genes and larger enrichment scores of adaptive immune 
cells, while non-vaccinated pigs had a stronger innate immunity than vaccinated pigs, including 
higher expression of innate immune response genes and larger enrichment scores of innate 
immune cells in blood. These findings are consistent with co-infection being the first exposure to 
PRRSV for non-vaccinated pigs but second exposure for vaccinated pigs, while co-infection 28 
days after vaccination provides sufficient time to stimulate the adaptive immune response. These 
two transcriptome studies in tonsil and blood also highlighted the importance of measuring cell 
enrichments when evaluating transcriptomics in a multicellular tissue to more comprehensively 
understand transcriptome responses. The objective of the final study was to evaluate the effects 
of natural variants in the CD163 gene (gene edited pigs lacking CD163 are completely resistant 
to PRRSV) and in several other candidate genes on host response to PRRSV infection and to 
PRRSV/PCV2b co-infection. Results from this study showed that several SNPs in these 
candidate genes were significantly associated with PRRSV and PCV2b viral load following 
infection, and with average daily gain before and post PRRSV-PCV2b co-infection. The effects 
of some SNPs depended on previous vaccination for PRRS or genotype at the WUR SNP. The 
identified SNPs are potential genetic markers to select for increased natural resistance to PRRSV 
and/or PCV2. In conclusion, the work described in this dissertation has the improved knowledge 
of the molecular basis for host response to PRRSV infection and to co-infection with PRRSV 
and PCV2b, and identified genes and SNPs associated with host response. Future work is needed 
to confirm the impact on PRRSV resistance of the identified candidate genes and pathways on 
xi 
PRRSV resistance. In addition, the information uncovered in this dissertation may provide leads 
for the design of new vaccines to control viral disease in pigs.  
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CHAPTER 1.    GENERAL INTRODUCTION 
Porcine reproductive and respiratory syndrome (PRRS) is the most costly viral disease in 
the pig industry across the world. PRRS has been estimated to cost $664 million ($1.8 million 
per day) in combined production-related losses in breeding- and growing-pig herds annually in 
the US (Holtkamp et al. 2013). This assessment of the economic impact of PRRS was 18% 
greater than the estimated costs in 2005 (Neumann et al. 2005). In 2017, Nathues et al. (2017) 
estimated the annual losses of an individual farm in Europe that was severely affected in 
breeding, nursery, and fattening stages at about $793,000. 
The PRRS disease is caused by the PRRS virus (PRRSV), which is a positive single-
strand, enveloped RNA virus belonging to the order Nidovirales, family Arteriviridae (Snijder et 
al. 2013). The PRRSV has high genetic and antigenic heterogeneity, and effective immune 
evasion strategies (Kimman et al. 2009; Mateu et al. 2008; Rowland et al. 2007). PRRSV is 
highly transmissible by infected animals through semen and oral-nasal secretions (Christopher-
Hennings et al. 2008), which can cause a second outbreak. PRRSV can persist in lymphoid 
tissues, including lymph nodes and tonsils for 251 days in asymptomatic carrier pigs (Allende et 
al. 2000; Wills et al. 1997), which may result from the weak antiviral immune response of the 
host. Because of these, traditional disease control strategies, including veterinary health 
management, biosecurity, depopulation, and vaccination have been generally unsuccessful to 
control PRRS completely (Lunney et al. 2016; Murtaugh et al. 2011).  
Another potential strategy to control disease is genetic improvement of host natural 
resistance to infection through animal breeding, in particular through the use of genomic tools. 
Ait-ali et al. (2007) found reduced PRRSV replication in macrophages from Landrace pigs 
compared to macrophages from other four commercial pig lines, which suggests that the genetics 
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of the Landrace breed may play a role in the delayed or reduced response after PRRSV-infection 
in pigs. Petry et al. (2005) also found that a Large White/Landrace line had decreased viremia 
and reduced rectal temperatures following infection with PRRSV compared to a 
Hampshire/Duroc line. These observations suggested underlying genetic variation and motivated 
establishment of the PRRS Host Genetics Consortium (PHGC) in 2007, with initial funding from 
the National Pork Board (Lunney et al. 2011). The main objectives of the PHGC were to 
investigate the genetic basis of host response to PRRSV infection in nursery pigs and to identify 
genomic regions or/and genes associated with resistance and persistence of pigs to PRRSV 
infection (Lunney et al. 2011). The final goal of the PHGC project was to develop genetic tools 
to improve prediction and selection in pig breeding programs in order to reduce the losses of 
PRRS in the pig industry.  
Over the past decade, the PHGC has not only conducted PRRSV-only infection trials 
with two genetically distinct North American PRRSV, NVSL-97-7895 (NVSL) and KS-2006-
72109 (KS06), but also PRRSV and porcine circovirus 2b (PCV2b) co-infection trials. All the 
PHGC trials were completed at biosecure facilities at Kansas State University (KSU), where 
groups of 200 commercial nursery pigs in each trial were followed for 42 days post infection 
(dpi). In the PHGC trials, all pigs were infected and all pigs were genotyped using the Porcine 
SNP60 BeadChip (Ramos et al. 2009) or the GeneSeek-Neogen PorcineSNP80 BeadChip 
(GeneSeek, Igenity, Lincoln, NE), and comprehensive phenotypic, immunological, and 
transcriptomic data were collected. Results from the PHGC showed that host response to PRRSV 
is moderately heritable but highly polygenic (Waide et al. 2017) beyond the effects of a putative 
causative intronic SNP, rs340943904, in the guanylate binding protein 5 (GBP5), which 
introduces a splice acceptor site with five extra nucleotides into the transcript, resulting in an 
3 
early stop codon (Koltes et al. 2015). This SNP was found to be in complete linkage 
disequilibrium (LD) with SNP rs80800372 (WUR10000125, WUR) on Sus scrofa chromosome 
4 (Koltes et al. 2015). In a genome-wide association study, the WUR SNP was found to be 
highly associated with PRRS resistance and growth rate under PRRSV infection (Boddicker et 
al. 2012), which included the WUR SNP but not the putative causative mutation SNP 
rs340943904 in the GBP5 gene. The effect of the WUR SNP on viral load (VL) and weight gain 
after PRRSV infection was confirmed for infection with two North American PRRSV isolates, 
for response to vaccination with a PRRS modified live virus (MLV), for PRRS-PCV2b co-
infections (Boddicker et al. 2012; Dunkelberger et al. 2017; Hess et al. 2016), and for an 
attenuated European PRRSV strain (only growth rate) (Abella et al. 2016). 
The PRRSV can persist in tonsil tissue, where it avoids immune response and can mutate 
or just persist and then return to the blood, causing re-breaks of the disease (Wills et al. 1997). 
Hess et al. (2018) found that low tonsil viral level was phenotypically associated with an earlier 
and faster viral clearance from blood, with lower VL in serum from 0 to 42 days post infection 
(dpi), and with lower serum viremia at 42 dpi. The first study in this dissertation was designed to 
identify differences in gene expression in tonsil at 42 dpi, depending on WUR genotype, PRRS 
isolate (NVSL or KS06), and PRRS viral level in tonsil at 42 dpi, in order to obtain a greater 
understanding of the mechanism of PRRSV persistence and help to identify bio-markers for 
PRRSV persistence in tonsil tissue. This may lead to the development of more effective 
strategies to reduce the chance of PRRS re-breaks. 
Previous PHGC results have shown that pigs vaccinated (Vx) with a PRRS MLV had 
lower PRRS VL but higher PCV2b VL following co-infection with PRRSV and PVC2b than 
non-vaccinated (NonVx) pigs (Dunkelberger et al. 2017). This indicates that PRRS vaccination 
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can partially protect pigs against PRRSV infection but enhances PCV2b infection (Dunkelberger 
et al. 2017). The objective of the second study in this dissertation was to explore the host-
mechanisms responsible for these differences by identification of differentially expressed genes 
(DEGs) for the effects of PRRS-MLV vaccination and WUR genotype across ten time points 
before and after co-infection with PRRSV and PCV2b and to understand the biological function 
of these DEGs. Results of this study can help to identify mechanisms involved in the effect of 
PRRS-MVL vaccination and WUR genotype on pig blood transcriptome response following co-
infection with PRRSV and PCV2b.  
In 2016, generation of CD163 gene knockout pigs that are completely resistant to the 
PRRS virus (PRRSV) isolate NVSL 97-7895 was reported (Whitworth et al. 2016). There are, 
however, societal concerns about the use of gene edited pigs and possible negative side effects 
on the animal are not clear. It is, however, possible that natural genetic variation exists in the 
CD163 gene that provides complete or partial resistance. Variation in the CD163 gene was not 
included in the GWAS referred to previously because the CD163 gene was absent from the build 
of the porcine genome that the SNP panels were based on. Therefore, the third study in this 
dissertation was to identify associations of naturally occurring SNPs in the CD163 gene and in 
three other candidate genes with host immune response to PRRSV-only infection and to PRRSV 
and PCV2b co-infection with PRRS vaccination (VxStatus) for potential use in marker-assisted 
selection in pig breeding programs. 
Organization of the Thesis 
The second chapter of this dissertation is a review of current literatures related to host 
immune response to PRRSV infection, the genetic basis of host immune response to PRRSV 
infection and co-infection with PCV2b, transcriptome response to PRRSV infection, and the 
effect of PRRSV infection on cell composition in blood and tonsil. The third chapter presents 
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results for the effect of PRRS isolate, viral level in tonsil, and WUR genotype on gene 
expression in tonsil 42 days after PRRSV infection. The studies described in Chapter 4 were 
designed to investigate the effect of  and WUR genotype on the blood transcriptome response of 
nursery pigs to co-infection with PRRSV and PCV2b. Results presented in Chapter 5 show the 
association of the natural variation in the CD163, CD169, TRAF1, and RGS16 genes with host 
response of nursery pigs to PRRSV-only infection and co-infection with PRRSV and PCV2b. 
Chapter 6 is a general discussion with a the summary of key results of these studies, their 
implications and limitations, and future research needs. Chapters 3, 4 and 5 are formatted for 
submission to relevant scientific journals. All data were generated by the PHGC.  
For the studies described in Chapter 3, I conducted the statistical and bioinformatic 
analyses, except the statistical analyses of differential expression (DE) of the tonsil RNA-seq 
data, I interpreted results, and wrote the manuscript; Joan Lunney helped to conceive the study, 
assisted with interpretation of results and coordinated the sample preparation for RNA; Kyu-
Sang Lim assisted with the RNA-seq data processing and interpretation of results; Yet Nguyen 
conducted statistical DE analysis of the tonsil RNA-seq data; Raymond Rowland helped to 
conceived the study and led the animal infection trials and sample collection; Andrew Hess 
selected animals for the tonsil RNA-seq and calculated phenotypes related to tonsil and serum 
viral levels; Kristen Walker conducted RNA sample preparation and NanoString; Hamid Beiki 
provided information on new genes using Iso-Seq data; James Reecy helped to conceive the 
study and arranged the RNA-sequencing and initial processing and statistical analyses; 
Christopher Tuggle helped to conceive the study and assisted with interpretation of results; and 
Jack Dekkers helped to conceive the study, oversaw analyses, assisted with interpretation of 
results and preparation of the manuscript.  
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For the studies described in Chapter 4, I selected the pigs and samples to sequence and 
designed the plates for QuantSeq, contributed to arranging the QuantSeq sequencing of the 
samples, conducted all statistical and bioinformatic analyses, except DE statistical analysis of the 
QuantSeq data, interpreted results, and wrote the manuscript; Hyeongseon Jeon conducted the 
statistical DE analysis of the QuantSeq data, and assisted with statistical analyses of the 
phenotypes and cell enrichments; Joan Lunney helped to conceive the study, assisted with 
interpretation of results and coordinated the sample preparation for RNA; Kyu-Sang Lim assisted 
with the QuantSeq data processing; Kristen Walker conducted RNA sample preparation; 
Christopher Tuggle helped to conceive the study and assisted with interpretation of results; 
Raymond Rowland helped to conceive the study and led the animal infection trials and sample 
collection; and Jack Dekkers helped to conceive the study, oversaw analyses, and assisted with 
interpretation of results and preparation of the manuscript.  
For the studies in Chapter 5, I conducted all statistical and bioinformatic analyses, 
interpreted results, assisted with genotyped SNP selection, and wrote the manuscript; Jenelle 
Dunkelberger assisted with the single SNP analyses of the co-infection trials; Kyu-Sang Lim 
selected the genotyped SNPs selection and coordinated SNP genotyping; Joan Lunney helped to 
conceive the study and coordinated the sample preparation for DNA; Christopher Tuggle helped 
to conceive the study and assisted with interpretation of results; Raymond Rowland helped to 
conceive the study and led the animal infection trials and sample collection; and Jack Dekkers 
helped to conceive the study, oversaw analyses, assisted with interpretation of results and 
preparation of the manuscript.  
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CHAPTER 2.    LITERATURE REVIEW 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a positive-sense, single-
stranded RNA virus. The PRRSV RNA genome is approximately 15 kb long and consists of 11 
known open reading frames (ORFs). PRRSV belongs to the Nidovirales order, Arteriviridae 
family, Variarterivirinae subfamily, and Betaarterivirus genus. The family Arteriviridae includes 
equine arteritis virus, mouse lactate dehydrpgenase-elevating virus and simian hemorrhagic fever 
virus. The Arterivirus genome is a 3’-polyadenylated, polycistronic positive-stranded RNA. 
Arteriviruses cause acute disease with fever, a respiratory disorder, or abortion, and 
asymptomatic and persistent infections (Snijder et al. 2013).  
PRRSV has two main genotypes: PRRSV-1 (European genotype 1) and PRRSV-2 (North 
America genotype 2). PRRSV-1 and PRRSV-2 share approximately 60% identity at the 
nucleotide level and produce similar disease signs and epidemiology. PRRS was first reported in 
the United States in 1987 (Keffaber 1989) and in Europe in 1990 (Wensvoort et al. 1991). 
Molecular analysis of the VR-2332 and Lelystad prototype PRRS viruses (U.S. and European 
isolates, respectively) suggests that these divergently evolved strains emerged on the two 
continents almost simultaneously, perhaps because of similar changes in swine management 
practices (Murtaugh et al. 1995; Nelsen et al. 1999). Since its initial emergence, PRRSV has 
spread worldwide, including the circulation of European genotype viruses in U.S. swine herds 
(Ropp et al. 2004).  
Pig Immune Response to PRRSV Infection, Vaccination or Co-infection  
Innate Immune Response 
The innate immune system plays an important role in initial detection of invading viruses. 
The innate immune response can inhibit viral replication and invasion and stimulates the 
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adaptive immune response for the clearance of viral-infected cells. However, PRRSV can 
modulate host innate and adaptive immunity to evade the immune system, resulting in a weak 
and slow immune response and poor control of virus replication (Lunney et al. 2016). 
Type I interferons (IFN-α and IFN-β), which can be produced by virus-infected cells, are 
essential in inducing effective innate anti-viral immune response through the expression of 
interferon-stimulated genes (Baum et al. 2010). However, compared to other viral infections, 
PRRSV can modulate host innate immunity by inhibition of innate cytokine production, which 
delays activation of the adaptive immune response (Van Reeth et al. 1999). PRRSV can evade 
innate antiviral response by delaying or suppressing the type I interferon transcriptional response 
(Ait-Ali et al. 2011; Miller et al. 2004; Van Reeth et al. 1999). Field isolates of PRRSV (MN184 
and MN1-18-2) and the PRRS modified live virus (MLV) vaccine not only induced relatively 
low levels of IFNα production (Alibina et al. 1998) but also reduced natural killer (NK) cell 
activity in pigs (Dwivedi et al. 2011; Renukaradhya et al. 2010). Although plasmacytoid 
dendritic cells can efficiently generate type I IFN for anti-viral response through Toll-like 
receptor 7 (TLR7) (Takeuchi et al. 2009), PRRSV can inhibit the IFN-α response of 
plasmacytoid dendritic cells (Baumann et al. 2013). Previous study has shown that PRRSV 
nonstructural protein inhibits interferon synthesis in PRRSV-infected cells (Chen et al. 2010). 
Because IFN-α can up-regulate expression of the IFN-γ gene, the reduction of IFN-α production 
after PRRSV infection impedes the development of adaptive immunity. In vitro, PRRSV 
inhibited INF-γ response in peripheral blood mononuclear cells (PBMC), especially from nursery 
pigs (Klinge et al. 2009).  
NK cells are innate immune cells and have important roles in providing innate defense 
against virus infection through cytotoxic activity and by producing certain cytokine and 
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chemokines (Biron et al. 2002). Activation of NK cells is regulated by signal transmission by 
activating cellular receptors that recognize the ligands on virus-infected cells and, specifically, 
inhibitory receptors for the major histocompatibility complex (MHC) I (Watzl 2008). During 
viral infection, differentiation, development, and functions of NK cells are modulated by IL-2, 
IL-12, IL-15, IL-18, IFNα/β, and IFN-γ (Nguyen et al. 2002; Williams et al. 1998). PRRSV 
causes innate immunosuppression by suppressing the cytotoxic activity of NK cells, which was 
further reduced by co-infection with porcine respiratory coronavirus (PRCV) (Renukaradhya et 
al. 2010). The defective development of NK cells cytolytic activity is mediated through the 
STAT1 pathway (Lee et al. 2000). Nursery pigs took longer for PRRSV to clear from blood than 
finishers and adult pigs because of their still poorly developed innate immune system (Klinge et 
al. 2009), although suppression of NK cells cytotoxic activity induced by PRRSV infection does 
not depend on the NK cell frequency in PBMC or lung (Dwivedi et al. 2011; Renukaradhya et al. 
2010).  
The IL-4 cytokine promotes Th2 immune response, suppresses Th1 immune response, 
and plays an essential role in antibody secretion in humans and mice (Burstein et al. 1991; 
Paludan 1998). However, the effect of IL-4 is different in pigs, including inhibition of IL-6 and 
antibody production in pigs, and suppressing transcription of inflammatory cytokine genes 
(TNF-α, IL-1α, IL-1β, and IL-8) in porcine alveolar macrophages, as well as B cell proliferation 
(Murtaugh et al. 2009; Zhou et al. 1994). In the early stage of PRRSV infection, IL-4 production 
increased significantly in more than 90% of pigs (Dwivedi et al. 2012), resulting in delayed 
generation of adaptive immunity.  
In summary, PRRSV can modulate host innate immune response by delaying or 
suppressing Type I interferon production (Ait-Ali et al. 2011; Miller et al. 2004; Van Reeth et al. 
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1999), defective development of NK cells cytolytic activity (Dwivedi et al. 2011; Renukaradhya 
et al. 2010), and increasing IL-4 production (Dwivedi et al. 2012; Murtaugh et al. 2009; Zhou et 
al. 1994) to delay activation of an adaptive immune response. 
Adaptive Immune Response 
Adaptive immune response generates an antigen-specific immune response. It includes 
humoral and cellular immunity. Humoral immunity is also called antibody-mediated immunity. 
The major difference between humoral and cellular immunity is that humoral immunity produces 
antigen-specific antibodies by plasma B cells whereas cellular immunity does not. Instead, in 
cellular immunity, the infected cells are destroyed by cytotoxic T cells through stimulating 
apoptosis. Both of them can generate memory cells to lead to faster and efficient response to 
recurrent infections. Both humoral immunity and cellular immunity play a role in host defense to 
PRRSV.  
Humoral immune response 
A rapid and robust antibody response is mounted following PRRSV infection but, 
predominantly, PRRSV antibodies have little neutralizing capacity and the antibody response 
declines after about 3 months (Meier et al. 2003). Besides virus neutralization, protective 
antibodies may have an effect on complement-dependent antibody-mediated cell lysis, or 
antibody-dependent cell-mediated cytotoxicity (Whitton 1996). In the early stage of PRRSV 
infection, increased production of IL-4 can suppress or delay B cell proliferation and antibody 
reproduction in pigs (Murtaugh et al. 2009; Zhou et al. 1994). Based on 8 pigs, PRRSV 
antibodies were first detected in serum samples by ELISA at 9 to 13 days after PRRSV infection 
and the peak of PRRSV antibody titers occurred at 28 to 42 days post infection (dpi) (Yoon et al. 
2011). Using indirect immunofluorescence, specific IgM antibody titers appeared in  MARC-145 
cells infected by sera samples collected from PRRSV-infected pigs at 7 dpi, peaked by 14 to 21 
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dpi, and then decreased rapidly to undetectable levels by 35 to 42 dpi; specific IgG antibody 
titers in MARC-145 cells infected by sera samples collected from PRRSV-infected pigs peaked 
by 21 to 28 dpi and remained level until the end of experiments at 42 to 63 dpi (Loemba et al. 
1996). Although anti-PRRSV antibodies appear early after PRRSV challenge, they did not 
neutralize PRRSV in vitro (Yoon et al. 1994) but caused antibody-dependent enhancement of 
PRRSV infection (Yoon et al. 1996). Viral neutralizing antibodies in MARC-145 cells infected 
by sera samples collected from PRRSV-infected pigs were first detected by 21 to 28 dpi 
(Loemba et al. 1996). A PRRS-MLV vaccine induced antibody response within 14 days post 
vaccination (dpv) but PRRSV-specific neutralizing antibodies did not appear until 4 weeks after 
inoculation (Foss et al. 2002). Passive transfer of PRRSV neutralizing antibodies prior to 
challenge protected pigs exposed to PRRSV by inhibiting virus replication (Yoon et al. 1996). 
Seroneutralization of PRRSV was correlated with antibody response to certain epitopes of the 
glycoprotein 5 of the PRRSV (Gonin et al. 1999). The maximum antibody titers against the 
glycoprotein 5 were achieved at about 28 dpv (Foss et al. 2002). Antibodies against the envelope 
E protein of the PRRSV were detected at 7 dpi, while antibodies against the nucleocapsid N and 
membrane M proteins appeared at 14 dpi (Loemba et al. 1996). 
In summary, during PRRSV infection or vaccination, antibody development in pigs is 
rapid and robust but the anti-PRRSV antibodies have little neutralizing capacity before about 7 
dpi (Meier et al. 2003) or within 14 dpv (Foss et al. 2002). PRRSV-specific neutralizing 
antibodies can be detected at about 28 dpi or dpv (Foss et al. 2002; Loemba et al. 1996). This 
delayed production of neutralizing antibodies may result from suppression of the innate immune 
response by the PRRSV, as discussed above, suppressing or delaying B cell proliferation 
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(Murtaugh et al. 2009; Zhou et al. 1994), or antibody-dependent enhancement of PRRSV 
infection (Yoon et al. 1996).  
Cell-mediated immune response 
The cell-mediated response to PRRSV is less well understood. Although a specific cell-
mediated immune response to PRRSV develops slowly, it may provide some degree of clinical 
protection (Bautista et al. 1997; Meier et al. 2003). T-cell mediated proliferation response to 
PRRSV was first detected at 28 dpi, reached a peak at 49 dpi, and declined after 77 dpi (Bautista 
et al. 1997). In the proliferation response, the major effector cells were CD4+ T cells (Bautista et 
al. 1997). INF-γ, produced by T cells, plays an essential role in the cell mediated immune system 
by inhibiting PRRSV replication in porcine macrophages (Bautista et al. 1999) and in MARC-
145 cells by decreasing the number of infected cells, the amount of viral RNA progeny released 
into the culture medium, and PRRSV RNA content in individual MARC-145 cells (Rowland et 
al. 2001).  
The percentage of IFN-γ positive cells in PRRSV-infected lungs increased significantly 
from 7 to 28 dpi when pigs were infected with a high virulent PRRSV isolate but not when they 
were infected with a less virulent isolate (Thanawongnuwech et al. 2003). The high virulent 
PRRSV isolate also induced more severe lung lesions than a low virulent isolate 
(Thanawongnuwech et al. 2003). A PRRS-MLV vaccine suppressed cell-mediated immune 
response by delaying the development of IFN-γ production at 14 dpv (Meier et al. 2003). IL-12 
can enhance the production of IFN-γ, promote Th1 cell differentiation, and stimulate NK cells 
and T cells (Wolf et al. 1994). Expression of IL-12 protein in serum samples increased and 
reached a peak at 10 days following PRRSV infection (Gómez-Laguna et al. 2009).  
Furthermore, PRRSV can evade the cell-mediated immune response by stimulation of 
immunosuppressive cytokines, IL-10, and TGF-β by inhibiting cell recruitment and cytokine 
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production by innate immune cells (Renukaradhya et al. 2010; Wongyanin et al. 2012). IFN-γ 
can suppress IL-10 production by increasing GSK3 activity and suppressing MARK activation, 
which can induce suppression of CREB and AP-1 activity that induce IL-10 expression (Hu et al. 
2006). 
T cells play crucial roles in the anti-PRRSV adaptive immune responses, including 
cytolytic activity, antigen presentation, B cells activation, and regulation of inflammation. In 
pigs, T cells can be classified into a number of subpopulations, mainly based on cluster of 
differentiation (CD) marker phenotyping for CD3, CD4, and CD8 (Gerner et al. 2009). The three 
main subpopulations of T cells are T cytotoxic cells (CD3+CD4-CD8+), T-helper cells 
(CD3+CD4+CD8-), and memory T cells (CD3+CD4+CD8+). The percentage of CD4+ cells in 
the mononuclear cell fraction of peripheral blood decreased until 3 days after PRRSV infection 
of 4.5 months old pigs, then increased, and peaked at 7 dpi, and was lower than in the control 
group without infection from 0 to 35 dpi (Nielsen et al. 1997). The percentage of CD8+ cells in 
the mononuclear cell fraction of peripheral blood in 4.5 months old pigs decreased from 0 to 3 
dpi, then increased, and was higher than in the control group until 15 dpi (Nielsen et al. 1997). 
This is consistent with the increasing percentage of CD4-CD8+ cells, including cytotoxic T-cells 
and NK cells, and no increase in the percentage of CD4+CD8-, CD4+CD8+, and other myeloid 
cells in the lungs of PRRSV-infected pigs (Samsom et al. 2000). However, the frequency of 
CD4+CD8+ T cells and myeloid cells in PBMC increased in pigs co-infected with PRRSV and 
PRCV (Renukaradhya et al. 2010). CD8+ and CD4+CD8+ cells were also increased in lymphoid 
tissues following infection with the European PRRSV field isolate 2982 (Gómez-Laguna et al. 
2009). PRRSV can stimulate Foxp3+ T-regulatory cells (Tregs) to evade cell-mediated immune 
response (Wongyanin et al. 2012). 
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In summary, PRRSV coordinates immunosuppressive functions by mediating IL-10, 
TGF- β, and Tregs to inhibit immune cell recruitment and cytokine production, resulting in 
evasion of cell-mediated immune response (Renukaradhya et al. 2010; Wongyanin et al. 2012). 
INF-γ plays an essential role in the cell mediated immune system to inhibit PRRSV replication 
(Bautista et al. 1999; Rowland et al. 2001). IL-12 can enhance the production of IFN-γ (Wolf et 
al. 1994) and IFN-γ can suppress IL-10 production (Hu et al. 2006). 
Genetic Basis of Host Immune Response to PRRSV and Co-infection with PCV2 
Although biosecurity, depopulation, and vaccination are partial effective to prevent 
outbreaks and transmission of PRRSV and to reduce the duration of clinical signs, the variability 
and complexity of the PRRSV make it difficult to fight the impact of PRRS on the pig industry. 
Improvement of host genetics can be a complementary strategy for prevention of PRRSV 
infection and PRRSV clearance.  In 2007, aiming to investigate the genetic basis of host 
response to PRRSV infection in nursery pigs, the PRRS Host Genetics Consortium (PHGC) was 
established (Lunney et al. 2011). Results of the PHGC experimental PPRSV infection trials 
showed that host response to PRRSV is moderately heritable but highly polygenic (Waide et al. 
2017). In spite of this, genotype at the SNP rs80800372 (WUR) on Sus scrofa chromosome 4 
was found to be significantly associated with PRRS viral load (VL), which is quantified as area 
under the curve of log-transformed serum viremia using a semi-quantitative PCR assay from 0-
21 dpi, and weight gain (WG) from 0-42 dpi, as a measure of resilience after PRRSV challenge 
(Boddicker et al. 2012). Koltes et al. (2015) identified a putative causative quantitative trait 
nucleotide, rs340943904, in an intron of guanylate binding protein 5 (GBP5), for which the G 
allele introduces a splice acceptor site in intron 9 that inserts five nucleotides into the transcript, 
resulting in shifted reading frame and an early stop codon. The rs340943904 G allele was found 
to be in complete linkage disequilibrium (LD) with the unfavorable associated “A” allele at 
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WUR (Koltes et al. 2015). Pigs with the AB genotype at the WUR SNP had higher levels of the 
wild-type transcript of GBP5 than AA pigs, and the +5 bp insert transcript was expressed more 
in AA pigs than in AB pigs (Koltes et al. 2015). The association of the WUR SNP on PRRSV 
resistance and resilience after PRRSV exposure was confirmed for two genetically distinct North 
American PRRSV isolates, KS-2006-72109 (KS06) and NVSL-97-7895 (NVSL) (Boddicker et 
al., 2014b; Hess et al., 2016), for PRRSV and PCV2b co-infection and PRRS-MLV vaccination 
(Boddicker et al. 2014; Dunkelberger et al. 2017; Hess et al. 2016), and for an attenuated 
European PRRSV strain (only associated with growth rate) (Abella et al. 2016). The favorable 
and dominant “B” allele was at a low allele frequency (2 to 40%) in all breeds and lines used in 
the PHGC trials (Boddicker et al. 2014).  
GBP5 directly regulates NLRP3 inflammasome assembly (Shenoy et al. 2012). Schroyen 
et al. (2015) hypothesized that pigs with the AB genotype at WUR can inhibit PRRSV entry and 
replication more quickly than pigs with the AA genotype using the PI3K-Akt pathway. Krapp et 
al. (2016) showed that GBP5 is an inhibitor of HIV-1 infectivity inducted by interferon, and the 
mutation in the GBP5 gene, which can truncate the GBP5 transcript, results in loss of GBP5 anti-
HIV activity. HIV is also a single-stranded RNA virus, like PRRSV, so that the effect GBP5 on 
HIV infection may explain why AA pigs have higher PRRSV viral load. 
The PRRSV isolates, NVSL-97-7895 (NVSL) and KS-2006-72109 (KS06), are distinct 
from each other based on their nucleotide sequence of ORF5 (encodes the glycoprotein 5 
structural protein), which is 89% identical at both the glycoprotein 5 nucleotide and amino acid 
sequence levels (Ladinig et al. 2015). The NVSL isolate is more virulent and less persistent in 
serum than the KS06 isolate, and AB pigs had significantly lower serum VL than AA pigs for 
both isolates (Hess et al. 2016). When infected with the NVSL virus, AB pigs grew significantly 
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faster than AA pigs, and the same directional trend, but not significant, was found for WUR in 
KS06-infected pigs (Hess et al. 2016). For these two PRRSV isolates, the estimated heritability 
was moderately high for VL (KS06: 0.51 ± 0.09; NVSL: 0.31± 0.06) and WG (KS06: 0.31 ± 
0.09; NVSL: 0.33 ± 0.06), suggesting that 30 to 50% of the phenotypic variation in host response 
of nursery pigs to experimental infection with PRRSV results from the differences in host 
genetics (Hess et al. 2016). Estimates of the genetic and phenotypic correlations between VL and 
WG were negative for KS06 (-0.52 ± 0.17) and NVSL (-0.74 ± 0.10), indicating that genes 
improving PRRSV resistance in pigs also tend to increase growth rate after PRRSV challenge 
(Hess et al. 2016). The estimate of the genetic correlation between host response to KS06 and 
NVSL was 0.86 ± 0.19 for VL and 0.86 ± 0.27 for WG, which suggests that the genetic control 
of host response to experimental infection with PRRSV is very similar between PRRSV isolates 
(Hess et al. 2016). 
In the PRRSV and PCV2b co-infection trials, Dunkelberger et al. (2017) estimated 
heritability for PRRS VL, PCV2b VL, and average daily gain (ADG) to be 0.29, 0.09, and 0.04, 
respectively. After PRRS-MLV vaccination, AB (AB genotype at WUR) pigs had lower vaccine 
VL and grew significantly faster than AA (AA genotype at WUR) pigs, which is consistent with 
results from vaccination with a European modified live PRRSV strain (Abella et al. 2016). After 
PRRSV/PCV2b co-infection, AB pigs had significantly lower PRRSV VL than AA pigs, but 
growth rate was not significantly different between AA and AB pigs (Dunkelberger et al. 2017). 
In addition, a significant interaction between WUR genotype and PCV2b VL was identified: 
when previously vaccinated with a PRRS-MLV, AB pigs had significantly lower PCV2b VL 
following co-infection with PRRS and PCV2b than AA pigs, but this did not hold for non-
vaccinated pigs (Dunkelberger et al. 2017).  
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In summary, GBP5 is associated with host response to PRRS, especially innate immune 
response (Koltes et al. 2015; Krapp et al. 2016; Shenoy et al. 2012). Beyond GBP5, genetic 
differences in host response were high polygenic (Dunkelberger et al. 2017; Waide et al. 2017). 
These previous results demonstrate that marker-assisted selection based on the genotype of WUR 
SNP can be a good strategy to improve host response to PRRSV-only infection and co-infection 
with PRRSV/ PCV2b. 
Transcriptome Responses to PRRSV Infection 
Peripheral blood is easy to be collected at multiple time points in the same animal and it 
connects to all organs and tissues in the body of an animal. Thus, the blood transcriptome can 
reflect the physiological and pathological status of the animal. 
Schroyen et al. (2015) selected 100 pigs with high versus low PRRS VL in serum and 
WG after PRRSV infection from three PHGC trials with the NVSL PRRSV to conduct a whole 
blood microarray experiment on samples collected at 0, 4, and 7 dpi. Limited DEGs were 
identified in single gene analyses (Schroyen et al. 2015).  However, using Weighted Gene Co-
expression Network Analysis (WGCNA), the expression patterns of several gene clusters (4 dpi 
versus 0 dpi) were associate with WUR genotype, PRRS VL and/or WG (Schroyen et al. 2015). 
For one of these gene clusters, consisting of 506 genes, the average expression was negatively 
correlated with WG after PRRSV infection and included several immune-related genes involved 
in innate immune response, complement activation, and Toll-like receptor signaling pathway, 
such as pathogen-recognition receptors, interferon stimulated genes, cytokines, chemokines, 
genes regulating complement activation, and apoptotic genes (Schroyen et al. 2015). Some of 
these genes were specifically expressed in CD14+ monocytes and CD33+ myeloid cells 
(Schroyen et al. 2015). This was consistent with the finding of Gucht et al. (2005) that increasing 
expression of CD14 gene following PRRSV infection in pigs was caused increases in the number 
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of CD14+ monocytes in lungs, which can differentiate to macrophages during the acute stage of 
PRRSV infection. This finding also indicates that changes in gene expression following PRRSV 
infection can result from changes in the numbers of different types of immune cells in lungs.  
Because the porcine alveolar macrophages (PAM) are the main cells that PRRSV can 
infect, Zeng et al. (2018) compared the transcriptome of PAMs that were infected with the 
Chinese highly pathogenic PRRSV (HP-PRRSV) JXwn06, with that of non-infected PAMs, and 
found that DEGs involved in proinflammatory cytokines and chemokines, antigen presentation 
and processing, phagocytosis, and IFN-related signaling pathways were down-regulated in the 
PRRSV-infected PAMs (Zeng et al. 2018). This indicates that the PRRSV JXwn06 can inhibit 
innate immune response in PAMs after PRRSV infection (Zeng et al. 2018). Miller et al. (2012) 
evaluated the transcriptome in tracheobronchial lymph nodes (TBLN) of JXwn06 infected pigs 
and showed that pro-inflammatory genes were up-regulated at 13 dpi for a protective immune 
response compared to sham-infected pigs. Pigs infected with JXwn06 also had more severe 
interstitial pneumonia than pigs infected with the North American prototype isolate VR-2332 
(Miller et al. 2012). Liang et al. (2016) showed that a Chinese indigenous breed, Tongcheng 
pigs, had stronger PRRSV resistance than Large White pigs, including less severe symptoms, 
lower viral load, and lower IL-10 levels in serum, but higher IFN-γ generally from 1 to 7 dpi 
(Liang et al. 2016). In PAMs of 5-week-old Tongcheng boars 5 or 7 days after infection with 
HP-PRRSV (PRRSV-WUH3), Zhou et al. (2011) found that IFN-induced genes were up-
regulated and the intracellular zinc ion concentration was higher compared to the PAMs from 
uninfected pigs, which may be part of the antiviral response in Tongcheng pigs. Genes involved 
in intracellular calcium and zinc homeostasis, protein degradation and folding, and cytoskeleton 
and exocytosis organization play important roles in PAMs during HP-PRRSV infection (Zhou et 
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al. 2011). By PAMs RNA-seq from PRRSV infected and control pigs of the Tongcheng and 
Large White breeds at 7 dpi, Liang et al. (2017) found that Tongcheng pigs may activate 
leukocyte extravasation and suppress apoptosis of infected macrophages to reduce lung lesions 
compared to Large White pigs. Islam et al. (2017) investigate the PBMC transcriptome profiles 
after PRRS vaccination in Pietrain pigs to evaluate immune response. Their gene ontology terms 
results from the PBMC transcriptome showed that, during the innate immunity early response 
phase, PRRS vaccination induced genes involved in the viral life cycle, inflammatory response, 
cytokine activity, and regulation of lymphocyte activation, while during the later adaptive 
immunity phase, PRRS vaccination induced genes involved in immunoglobulin production, 
cytolysis, and T cell mediated cytotoxicity (Islam et al. 2017). Furthermore, significant 
transcriptome pathways analyses by Islam et al. (2017) showed that PRRS vaccination induced 
genes that were enriched for the IFN-γ pathway, the B cell receptor signaling, viral mRNA 
translation, interleukin signaling, and AP-1 transcription factor network pathways, and cytokine-
cytokine receptor interaction. Further, based on network analyses, UBB, LCK, RSP17, ATP5B, 
and STAT3 were predicted to regulate the innate immune transcriptional network, while SP1, 
IL7R, TGFB1, GZMB, and RAD21 were predicted to regulate the transcriptional response of the 
adaptive immune to PRRS vaccination in PBMC (Islam et al. 2017). 
Tonsils can enhance an efficient immune response through the movement of cytokines, 
chemokines, and lymphocytes from tonsils to other lymphoid tissues (Horter et al. 2011). 
However, adaptations of some pathogens allow them to avoid the tonsil immune defenses and for 
tonsils become a site of entry, replication, and colonization of these pathogens (Horter et al. 
2011). PRRSV can persist in lymphoid tissues, including tonsils and lymph nodes for 251 days 
in asymptomatic carrier pigs (Allende et al. 2000; Wills et al. 1997). Guo et al. (2018) found that 
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PRRSV persisted in the germinal center of lymph nodes as double-stranded RNA (dsRNA), 
which did not stimulate antiviral immunity based on RNA array analysis of antiviral cytokines. 
Persistent infection of regional lymph nodes of a subset of pigs can lead to a second outbreak, 
hindering the successful control of viral infection because PRRSV can be transmitted from 
persistent carriers to naïve pigs through oral-nasal secretions and semen (Christopher-Hennings 
et al. 2008). Lunney et al. (2010) suggested that a combination of cytokine activities in blood 
should be considered to understand the anti-viral immune response during PRRS persistence 
because only one cytokine was found to have small effects on virus replication at the persistent 
stage. Asymptomatic persistent carrier pigs are difficult to identify by current diagnostic assay 
through viral antigens (Lunney et al. 2016). Therefore, we need to know more about the genes 
associated with host immune response to PRRSV persistence in tonsils and how these genes 
interact with each other in a pathway or a network. As far as we know, the mechanism of 
PRRSV persistence in pigs based on tonsil transcriptome analysis has not been investigated.  
The Effect of PRRSV Infection on Cell Composition in Blood and Tonsil 
Peripheral blood is composed of a variety of cells, including anucleated red blood cells 
(96%) and platelets (3%), and nucleated white blood cells (WBC, 1%), representing 
approximately 20 to 40% of total blood volume (Mohr et al. 2007). Blood cells play roles in 
transporting immune cells and in mediating immune response and coagulation. WBCs consist of 
granulocytes (neutrophils, eosinophiles, and basophils), monocytes, and lymphocytes (B cells, T 
cells, and natural killer cells). Shi et al. (2008) showed that both PRRSV- or PCV2-only 
infection, or co-infection with PRRSV and PCV2 led to changes in blood immune cells 
composition of piglets from 0 to 49 dpi. At 3 and 7 dpi, the total and differential peripheral blood 
leukocyte counts decreased dramatically in the co-infection group compared to the single 
infection group and the control group without infection (Shi et al. 2008). For PRRSV only 
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infection, the total WBC was significantly lower at 7 dpi but higher at 10, 14, and 28 dpi 
compared to the control group (Shi et al. 2008). With PCV2 only infection, the WBC counts 
were significantly lower than for the control animals at 10 and 14 dpi (Shi et al. 2008). In 
addition, the transcriptome profiles of PBMC in Pietrain pigs showed that the cellular sub-
population of PBMC may have functions in host immune response to PRRS vaccination (Islam 
et al. 2017). Changes in the number of lymphocytes, erythrocytes, and platelets were higher in 
Large White pigs than in Tongcheng pigs following infection with PRRSV RPMI-1640 strain 
(Liang et al. 2016). Therefore, it is important to consider changes and differences in cell 
composition in blood across multiple time points and between groups of pigs with different 
treatments during PRRSV infection. 
Kawashima et al. (1999) observed that the number of both CD4+ T cells and CD8+ T 
cells decreased, and the number of B cells increased in tonsils from 0 to 10 dpi after PRRSV 
infection of pigs at 53 to 55 days age compared to the number before infection. This finding 
indicates that the amounts of immune cells in tonsils have roles on developing innate and 
adaptive immune response. Tonsil tissue is composed of crypts, lymphoepithelium, lymphoid 
follicles, parafollicular regions, connective tissues, and multiple types of immune cells including 
lymphoid cells (T cells and B cells), dendritic cells and macrophages (Horter et al. 2003). 
Therefore, it is also important to consider cell composition differences in tonsils among pigs 
during PRRSV infection. 
Overall, investigation of host gene expression response to PRRSV infection can help us 
to more deeply understand the mechanism on PRRSV resistance and persistence in order to 
create new strategies to combat PRRS. Because many tissues, including blood and lymphoid 
tissues, consist of multiple cell types and PRRSV infection can induce changes in the numbers 
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and composition of cells, especially immune cells, it is essential to consider cell composition in 
the tissues when studying the transcriptome. 
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Abstract 
Background: Porcine reproductive and respiratory syndrome (PRRS) is a threat to pig 
production worldwide. The objective of this study was to obtain a better understanding of the 
mechanisms of persistence of this virus in tonsil, which could improve measures of PRRS 
prevention and control. About 200 pigs in each of two trials were infected with one of two PRRS 
virus (PRRSV) isolates, NVSL (trial 1) or KS06 (trial 2). The transcriptome data from tonsil 
samples collected at 42 days post infection (dpi) were generated by RNA-seq on 51 pigs that 
were selected to contrast the two isolates, high and low tonsil viral level at 42 dpi (TVclass), and 
two genotypes at a genetic marker (WUR: AB and AA) for the GBP5 candidate resistance gene. 
Pigs with the AA genotype putatively produce a non-functional GBP5 protein. On these same 
samples, the expression of 230 immune genes was also quantified using NanoString technology. 
The expression data were analyzed by linear models that did or did not account for cell 
enrichments (CE) in the samples, as predicted from the RNA-seq data by the xCell software. 
Results: KS06-infected pigs, high tonsil virus level (High-TVclass) pigs, and AA WUR 
genotype pigs were predicted to have enrichment of B cells, T cells, and dendritic cells in tonsils 
when compared to NVSL-infected pigs, low tonsil virus level (Low-TVclass) pigs, and AB pigs, 
respectively, suggesting important immune cell dynamics at 42 dpi in tonsils. The number of 
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differentially expressed genes (DEGs) differed markedly between the models with and without 
accounting for CE, especially for the interaction of WUR with Isolate and TVclass. This 
indicates that differences in CE in tissues that consist of multiple cell types, such as tonsil, can 
have a large impact on observed differences in gene expression. Based on both the NanoString 
and RNA-seq data, KS06-infected pigs showed greater activation, or less inhibition, of immune 
responses in tonsils at 42 dpi than NVSL infected pigs, with and without accounting for CE. This 
suggests that NVSL may be better than KS06 at evading host immune response and persist in 
tonsils by weakening, or preventing, host immune responses. High-TVclass pigs at 42 dpi 
showed larger enrichment scores of immune cells in tonsils than Low-TVclass pigs, potentially 
to trigger stronger immune responses. For the effect of TVclass, the presence of more virus in 
tonsils at 42 dpi was associated with a stronger immune response, especially innate immune 
response through interferon signaling, but these differences were not significant when accounting 
for CE. This is consistent with High-TVclass pigs having larger enrichment scores of immune 
cells in tonsil at 42 dpi. High-TVclass pigs with the favorable AB WUR genotype induced a 
stronger tonsil inflammatory response and a stronger cell-mediated immune response than KS06-
infected pigs or the more susceptible AA pigs. Results obtained from NanoString and RNA-seq 
were generally consistent when based on fold change and biological function terms of the 
overlapping DEGs. 
Conclusions: Results of this study provide insights into the effects of PRRSV isolate on 
host immune response and into the potential mechanisms of PRRSV persistence in tonsils. The 
WUR genotype was associated with different effects on immune response in tonsils of pigs 
during the persistence stage, dependent on viral isolate and tonsil viral level. It is important to 
consider tissue CE differences to better understand host immune response based on the 
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transcriptome tissues that consist of multiple cell types. Our results highlight the complexity of 
pig responses to PRRSV challenge and persistence. The data suggest mechanisms that could be 
targeted to improve strategies to reduce the risk of a second viral break resulting from PRRSV 
persistence. 
Keywords: PRRSV, Persistence, Tonsils, Pig, Isolate, WUR, RNA-seq, Cell compositions 
Background 
Porcine respiratory and reproductive syndrome (PRRS) is the most economically 
significant disease in modern pig production worldwide and has been estimated to cost $664 
million annually in combined production losses in breeding- and growing-pig herds in the United 
States [1] and about $793,000 per average European farm that was severely affected in breeding, 
nursery and fattening stages [2]. The PRRS disease is caused by the PRRS virus (PRRSV), 
which is a positive single-strand, enveloped RNA virus belonging to the order Nidovirales, 
family Arteriviridae [3]. PRRSV can modulate host immune response by inhibiting natural killer 
cell cytotoxic activity [4] and IFNα production [5] but stimulates the negative regulator 
interleukin-4 (IL-4) [6], which can result in a weak and slow immune response and poor control 
of virus replication. The weak antiviral immune response can lead to a persistent infection in a 
subset of pigs, which can cause a second outbreak because PRRSV can be transmitted to naïve 
pigs through oral-nasal secretions and semen [7]. The PRRSV can persist in lymphoid tissues, 
including tonsils and lymph nodes, for 251 days in asymptomatic carrier pigs [8, 9]. In addition, 
clinical signs of PRRS vary largely between individual pigs and between PRRS strains, which is 
largely due to the genetic diversity within the structural and non-structural proteins of the virus 
and may result from mutations during viral replication in the host, all of which contributes to the 
difficulty in controlling this disease with vaccines [10]. Thus, more knowledge is needed about 
the mechanism of host resistance and viral persistence during PRRSV infection in pigs.  
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The PRRS Host Genetics Consortium (PHGC) was established in 2007, aiming to 
investigate the genetic basis of host response to PRRSV infection in nursery pigs [11]. Results 
showed that host response to PRRSV is moderately heritable but highly polygenic [12], beyond 
the effects of a putative causative intronic SNP, rs340943904, in the guanylate binding protein 5 
(GBP5), which introduces a splice acceptor site with five extra nucleotides into the mRNA 
transcript, resulting in an early stop codon [13]. This SNP was found to be in complete linkage 
disequilibrium (LD) with SNP rs80800372 (WUR) on Sus scrofa chromosome 4 [13], which was 
found to be highly associated with PRRS resistance and growth rate under PRRSV infection 
[14]. The effect of the WUR SNP on viral load (VL) and weight gain (WG) after PRRSV 
infection was confirmed for two genetically distinct North American PRRSV isolates, NVSL-97-
7895 (NVSL) and KS-2006-72109 (KS06), for vaccination with a PRRS modified live vaccine 
(MLV), for PRRS-PCV2b co-infections [14–16], and for infection with an attenuated European 
PRRSV strain (only growth rate) [17]. Assembly of the NLRP3 (nucleotide-binding domain, 
leucine-rich-containing family, pyrin domain-containing-3) inflammasome can be regulated by 
GBP5 [18]. Based on analysis of the blood transcriptome following PRRSV infection, Schroyen 
et al. (2015) hypothesized that pigs with the AA genotype at WUR may be more susceptible to 
PRRSV entry and replication than pigs with the AB genotype through regulating the PI3K-Akt 
pathway. Results from the same PHGC trials as used in the present study have shown that the 
NVSL strain is more virulent and less persistent in serum than the KS06 strain, and that pigs with 
the AB or BB genotype at the WUR SNP have significantly lower serum viremia than AA pigs 
following infection with either PRRSV isolate [16]. Overall, the effect of WUR genotype on 
PRRSV persistence differed depending on virulence of the PRRSV isolate [16]. Moreover, anti-
viral immune responses of pigs varied substantially depending on PRRSV isolate [19, 20]. 
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Therefore, it is important to understand the mechanisms of host response following infection 
with different PRRSV isolates.  
Previous studies have investigated the genetic basis of host response during the acute 
stage of PRRSV infection, but little is known about the genetic basis of PRRSV persistence. Guo 
et al. (2018) found that a higher level of double-stranded RNA (dsRNA) of the PRRSV in the 
germinal center of lymph nodes, a mediator for viral persistence, did not stimulate antiviral 
immunity. In addition, using five PHGC trials, including the two trials used here, Hess et al. [22] 
found that low tonsil viral level at 42 days post infection (dpi) was phenotypically associated 
with an earlier and faster rate of maximal viral clearance from blood, with lower viral load in 
serum from 0 to 42 dpi, and with lower serum viremia at 42 dpi. Abella et al. [17] found that pigs 
that were non-viremic between 4 and 42 days post vaccination did not become a reservoir for an 
attenuated European PRRSV strain in tonsils. Furthermore, Lunney et al. [23] showed that 
variation in levels of three serum cytokines (IL-8, IL-1β, and IFN-γ) were significantly 
correlated with serum virus levels from 1 to 21 dpi, accounting for 84% of the variation in virus 
levels of lymphoid tissues, which was defined by presence of virus in inguinal lymph nodes, 
submaxillary lymph nodes, and/or tonsils served as a predictor of PRRS persistence. This study 
also suggested that, in order to understand the role of immune system in PRRSV persistence, a 
combination of serum cytokine activities should be considered because one cytokine can only 
account for a minor amount of variation in viral titer at the persistent stage. Therefore, we need 
to know more about the genes associated with host response to PRRSV persistence in lymphoid 
tissues, especially in tonsils, and how these genes work together in a network.  
Different immune cell types in tonsils may have individual roles in developing innate, 
cellular, and humoral immunity. For example, tonsils contained a higher percentage of B cells 
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than blood and other lymphoid tissues [24], and the percentages of antiviral antibody secreting B 
cells in tonsils increased significantly from 3 to 60 dpi after PRRSV infection [25]. Kawashima 
et al. [26] also observed differences in the numbers of CD4+, CD8+ and B cells in tonsils from 0 
to 10 dpi after PRRSV inoculation of 53-55 day-old pigs. Generally, the number of B cells 
increased and the numbers of CD4+ T cells and CD8+ T cells decreased in tonsils after PRRSV 
infection until 10 dpi compared to those before infection [26]. Therefore, it is important to 
consider cell composition in tonsils during PRRSV infection. In this study, we compared host 
tonsil transcriptome responses to infection with two genetically distinct North American PRRSV 
isolates and between pigs with high and low tonsil viral levels at 42 dpi using RNA-seq and 
NanoString methods with and without conditioning on cell enrichments (CE) in tonsils. 
Results 
Viral Levels in Blood and Tonsils and Sample Selection 
Across all pigs in the two PHGC trials used here, the NVSL-infected pigs (trial 1) had 
higher viral load in serum from 0 to 42 dpi (VLTotal) than KS06-infected pigs (trial 2) (Figure 
3.1A) but this difference was not significant. The correlation of tonsil viral level at 42 dpi 
(adjusted for the use of different kits for semi-quantitative TaqMan PCR assay for PRRSV RNA 
in NVSL and KS06 trials) [22] with VLTotal was 0.14 (Figure 3.1A). Although 168 of the 337 
pigs in total (80.9% of the 180 NVSL-infected pigs and 22.8% of the 157 KS06-infected pigs) 
had no detectable viremia levels at 42 dpi, PRRSV RNA could still be detected in tonsils at 42 
dpi for all pigs (Figure 3.1B). The NVSL-infected pigs in PHGC5 (n=180) had significantly 
(p=0.02) higher tonsil viral level at 42 dpi than the KS06-infected pigs in PHGC14 (n=157) 
(3.65±0.06 versus 3.43±0.07 log10(Viral Copies/mg)). However, the NVSL-infected pigs had 
significantly (p=0.01) lower virus levels in serum at 42 dpi (V42dpi) than the KS06-infected pigs 
(1.40±0.09 versus 0.95±0.08 log10(Viral Copies/μL)). Figure 3.1 also identifies the 51 tonsil 
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samples that were selected for RNA-seq and NanoString analyses based on high and low tonsil 
viral level and RIN score. 
Tonsil Transcriptome Alignment and Mapping 
To summarize the alignment and mapping results for the RNA-seq data, after excluding 
two samples with small library size (179,735 and 456,204 reads), more than 1.5 billion 
(1,573,259,257) 100-base paired-end reads were produced in total for the 51 tonsil RNA 
samples. The number of reads per sample ranged from 967,422 to 71,136,944, and the average 
was 30,848,221, comprising on average 3.5 gigabases of sequence data per sample. On average, 
97.5% of reads were mapped to build 11.1 of the pig reference genome, of which 36.7% were 
unique mapping reads and 60.9% were multiple mapping reads. Based on the unique mapping 
reads, 24,432 genes had an average read count larger than zero across all samples, accounting for 
about 63.7% of all 38,371 annotated genes, including 25,880 Ensembl genes and 12,491 “novel 
genes”, referring to genes that were first identified using single-molecule long-read isoform 
sequencing (Iso-Seq) data by Beiki et al. [54]. Genes with average read counts less than 8 were 
removed from the analysis. The remaining genes were required to have larger than zero mapped 
reads in at least four samples. In total, 19,107 genes were determined to be expressed in tonsil, of 
which 12,243 were annotated in Ensembl (47.3% of the 25,880 genes in Ensembl) and 6,863 
were novel genes from Iso-Seq (54.9% of the 12,491 novel genes from Iso-Seq), including the 
GBP5 gene.  
Factors Affecting Cell Enrichments in Tonsils 
The tonsil RNA-seq transcriptome data was analyzed using the xCell software to identify 
cell type enrichments and to produce an aggregated immune score (the sum of scores of B cells, 
CD4+ T cells, CD8+ T cells, DC, eosinophils, macrophages, monocytes, mast cells, neutrophils, 
and NK cells, and the sum of the scores is divided by 1.5) [27]. Based on least squared means of 
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xCell immune scores, the High-TVclass pigs had significantly larger enrichment immune scores 
of the immune cells per unit of library size of the tonsil RNA-seq than the Low-TVclass pigs 
(p=0.034) (Table 3.1). In addition, tonsils from KS06-infected pigs and from AB genotype pigs 
numerically had larger enrichment scores of immune cells than tonsils from NVSL-infected and 
AA genotype pigs, respectively, but these differences were not significant (p=0.27 and 0.46, 
respectively). For lymphoid and myeloid cells and their subsets, tonsils from KS06-infected pigs, 
from High-TVclass pigs, and from AA genotype pigs contained significantly (p<0.1) larger 
enrichment scores of specific immune cells (except plasmacytoid dendritic cells and naïve B-
cells) than tonsils from NVSL-infected pigs, from High-TVclass pigs, and from AB genotype 
pigs, respectively (Table 3.1). 
After analyzing the 64 cell types in xCell for the effects of Isolate, TVclass, WUR, age, 
sex, and two-way interactions among Isolate, TVclass and WUR, 28 cell types were found to 
have significant effects (p<0.05) for at least one of these factors and were put in the significant 
(Sig) group of cell types, while the remaining 34 cell types were allocated to the nuisance (Nui) 
group.  In the Sig group, 14 of 28 cell types were immune cells, while in the Nui group, 20 of 34 
cell types were immune cells. Based on the CE in the tonsil samples predicted by xCell, the 
enrichment of 4 and 12 cell types were significant different between the two isolates and 
between high and low TVclass, respectively (Table 3.1). The PCA plots of the CE estimates 
across the 51 samples, which did not differentiate samples well by Isolate and TVclass, suggest 
that Isolate and TVclass did not account for large amounts of the variation in the 28 cell types in 
the Sig group (Figure 3.S1). The first three principal components of the Sig group (SigPC1, 
SigPC2, and SigPC3) explained 31, 22, and 18.4% , respectively, of the variance of enrichment 
estimates for these cell types, while NuiPC1, NuiPC2, and NuiPC3 explained 55.3, 17.9, and 8%, 
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respectively, of the variance of enrichments for cell types in the Nui group. The top three cell 
types explained by each PC are shown in Table 3.S3.  
Sample Clustering Analysis and DEGs Based on RNA-seq 
Hierarchical clustering of the top 200 most variable genes across all samples did not 
show very clear clustering of samples by our factors of interest (see Figure 3.S1). There was a 
trend of clustering of some samples by Isolate (see Figure 3.S1), which was consistent with the 
number of DEGs identified in the model without accounting for CE (Table 3.2). Differences in 
cell composition had significant effects on the tonsil transcriptome at 42 dpi based on changes in 
the numbers of DEGs for Isolate, TVclass, and their interaction, when CE was included in the 
model, and identification of a large number of DEGs for the effect of the fitted PC’s for CE 
(Table 3.2 and Table 3.S3). The number of DEGs identified for Isolate was lower when CE was 
accounted for. TVclass revealed four DEGs when CE was accounted for and zero without CE. 
For the main effect of WUR, there were two DEGs in the model with CE and zero DEG without 
CE. Significant effects of the two-way interactions of WUR with Isolate and TVclass on gene 
expression were only identified when CE was accounted for. For the effect of sex, the same 24 
genes were identified to be DEGs in models without and with CE (Table 3.S3), while 
correlations of log2FC and q values of these 24 DEGs in the two models were 1.00 and 0.94, 
respectively. Thus, the effect of sex on the tonsil transcriptome did not change substantially 
when accounting for CE.  
Effect of Isolate on Tonsil Transcriptome Based on RNA-seq 
For analysis of the RNA-seq data using the model without CE, at a q-value threshold of 
0.1, 1,074 DEGs were identified between the two isolates. In total, 12,244 genes were entered 
into Ingenuity Pathway Analysis (IPA) using pig gene names as gene ID, 10,254 of which were 
matched with human gene names in IPA. In the canonical pathway analysis, 18 significant 
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pathways related to immunity (we only included pathways belonging to immune response related 
categories in IPA, including “Cellular Immune Response”, “Cytokine Signaling”, “Humoral 
Immune Response”, and “Pathogen-Influenced Signaling”) involved DEGs for Isolate from the 
model without CE (Figure 3.S3). All 18 pathways were predicted to be more activated or less 
inhibited in tonsils of KS06-infected pigs than in tonsils of NVSL-infected pigs (Figure 3.S3). 
The most significant pathway for Isolate was the “GP6 Signaling Pathway” (Figure 3.S4A), 
which included 27 Isolate DEGs from the model without CE (Isolate-NonxCell DEGs). 
When accounting for CE in analysis of the tonsil RNA-seq data, only one significant 
pathway, “GP6 Signaling”, was identified, which included 11 DEGs Isolate from the model with 
CE (Isolate-xCell DEGs) (Figure 3.S4B). These 11 Isolate-xCell DEGs were also Isolate DEGs 
in the model without CE (Isolate-NonxCell) (Figure 3.S4A). Five Isolate-xCell DEGs that were 
expressed more in tonsils of KS06-infected pigs than in tonsils of NVSL-infected pigs were 
predicted to decrease “organismal death” and “growth failure” and increase “quantity of 
connective tissue cells”, regulated by GLI1 (Figure 3.2A). Twelve Isolate-xCell DEGs that were 
expressed more in tonsils of the KS06-infected pigs were predicted to increase “cell movement”, 
regulated by RETNLB and SMARCA4 (Figure 3.2B). A novel network based on Isolate-xCell 
DEGs was predicted by IPA to be involved in “cancer”, “hematological disease”, and 
“immunological disease” (Figure 3.2C). The Isolate-xCell DEGs (colored in red in Figure 3.2C) 
in this network were more highly expressed in tonsils of pigs infected with KS06 compared to 
NVSL when accounting for CE, except for DMBT1, RHPN2, and ZFAND2A (colored in green in 
Figure 3.2C). The proteins that were predicted to interact with these DEGs were “NFκB 
(complex)”, “HISTONE”, “RNA polymerase II”, and “histone-lysine N-methyltransferase” 
(Figure 3.2C).  
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Effect of Tonsil Viral Level and WUR Genotype on Tonsil Transcriptome Based on RNA-
seq  
For WUR genotype, two DEGs (EHPA4 and TENM4, q=0.1) were identified in the RNA-
seq data using the model without CE and two different DEGs (EPHA4 and DUOX2, q=0.1) were 
identified when using the model with CE. For TVclass, no DEGs were identified in the model 
without CE but four DEGs (FOSB, TSPAN10, ENSSSCG00000027998, and a novel gene 
XLOC_016982) were identified in the model with CE. Except TSPAN10, the other three DEGs 
had lower expression in the High- than Low-TVclass pig tonsils. Although not significant, the 
GBP5 gene was more highly expressed in tonsils of pigs with the AB versus the AA WUR 
genotype in models with and without CE (q=0.45 and 0.937), as expected. The GBP1 gene was 
not significantly differentially expressed for WUR, TVclass, or Isolate, both with or without CE 
in the model.  
In total, 107 genes were significant for the interaction between Isolate and WUR in the 
model with CE (Isolate*WUR-xCell DEGs) for the RNA-seq data (Table 3.2). Of these, 74 
DEGs had significantly higher levels of expression and three had lower levels of expression for 
AB versus AA genotype pigs when infected with KS06 (Table 3.3). No DEGs were identified 
between WUR genotypes for the NVSL-infected pigs (Table 3.3). In IPA, only the 
“Neuroprotective Role of THOP1 in Alzheimer’s Disease” pathway was significant for WUR 
effect within KS06-infected pigs. This pathway included four Isolate*WUR-xCell DEGs 
(KLK10, KLK12, TMPRSS11D, and TMPRSS11E), which were all significantly expressed more 
in AB than in AA genotype pigs when infected with KS06. For the interaction between TVclass 
and WUR (TVclass*WUR) based on the RNA-seq data, five DEGs were identified (Table 3.2 
and 3). LOXL4 was significantly expressed more in pigs with the AB than the AA genotype 
among pigs with Low-TVclass (AB_Low > AA_Low). GRHL3, AHNAK, and ARHGAP32 had 
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significantly higher expression levels in pigs with the AB than the AA genotype among pigs with 
High-TVclass (AB_High > AA_High), and ENSSSCG00000027998 was significantly expressed 
less in AB_High pigs than in AA_ High pigs. 
DEGs Based on NanoString and Their Biological Functions 
For the tonsil NanoString data for the 230 immune related genes, the number of identified 
DEGs with and without considering CE estimated from the RNA-seq data of the same samples 
are shown in Table 3.4. Based on IPA, the most significant pathway for isolate in the model 
without CE was “iCOS-iCOSL Signaling in T helper cells”, which was predicted to be more 
activated, or less inhibited, in KS06-infected pigs compared to NVSL-infected pigs (Figure 
3.S5A). The Isolate_NonxCell DEGs also played roles in increasing “transcription of RNA”, 
“cell movement”, and “quantity of T lymphocytes” in tonsils of KS06-infected pigs compared to 
NVSL-infected pigs. This result is consistent with the larger enrichment scores of immune cells 
in the tonsils of KS06-infected pigs, as predicted by xCell based on the RNA-seq data. 
Expression of the GBP5 gene was significantly associated with the effect of isolate and was 
expressed more in KS06-infected pigs than in NVSL-infected pigs, both with (q= 0.00023) and 
without (q=0.0012) CE in the model. Without accounting for CE, the GBP5 gene, which is 
involved in innate immune response, was predicted to be more activated, or less inhibited, in 
KS06-infected pigs compared to NVSL-infected pigs (p=0.009 and z=1.38, Figure 3.S6). When 
accounting for CE, biological functions associated with “activating phagocytosis of bacteria”, 
“cellular infiltration by eosinophils”, and “monocytopoiesis” involved Isolate_xCell DEGs from 
NanoString and were more activated, or less inhibited, in tonsils of KS06-infected pigs (Figure 
3.3A). No pathway was, however, significant for these DEGs based on Fisher’s Exact Test p-
value <0.05 and absolute z-score >2.0.  
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For DEGs with respect to TVclass in the model without CE, significant pathways were 
“Interferon Signaling” (Figure 3.S5B) and “Retinoic acid Mediated Apoptosis Signaling”. Both 
these pathways were predicted to be more activated, or less inhibited, in the High-TVclass pigs, 
and all DEGs involved in these pathways were expressed at a higher level in the High-TVclass 
pigs comparing to the Low-TVclass pigs. In the model with CE, the pathway “UVC-Induced 
MAPK Signaling” was significant for TVclass and included four DEGs: FOS, MAPK8, PRKCQ, 
and RRAS, which were all expressed less in tonsils of High-TVclass pigs than in tonsils of Low-
TVclass pigs. In addition, IL12A/B, TNF, and IL10, which are potentially regulated by NODAL, 
RPS6KA4/5, and IL25, had effects on increasing “quantity of IFNG in blood” and activating 
more, or inhibiting less, “formation of granuloma” in High-TVclass pigs compared to Low-
TVclass pigs (Figure 3.3B). 
For WUR, we only identified DEGs in the model with CE. There was, however, no 
significant pathway in IPA for the effect of WUR genotype. Predicted activation states of 
“accumulation of myeloid cells”, “influx of blood cells”, and “chemotaxis of granulocytes” were 
higher in AB compared to AA pigs, and the predicted inhibition state of “antibody-dependent 
cell-mediated cytotoxicity” was higher in AB compared to AA pigs (Figure 3.3C). Moreover, 
when accounting for CE, expression of the GBP5 gene was significantly higher in tonsils of AB 
versus AA pigs, as expected. Although not significant (q=0.22), the same trends for GBP5 
expression were found without accounting for CE. 
In the model with CE, the interactions of Isolate and TVclass with WUR were significant 
for the tonsil gene expression or 84 and 42 genes, respectively (Table 3.4). For the WUR effect 
within KS06-infected pigs, only one significant immune response pathway, “IL-8 signaling” 
pathway, was more activated, or less inhibited, in AB than in AA pigs. In this pathway, five 
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Isolate*WUR DEGs (IKBKE, ITGAM, PIK3CG, RRAS, and VEGFB) were expressed more in 
AB than in AA pigs when infected with KS06 (AB_KS06 > AA_KS06), and one Isolate*WUR 
DEG, TLR9, was expressed less in AB_KS06 than in AA_KS06 pigs. No significant pathway 
was identified for the effect of WUR genotype when pigs were infected with NVSL. For the 
effects of WUR genotype, only one pathway, “interferon signaling” pathway, was significantly 
less activated, or more inhibited, in AB than in AA pigs from the High-TVclass. Three 
TVclass*WUR DEGs (IFNG, STAT1 and TAP1) were involved in this pathway and all of them 
were expressed less in the AB_High than in the AA_High pigs. For the WUR effect in the Low-
TVclass pigs, only one pathway, “ceramide signaling” pathway, was significant to be more 
activated, or less inhibited, in AB than in AA pigs. In this pathway, three TVclass*WUR DEGs 
(FOS, RRAS, and TNF) were expressed more in AB_Low than in AA_Low pigs, and one 
TVclass*WUR DEG, TLR9, was expressed less in AB_Low than in AA_Low pigs. The 
interaction between Isolate and WUR genotype was significant for the expression of GBP5 
(q=0.04) but the interaction of TVclass and WUR was not (q=0.19). 
Comparison between RNA-seq and NanoString 
Of the 230 genes evaluated by NanoString, 203 genes were also detected as expressed in 
the RNA-seq data. The correlation of the normalized counts obtained from RNA-seq and 
NanoString for each of the 203 genes ranged from -0.52 to 0.70, with a mean ± SE of 0.19 ± 
0.01. For the GBP5 gene, the correlation was 0.59. Among these 203 genes, twelve of the 18 
Isolate_NonxCell DEGs based on RNA-seq were also Isolate_NonxCell DEGs based on the 
NanoString data (Table 3.5). These 12 overlapping DEGs had the same trend of expression 
differences between KS06- and NVSL-infected pigs (Table 3.6). S100A8, the only 
Isolate*WUR_xCell DEG among these 203 genes based on the RNA-seq data 
46 
(log2FC(AB_KS06/AA_KS06) = 2.04, q=0.014) was also significant for Isolate*WUR_xCell 
based on the NanoString data (log2FC(AB_KS06/AA_KS06) = 2.29, q=0.00003).  
Because in the model without CE, only the effect of isolate showed more than one 
overlapping DEG between the RNA-seq and the NanoString data (Table 3.5), the comparison 
between RNA-seq and NanoString in terms of DEG biological function was only possible for 
this effect. In Figure 3.4, the top nine pathways were predicted to be significantly more activated, 
or less inhibited, in KS06-infected pigs compared to NVSL-infected pigs based on both the 
RNA-seq and the NanoString data. The other eight pathways were only significant in the 
NanoString data, which may be due to the limited number of DEGs based on the RNA-seq data 
(n=12) among the 203 genes. 
Discussion 
PRRSV Persistence in Tonsils and Blood 
Of the 337 pigs, 168 (had a non-zero tonsil viral level although they had non-detectable 
levels of serum viremia at 42 dpi (Figure 3.1B), 80.9% of the NVSL-infected pigs and 22.8% of 
the KS06-infected pigs. This indicates that absence of serum viremia does not imply clearance of 
the virus from the body since virus can persist much longer in tonsil. This is consistent with 
previous findings that viral dsRNA persisted in multiple lymphoid tissues, although no virus was 
detected in serum of PRRSV-infected pigs at 52 dpi, thereby escaping antiviral immune response 
[21]. Therefore, we expected to see prolonged effects of infection on gene expression in tonsil. 
We found that the 180 NVSL-infected pigs from PHGC trial 5 had significantly higher tonsil 
viral levels (p=0.02) and lower serum viremia (0.01) than the 157 KS06-infected pigs from 
PHGC trial 14, although this difference was not significant for the 53 samples selected for RNA-
seq (results not shown). However, Hess et al. [22], using data from the same two trials as used 
here, along with three additional PHGC trials from other genetic sources, found the difference of 
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tonsil viral levels between NVSL- (n=480) and KS06- (n=302) infected pigs not to be 
significant. This suggests that the effect of PRRSV isolate on tonsil viral levels at 42 dpi may 
differ between sources of genetics. For the 5 PHGC trials analyzed by Hess et al. [16], they 
found that KS06 was more persistent in serum than NVSL, as more KS06-infected pigs had 
estimated log10 serum viremia greater than 1 at 42 dpi, which is consistent with the results from 
our study. This indicates that the NVSL strain may be better at avoiding detection and persisting 
by weakening immune responses in tonsils than the KS06 strain. Similar to Hess et al. [22], 
although we identified a positive relationship between tonsil viral level and serum viremia at 42 
dpi, serum viremia was not a good predictor of tonsil viral level at 42 dpi in terms of PRRSV 
persistence.  
Effects of PRRSV Isolates, TVclass, and WUR Genotype on Cell Enrichments in Tonsils 
Tonsil tissue consists of multiple cell types, in particular immune cells, including T cells, 
B cells, macrophages, and DC, which provide, locally and systemically, innate, cellular, and 
humoral immunity [28]. The factors of interest in this study, i.e. Isolate, TVclass, and WUR 
genotype, can have effects on the number of some cell types in tonsils, resulting in differences in 
cell composition. When not accounted for, differences in cell composition could lead to 
identification of DEGs for Isolate, TVclass, or WUR genotype because cell types differ in gene 
expression. Because we did not directly measure cell composition of the tonsil samples, we used 
the xCell software [27] to estimate CE for each sample based on the tonsil transcriptome data. 
Because xCell was developed based on human sequencing data, using specific gene expression 
signatures for human cell types, xCell may not predict individual cells types well in pigs and 
further validation is needed. Nevertheless, although individual cell types may not be accurately 
predicted, we expect that the PCs we derived from the 62 predicted cell type enrichments capture 
general differences in cell composition between samples. 
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Cell types that were significantly different between factors of interest are listed in Table 1 
for the purposes of grouping cell types in Sig and Nui groups of cell types. P-values provided 
were not adjusted for multiple correction. Based on PCA conducted within the Sig and Nui 
groups, the top 6 and 5 PC’s in the Sig and Nui groups explained over 90% of the variance 
within each group. Based on this, the number of independent tests conducted was estimated to by 
6 + 5 = 11 and this was used for Bonferroni correction, resulting in an adjusted threshold for 
significance of 0.1/11=0.009. Based on the xCell results (Table 3.1), only three cell types, class-
switched memory B cells, CD8+ central memory T cells and basophils had significantly larger 
enrichment scores in the High-TVclass pigs than the Low-TVclass pigs (q<0.009). This indicates 
that pigs with high tonsil viral levels may recruit more immune cells, especially B cells, and T 
cells, to help clear the persistent virus from the tonsil. Basophils are involved in anti-parasite 
immunity and allergic responses. Basophils maybe have some unknown function to enhance 
anti-viral immunity. Even though all the other cell types in Table 3.1 were not significant, there 
was a trend towards higher CE scores for specific immune cells for KS06-infected pigs and pigs 
with the AA genotype for WUR than for NVSL-infected and AB pigs. This indicates that the 
KS06 strain may stimulate stronger immune response in tonsil at 42 dpi than the NVSL strain, 
and that AB pigs may not need to recruit as many immune cells in tonsils at 42 dpi to clear the 
virus as AA pigs. In addition to using methods developed for human data to estimate CE, another 
limitation of this study is that we first used the RNA-seq data to predict CE and then fitted PC’s 
of CE estimates in the model to identify DEGs independent of CE. This assumes that the 
expression of genes that are used as gene signatures for a specific cell type is not affected by the 
factors of interest (Isolate, TVclass and WUR genotype), since the level of expression of these 
genes is used to estimate tissue cellular heterogeneity [27]. However, because xCell uses more 
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than three gene signatures for each cell type [27], the impact of this assumption is expected to be 
limited.  
Comparison of RNA-seq and NanoString 
We evaluated gene expression using two platforms on the same set of 50 samples, RNA-
seq and NanoString. The twelve DEGs that overlapped between the NanoString and RNA-seq 
results displayed the same trend of fold change (Table 3.6). Nine of seventeen immune response 
related pathways of the Isolate-NonxCell DEGs were predicted to be more activated, or less 
inhibited, in the KS06-infected pigs compared to the NVSL-infected pigs based on both the 
NanoString and RNA-seq data (Figure 3.4), showing the consistency of these two platforms. 
However, the correlation of the normalized read counts obtained based on the NanoString and 
RNA-seq data for the 203 overlapping genes was low, ranging from -0.52 to 0.70, and averaging 
0.19. These low correlations may be the result of the relatively low RIN scores of the tonsil RNA 
samples, potentially due to RNA degradation during and after sample collection. In RNA-seq, 
sequencing reads are generated from whole transcripts and, as a result, the RIN score may have 
an effect on the quality of reads, which was confirmed by the significant effect of RIN on the 
observed read counts of genes based on the RNA-seq data. To deal with the effects of RNA 
quality in the RNA-seq analyses, we used two weights in the Voom software analyses: one 
weight accounts for heterogeneity in sample level variance, which can be due to RNA quality; 
the other weight is an observation level weight that considers the mean-variance relationship of 
read counts for each gene [29]. Unlike RNA-seq, NanoString just requires ~150 bp sequence 
from each transcript and requires no conversion of RNA to cDNA but identifies the RNA 
molecules directly, which are expected to make NanoString less sensitive to RNA quality. In 
contrast to RNA-seq, NanoString also does not encounter the issue of multiple mapping reads in 
the alignment process because a molecular barcode is designed specifically for each gene. This 
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also makes NanoString better able to detect low-abundance transcripts than RNA-seq, which 
depends on read depth to get reliable detection [30]. Therefore, we can put more confidence in 
the tonsil NanoString results than in the tonsil RNA-seq results for the 203 genes that overlapped 
in our analyses.  
Effects of PRRSV Isolate on Tonsil Gene Expression 
Analysis of results obtained from the tonsil NanoString data for the effect of isolate based 
on the model without CE by IPA identified 20 significant immune response related pathways. 
The most significant signaling pathway for the effect of isolate was “iCOS-iCOSL signaling in T 
helper cells”, which was more activated or less inhibited in the tonsils of the KS06-infected pigs 
(Figure 3.S5A). However, none of these 20 pathways were significant when accounting for CE. 
This indicates that, in the model without CE, the expression differences of immune-related genes 
that were identified between the two PRRSV isolates were due to differences in cell composition 
of tonsil between the two isolates. This is consistent with what we found for the effect of isolate 
on CE, which showed that the KS06-infected pig tonsils were predicted to have more immune 
cells, triggering stronger immune responses, than NVSL-infected pigs. Therefore, NVSL may 
inhibit or evade host immune response and persist in tonsils more effectively than KS06. This is 
consistent with findings of Guo et al. [22], who found that down-regulation of genes involved in 
B cell and T cell receptor signaling pathways, including ICOS and CD40L expression, results in 
inhibition of clearance of persistently infected cells and allows viruses to be maintained in lymph 
nodes of persistently infected pigs [21].  
Based on the RNA-seq results, the “GP6 signaling pathway” was the most significant 
pathway that involved DEGs for the PRRSV isolate effect in tonsils at 42 dpi based on both 
models, with and without accounting for CE. The DEGs for isolate that are involved in this 
pathway were expressed more in KS06- than NVSL-infected pigs, except PI3K in the model 
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without CE (Figure 3.S4). GP6, a membrane glycoprotein expressed in platelets and their 
precursor megakaryocytes, can stimulate platelet activation and thrombus formation. Platelets 
play an important role, not only in hemostasis and thrombosis, but also in immunity and 
inflammation. Many immune related receptors and ligands are present on platelets, including all 
nine Toll-like receptors (TLRs) and scavenger receptors. Platelets may sample the blood 
environment to help present the virus to other immune cells [31]. Platelet activation induces the 
acute phase response to infection and produces IL-1β in mice [32]. In addition, platelets can have 
interactions with monocytes and leukocytes via platelet P-selectin [33]. Therefore, KS06 may 
induce a stronger immune response through platelet activation than NVSL, regardless of cell 
composition. 
For the Isolate-xCell DEGs based on RNA-seq, the top novel network predicted by IPA 
was related to three disease-related functions: “cancer”, “hematological disease”, and 
“immunological disease” (Figure 3.2C). Of the 27 Isolate-xCell DEGs in this novel network, 24 
were expressed more in the tonsils of KS06- than of NVSL-infected pigs. These genes were 
predicted to interact with NF-kΒ, HISTONE, and RNA polymerase II, indicating that KS06 may 
cause a stronger immune response by promoting transcription of genes to produce important 
immune proteins, such as antibodies or cytokines. This is consistent with the IPA regulator 
prediction that the Isolate-xCell DEGs that were expressed more in the tonsils of the KS06-
infected pigs, activate cell movement and have less growth failure and organismal death (Figure 
3.2A and B). Thus, KS06 infection may induce more immune cell movement to clear the virus or 
relieve the resulting cell damage. 
In summary, at 42 dpi in tonsils, in order to clear the virus, the KS06 strain may stimulate 
more cell movement and immune cells such as B cells and T cells, more activation of the iCOS-
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iCOSL signaling pathway, including NF-kΒ activation in T helper cells through interaction with 
B cells, and more platelet activation through the “GP6 signaling pathway”. Therefore, the NVSL 
strain may have a greater ability than the KS06 strain to inhibit or evade host immune response 
and persist in tonsils.  
Effects of Tonsil Viral Level on Tonsil Gene Expression 
At 42 dpi, High-TVclass pigs may induce greater aggregation of immune cells in tonsils 
(Table 3.1) to trigger a stronger immune response than Low-TVclass pigs. When accounting for 
CE, the NanoString results identified stronger innate immune responses in High-TVclass pigs 
than in Low-TVclass pigs, with more IFNG in blood and activation of granuloma formation 
(Figure 3.3B). For the RNA-seq data when accounting for CE, the DEG for TVclass that were 
not evaluated using NanoString, also had functions to induce stronger immunity in High-TVclass 
pigs. For example, the TSPAN10 gene was significantly expressed more in High-TVclass pigs 
than in Low-TVclass pigs. The TSPAN10 gene has been implicated in Notch activation by 
promoting ADAM10, which plays an essential role as a “molecular scissor” in ligand-dependent 
cleavage of Notch protein and control of cell fate decisions [34]. Conditional knockouts of 
ADAM10 in mice revealed impaired B-, T-, and myeloid cell development and/or function [35–
37]. This indicates that High-TVclass pigs may have a stronger immune response than Low-
TVclass pigs related to B-, T-, and myeloid cell development and/or function through the Notch 
signaling pathway in tonsils. Therefore, TSPAN10 is a potential candidate gene to target for 
control of PRRSV persistence.  
The FOSB gene was not only a TVclass-xCell DEG (expressed more in Low-TVclass 
pigs when accounting for CE) but also an Isolate-xCell DEG (expressed more in NVSL-infected 
pigs) and an Isolate*WUR-xCell DEG based on the tonsil RNA-seq data. In the NanoString data, 
FOS was a TVclass DEG and was expressed more in Low-TVclass pig tonsils with or without 
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accounting for CE, but the FOSB gene was not included on the NanoString panel. Both FOS and 
FOSB are members of the FOS gene family and are activator protein-1 (AP-1) transcription 
factor subunits. FOS proteins play a role in regulating cell proliferation, differentiation, and 
transformation. A previous study showed that the FOSB gene was up-regulated in alveolar 
macrophages during the early phase of European PRRSV infection, compared to uninfected 
alveolar macrophages [38]. However, based on the RNA-seq data from this study, the FOSB 
gene was expressed more in Low-TVclass pig tonsils than in High-TVclass tonsils, when 
accounting for CE. This contradiction with our results may be due to differences between the 
North American and European serotype PRRSV, different infection stages, or the difference 
between tissues examined (tonsils versus alveolar macrophages).  
Effects of WUR allele on tonsil gene expression 
Based on the tonsil RNA-seq data, two DEGs were found for the effect of WUR 
genotype for both models (with and without CE). The EPHA4 gene was DEG for both models 
(q-value equal to 0.1 for both) and was expressed more in AB pigs than in AA pigs for both 
models. Unfortunately, EPHA4 was not included on the NanoString panel. The GBP5 gene was 
significantly expressed more in AB than AA pigs based on the NanoString data in the model 
with CE. The same directional trend, but not significant, was found for the GBP5 gene based on 
the RNA-seq data in the model with and without CE (q=0.45 and 0.94) and in the model without 
CE based on the NanoString data (q=0.22). The relatively low level of expression of the GBP5 
gene makes it difficult to detect differences. These trends are consistent with results by Koltes et 
al. [13] for expression in blood following PRRSV infection without accounting for CE. In human 
studies, Huttlin et al. [39] found that the GBP5 protein interacts with several other proteins in 
HEK293T cells, including EPHA4, GBP1, and SURF1, as well as with other genes that are 
currently not in the pig Ensembl database. We found that both the GBP5 and the EPHA4 gene 
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were both expressed more in AB than AA pigs in the model with CE. However, in our RNA-seq 
data, SURF1 was not expressed in tonsils and GBP1 was not significantly associated with WUR 
genotype in either model. The EPHA4, GBP1, and SURF1 genes were not included on the 
NanoString panel. In mouse, Rothgiesser et al. [40] found that both GBP5 and EPHA4 were NF-
κB-dependent genes. Higher expression of EPHA4 and GBP5 in AB than AA pigs is expected to 
induce a stronger immune response for AB pigs. 
Effects of Interaction Between WUR and Isolate on Tonsil Gene Expression 
The S100A8 gene is an important pro-inflammatory mediator that was significantly 
expressed more in AB pigs than in AA pigs when infected with KS06 in both the NanoString and 
the RNA-seq data when accounting for CE. Within the NVSL-infected pigs, S100A8 was not a 
DEG for WUR in either the RNA-seq or the NanoString data. In the NanoString data, the IL-8 
signaling pathway was more activated, or less inhibited, in AB pigs than in AA pigs, when 
infected with KS06. IL-8 is also known as CXCL8 and belongs to the CXC chemokine family. 
IL-8 can bind to CXCR1 and CXCR2 as cell-surface receptors and stimulate exocytosis, 
chemotaxis, and signal transduction, depending on the cell type [41]. These results indicate that, 
when infected with KS06, AB pigs activated a stronger innate immune response in tonsils at 42 
dpi than AA pigs. Of the 107 identified Isolate*WUR-xCell DEGs based on the RNA-seq data, 
74 (69%) were significantly expressed more in AB pigs than in AA pigs when infected with 
KS06 but there was no significant difference between AB pigs and AA pigs when infected with 
NVSL. In the RNA-seq results, four Isolate*WUR-xCell DEGs are serine proteases (KLK10, 
KLK12, TMPRSS11D, and TMPRSS11E), which play essential roles in inflammatory responses 
and in innate and adaptive immunity [42]. These genes were expressed more in AB than AA pigs 
when infected with KS06 and accounting for CE, but they were not DEGs for WUR in NVLS-
infected pigs, which was consistent with the NanoString results. In summary, the AB genotype at 
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WUR was associated with stronger immune response in tonsils at 42 dpi, especially innate 
immune response, for pigs infected with KS06 but not for pigs infected with NVSL. 
Effects of Interaction Between WUR and TVclass on Tonsil Gene Expression 
Based on the tonsil NanoString results, within the Low-TVclass pigs, FOS, which is a 
subunit of AP-1 that can stimulate activation of inflammatory genes in the “ceramide signaling” 
pathway, was significantly more activated in AB pigs than in AA pigs when accounting for CE, 
while no significant difference was observed in the High-TVclass pigs, nor based on the RNA-
seq data in either TVclass. Based on the tonsil RNA-seq data, LOXL4 was the only significant 
DEG for WUR within the Low-TVclass. It contains a highly conserved protein module, 
Scavenger Receptor Cysteine-Rich domain, that plays roles in innate immune response [43]. The 
LOXL4 gene can be stimulated by TGF-β1 through the Smad and AP-1 complex, which is 
composed of JunB/Fra2 and plays a role in vascular extracellular matrix (ECM) homeostasis 
[44]. This indicates that the greater expression of LOXL4 in AB versus AA pigs within the Low-
TVclass may result in stronger innate immune response of AB than AA pigs, but with no effect 
within High-TVclass pigs. This is consistent with what we found based on the NanoString data.  
In the tonsil NanoString results within the High-TVclass pigs, three TVclass*WUR-xCell 
DEGs (IFNG, STAT1 and TAP1) were expressed less in AB pigs than in AA pigs, and either 
activated the “interferon signaling” pathway less or inhibited this pathway more in AB pigs than 
in AA pigs. Based on the NanoString data, all three DEGs were expressed more in AB pigs than 
in AA pigs within the Low-TVclass group but these differences were not significant. In the 
RNA-seq data, STAT1 and TAP1 were also expressed less in AB pigs than in AA pigs within the 
High-TVclass group but, again, not significant (q=0.17 and 0.92), while IFNG was not identified 
in the RNA-seq data. The five TVclass*WUR-xCell DEG identified in the RNA-seq data were 
not included on the NanoString panel. 
56 
In the RNA-seq data, GRHL3 was one of five TVclass*WUR-xCell DEGs that were 
expressed significantly more in AB pigs than in AA pigs within the High-TVclass group, but not 
within the Low-TVclass group. The GRHL3 gene was also an Isolate*WUR-xCell DEG; it was 
expressed more in AB pigs than in AA pigs when infected with KS06 but was not significant 
within NVSL-infected pigs. Previous study showed that the GRHL3 protein decreases expression 
of mouse miR-21 mature microRNA in differentiated normal human keratinocytes [45]. miR-21 
is a negative regulator for TLR4 to activate NF-κB and decrease IL-10 production by targeting a 
pro-inflammatory tumor suppressor PDCD4 [46]. This indicates that GRHL3 may suppress miR-
21, and subsequently activate NF-kB and decrease IL-10 production. Based on our results, higher 
expression of GRHL3 in AB pigs, is predicted to stimulate innate immune responses more in AB 
pigs than in AA pigs within the High-TVclass group or when infected with KS06, but have no 
significant effect within the Low-TVclass group or when infected with NVSL. 
The AHNAK gene, which is highly expressed by CD4+ T cells [47], was another 
TVclass*WUR-xCell DEG, that was significantly expressed more in AB pigs than in AA pigs 
within the High-TVclass group, but was not significant within the Low-TVclass group. The 
AHNAK gene plays an important role in T cell calcium signaling triggered by TCR activation 
[47]. This indicates that AHNAK may have an effect on T cell activation depending on the 
interaction effect of TVclass and WUR. 
The ARHGAP32 gene was also significantly expressed more in AB pigs than in AA pigs 
within the High-TVclass group but was not significant within the Low-TVclass group. The 
ARHGAP32 protein plays a role in activating GTPase of RAC1 and RhoA protein [48]. The 
RAC1 protein plays an essential role in regulating NF-κB transcriptional activity in cells of the 
innate immune system [49]. Activation of RhoA is required for pro-inflammatory cytokines 
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production mediated by lipopolysaccharide in human monocytes through TLR4 and TLR2 [49]. 
Thus, ARHGAP32 may affect the level of innate immune response by increasing GTPase 
activity, depending on the interaction effect of TVclass and WUR. 
In summary, the effect of WUR on the tonsil transcriptome depends on the tonsil viral 
level and the PRRSV isolate. Further study is needed to validate these interaction effects of 
WUR genotype. 
Limitations of This Study 
The PHGC trials were designed to identify genetic variation in host response to PRRSV 
infections. Limitations of their design for the purposes of gene expression studies are that isolate 
and trial were confounded and that there was no control group without PRRSV infection. As a 
result, we can only compare gene expression differences between pigs with high and low tonsil 
viral levels and between the two Isolates (which is confounded with the effect of trial). We also 
did not have the baseline gene expression in tonsil from uninfected pigs and, therefore, we could 
not determine whether the expression of a gene was up- or down-regulated; or activated or 
inhibited.  
In addition, the unique mapping rate of the tonsil RNA-seq data was low (36.7% across 
samples) and the multiple mapping rate was high (60.9%). This may result from apparent 
degradation of the tonsil RNA samples based on the relatively low RIN scores. One possible 
cause for the low RNA quality may be that the time between euthanasia and sample collection, 
which was longer and variable because tonsil tissue is not readily accessible. We did try to select 
tonsil RNA samples with higher RIN but many had RIN less than 5.0.  
Another limitation of this study is that the total weight of each pig’s whole tonsil tissue 
was not known. Differences in tonsil size may indicate differences in host response to infection. 
Tonsils are aggregates of lymph nodules and diffuse lymphoid tissues [28], so it is difficult to 
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measure the size of tonsils or remove it completely for weighting. Because our analyses were 
based upon a standard sample size, it was not known whether there were differences in tonsil 
size based upon experimental factors that may have altered the total gene expression profile of 
the tonsil. Differences in tonsil size may result from differences in gene expression levels 
between treatments or factors, and these genes may play roles in cell movement, inflammation, 
immune cell proliferation, or apoptosis. This is consistent with our results of the biological 
functions of the DEGs such as “cell movement”, “cellular infiltration by eosinophils”, 
“monocytopoiesis”, “formation of granuloma”, “accumulation of myeloid cells”, “chemotaxis of 
granulocytes”, “influx of blood cells”, and “organismal death”.  
For the effect of TVclass, cause and effect relationships between tonsil viral level and 
gene expression in tonsils could not be determined. Unlike Isolate or WUR, TVclass was not 
conducted or pre-selected or assigned before 42 dpi. Instead, High- and Low-TVclass was 
classified based on the tonsil viral level at 42 dpi. Therefore, for TVclass, we have two 
hypothesis: (1) tonsil virus level is the result of differences in immune response (2) immune 
response is the result of the level of tonsil viral load. Because our results showed that pigs with 
High-TVclass were enriched in immune cells, High-TVclass may be the cause to trigger the host 
anti-viral immune response. 
Because we did not measure cell composition directly, cell enrichment was determined 
based on the RNA-seq data using the xCell software. Although the gene signatures for each cell 
type used by xCell were based on human sequencing data, we believe the results are relevant to 
pigs. The same holds for the biological function results from IPA, which are mostly based on 
information from human and mouse literature. However, pigs have substantial similarities to 
humans in anatomy, genome, and physiology and, thus, xCell and IPA are good sources to 
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identify significant enrichment of cell types and biological functions of DEGs associated with a 
treatment or factor of interest.  
Conclusions 
Transcriptional profiling in tonsil tissues at 42 dpi revealed an immune response to 
PRRSV persistence and may have been influenced by intercellular communication with other 
body tissues through blood. Because tissues consist of multiple cell types, considering cell 
composition differences in the tissue between treatments is important for understanding 
transcriptional profiling. The impact of PRRSV isolates on host immune responses provides 
insights into the potential means of viral persistence, especially in tonsils.  
In summary, we found higher immune responses in tonsils of KS06-infected pigs and in 
pigs with high levels of virus in tonsil, than in tonsils of NVSL-infected pigs and in pigs with 
low levels of virus in tonsil at 42 dpi. We hypothesize that NVSL can persist in tonsils longer 
than KS06 and that the presence of more virus in tonsils (high tonsil viral level) induces stronger 
immune responses, especially innate immune responses. Genes that were significantly impacted 
by the interaction between WUR genotype and Isolate may play a critical role in innate immune 
response, especially the IL-8 signaling pathway, which indicates that WUR may have different 
effects on tonsil immune responses during persistence in pigs infected by different PRRSV 
isolates.  
This study highlights the importance of measuring cell composition in heterogeneous 
tissues to more comprehensively understand the mechanisms of PRRSV persistence to improve 
strategies to reduce the risk of a second break resulting from PRRSV persistence. Although we 
used the xCell software, which is designed based on human data, to predict CE scores in porcine 
tonsils, our data affirmed the likelihood of the importance of cell migration during persistence.  
Integration of information from Iso-Seq data provided important information on differential 
60 
expression of novel genes in tonsils. These novel DEGs can be potential candidate genes to help 
control PRRSV persistence. Future studies should examine protein expression levels and validate 
the estimated tonsil cell composition. Use of single cell sequencing and gene knockouts would 
help confirm mechanisms of PRRSV persistence and identify candidate genes to target to 
decrease PRRSV persistence. 
Methods 
Experimental Design, Sample Collection and PRRSV Test 
At an average age of 28 days, 184 and 180 Duroc´Landrace/Yorkshire commercial 
nursery pigs from the same genetic source, were experimentally infected (intramuscularly and 
intranasally) with 105 (TCID50) of NVSL or KS06, respectively, in two separate PHGC 
infection trails (PHGC5 with NVSL and PHGC14 with KS06) [16]. At 42 dpi, pigs were 
euthanized and serum and tonsil samples were collected (to the greatest possible extent, the 
central portion of the tonsil, at the oral side of the soft palate, was sampled through its entire 
depth). Tonsil samples were frozen and stored at -80oC until analyzed. Tonsil viral level and 
serum viremia were evaluated by a semi-quantitative PCR assay for PRRSV RNA, as described 
in Boddicker et al. [14]. Two assays, the Applied Biosystems AgPath ID NA and EU PRRSV 
reagents (AB assay), and the Tetracore US and EURO PRRSV Master Mix reagents (Tetracore 
assay), were used to measure the tonsil viral levels for the NVSL and KS06 trails, respectively, 
because the cDNA from the KS06 isolate failed to be amplified by the AB primers [16]. 
Therefore, the tonsil virus levels for NVSL were adjusted to their Tetracore equivalent, as 
described in Hess et al. [16]. VLTotal in serum was calculated by area under the Wood’s curve 
from infection until euthanasia at 42 dpi, as a measure that includes both the level of viremia and 
the extent to which viremia is maintained [22, 50]. Additional details of these trials and assays 
are presented in Hess et al. [22]. 
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Sample Selection 
Total RNA was isolated from aliquots of frozen tonsil samples collected on 337 pigs 
using RNeasy RNA isolation kit (Qiagen, Germantown, MD, USA) according to the 
manufacturer’s protocol. RNA concentration was first measured with a NanoDrop ND-1000 UV-
vis Spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE, USA). As a measure of 
RNA quality, RNA integrity number (RIN) of the extracted RNA was determined for each 
sample using the RNA Nano 6000 Assay kit on an Agilent Bioanalyzer 2100 system (Agilent 
Technologies, Santa Clara, CA, USA). A total of 53 tonsil samples were selected for gene 
expression analyses based on high or low PRRSV level (at least one standard deviation from the 
mean) in the tonsil (High and Low-TVclass) and RIN scores of the extracted RNA. Overall, 
samples from 180 pigs from PHGC5 and from 157 pigs from PHGC14 (15 NVSL_High, 15 
NVSL_Low, 12 KS06_High, and 11 KS06_Low samples) were selected for RNA-seq analyses 
(Figure 3.1). NanoString analyses were performed on these same samples. 
RNA-sequencing and Preprocessing of RNA-seq Reads 
For tonsil RNA-seq, library construction and sequencing were performed by the DNA 
facility at Iowa State University. The cDNA libraries of the selected 53 RNA samples were 
constructed from total RNA using the Illumina TruSeq® RNA Sample Preparation Kit v2 
(Illumina, San Diego, CA, USA) according to manufacturer’ s instructions. The cDNA from all 
53 samples was pooled in approximately equimolar amounts after ligating adapters with unique 
barcodes for each sample and loaded on each of five lanes of an Illumina® HiSeq 3000 flow cell 
for 100 base paired-end sequencing.  
Raw reads from the fastq files obtained from each of the five lanes were checked for 
quality using FastQC (Version 0.11.3) [51], trimmed using Trimmomatic (Version 0.36) [52], 
and aligned to build 11.1 of the pig genome using STAR (Version 2.5.3) [53]. To avoid multiple 
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mapping issues for the hemoglobin (HB) genes, HBB-like (ENSSSCG00000014727) and one of 
two similar exon sequences within HBA (ENSSSCG00000007978) were masked in the reference 
genome sequence. For gene annotation, Ensembl pig 11.1 gene annotation was used, combined 
with annotation for an additional 12,491 novel genes that were identified by Pacific Biosciences 
single-molecule long-read isoform sequencing (Iso-Seq) of a cross-bred pig and RNA-seq data of 
nine pig tissues (brain, hypothalamus, liver, muscle, thymus, pituitary, small intestine, spleen and 
diaphragm) [54]. The current version of Ensembl gene annotation (SSC11.1) does not include 
GBP5. Instead, the WUR SNP (rs80800372) and the putative causative GBP5 intronic SNP 
(rs340943904) are located in three of nine transcripts that are incorrectly annotated as guanylate 
binding protein 1 (GBP1): ENSSSCT00000065307, ENSSSCT00000060466, and 
ENSSSCT00000044130 [13]. Thus, the gene annotation file was changed to recognize these 
three transcripts as GBP5. BAM output files from STAR were used to build an index using 
Samtools (Version 1.3.1.1) [55] and used as inputs for counting reads using htseq-count [56] 
with the merged Ensembl gene annotation and IsoSeq novel gene annotation as a gtf file. The 
resulting read count data for each of the 5 lanes were then combined into one dataset for each 
tonsil sample. Two samples in the NVSL-low group with low read counts (5,024 and 5,057) and 
high proportions of zero read counts (89 and 91%) were excluded from analysis, leaving 51 
samples. 
NanoString Gene Expression Analysis 
All but one (Low TVclass, KS06 Isolate, and AA WUR genotype, marked in red in 
Figure 3.1) of the 51 samples used in RNA-seq were also evaluated using NanoString gene 
expression technology. RNA preps were diluted with RNA-free water to 25-100 ng/ul. Using a 
uniquely designed swine immune codeset (nCounter XT CodeSet Gene Expression Assay 
NanoString Technologies Seattle, WA), hybridization buffer was added to the reporter codeset to 
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create a master mix. An aliquot of the mastermix was mixed with 5 ul of each RNA sample, 
followed by the capture probe. The samples were placed at 65⁰C in a pre-heated thermal cycler 
for at least 16 hours. One sample with 100 ng RNA per lane was loaded then processed in the 
nCounter (NanoString Technologies) [31]. The custom-designed CodeSet of 230 genes was 
selected from genes and pathways associated with porcine blood, lung, lymph node, 
endometrium, placenta or macrophage response to infection with PRRSV [57]. These genes are 
involved in innate and adaptive immune response, as well as apoptosis and mitosis pathways 
based on IPA and KEGG Pathway Database [57]. Not all genes in a given pathway were selected 
to avoid over-representing pathways. In addition, some selected genes are involved in multiple 
pathways. Nine housekeeping genes were included in the CodeSet.  
Gene Expression Data Visualization 
For data visualization, hierarchical clustering was performed using R version 3.3.1 [58]. 
The 51 RNA-seq samples were clustered to identify any obvious outliers and for clustering of 
samples by factors of interest, including Isolate, TVclass, WUR, sex, and RIN. We calculated the 
sample distance matrix using the “euclidean” method, applied hierarchical clustering using the 
“average” agglomeration method of the hclust R function, principal component analyses (PCA) 
using the prcomp R function without scale, and plotted sample dendrograms against the factor 
colors using the plotDendroAndColors R function. The 200 most variant genes were used after 
upper quartile normalization.  
Cell Composition Estimation 
Tonsils consist of numerous cell types [28], so any DEGs identified could be the result of 
changes in cell composition. The software xCell [27] was used to estimate the CE of each sample 
for 64 immune and stromal cell types based on the gene expression levels of signature genes for 
each cell type. All 51 samples were analyzed simultaneously, using the tonsil RNA-seq data for 
64 
6,993 genes for which Sus Scrofa gene names from Ensembl overlapped with the xCell gene list, 
which includes 10,782 genes with human gene names. The output data, used for subsequent 
analyses, were the CE scores after transformation of raw cell composition scores to percentages 
and adjustment using the spill over compensation matrix from xCell [35]. We analyzed the 
resulting CE scores for each cell type using a linear model with the fixed effects of Isolate, 
TVclass, WUR, sex, RIN (covariate), age (covariate), and the 2-way and 3-way interactions 
among Isolate, TVclass, and WUR. The best model for each cell type was selected based on the 
Bayesian information criterion (BIC) through backward selection using the stepAIC function in 
R. ANOVA was used to test significance of the effects of the factors or covariates in the best 
model for each cell type. Based on this, cell types were assigned to a “significant cell type” 
group (Sig) if at least one of the factors of Isolate, TVclass, WUR, their interactions, sex, or age, 
was significant (p<0.1) for that cell type; otherwise, it was assigned to the “nuisance cell type” 
(Nui) group. The rationale for this was that effects of cell types in the Sig group were more 
important to account for in the differentially expression (DE) analysis than the effects of cell 
types in the Nui group because the former are expected to impact the estimates of effects of 
factors of interest on DE. However, because cell types in the Nui group may explain part of the 
random variation in the gene expression data, they are also be important to consider in DE 
analysis. Considering the limitation of our sample size (n=51), PCA was used for each group of 
cell types for dimensionality reduction for CE scores for inclusion in the DE analysis.  
A linear model with the fixed effects of Isolate, TVclass, WUR, sex, and RIN (covariate) 
as the same as the linear model used in the DEG analysis without CE using the tonsil RNA-seq 
data was used to determine the effect of factors of interest (Isolate, TVclass and WUR) on the 
CE scores for each cell type. The lsmeans function of R was used to estimate differences in least 
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squared means for each cell type to quantify the effects of Isolate, TVclass, and WUR genotype 
on CE. The Bonferroni correction set the significance cut-off at 0.003 (α/ n, α=0.1, n=33, the 
number of the immune cell types in xCell).  
Differential Expression Analysis of Tonsil RNA-seq Data 
The R language (version 3.3.1) was used for all statistical analyses. After removing 
transcripts with mean read counts across all 51 samples less than 8 and less than 4 samples with 
read counts larger than zero, 19,107 genes were determined to be expressed in tonsil at 42 dpi. 
Of these, 12,243 were annotated in Ensembl pig 11.1, while the rest were novel genes identified 
by Iso-Seq [54]. This included the GBP5 gene, which was annotated as being part of the GBP1 
gene in Ensembl pig 11.1. 
Differential expression analyses were performed using the linear model pipeline 
implemented in the voomWithQualityWeights function of the R limma package [29, 59]. Briefly, 
read counts were first log-transformed as log2[(n+0.5)*106/(m+1)], where n is the read count of a 
given gene in a sample and m is the upper-quartile of read counts in the sample across all genes 
[36]. Then, sample level weights and observational level weights were estimated. Using the 
combination of these two weights in the linear model for statistical analysis can increase power 
and reduce false discoveries compared to other methods [29]. In the linear model, covariates and 
fixed effect factors considered included Isolate, TVclass, WUR, sex, RIN, age, and tonsil viral 
level. To identify the best model to be used across genes in terms of inclusion of the covariates 
of age, RIN, and tonsil viral level, the backward variable selection method of Nguyen [60] was 
applied. This method uses pseudo-covariates to control the expected proportion of selected 
covariates that are irrelevant for the RNA-seq dataset [60]. Factors not subject to variable 
selection were sex and the combination of Isolate, TVclass, and WUR. After variable selection, 
the 2-way and 3-way interactions among Isolate, TVclass, and WUR from the selected model 
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were considered for inclusion in the final model. The same method was used when including CE 
in the model, by considering the first three principal components of each of the significant and 
nuisance groups of cell types (SigPC1, SigPC2, SigPC3, NuiPC1, NuiPC2, and NuiPC3) as 
candidate covariates. Storey’s method [61] with an estimate of the proportion of true null 
hypotheses using the histogram-based method of Nettleton et al. [62] was applied to control the 
false discovery rate (FDR) at less than 0.1 for identification of DEG for Isolate, TVclass, and 
WUR. In order to understand the biological function of DEGs that were significant for the 
Isolate*WUR interaction, we evaluated contrasts between AB genotype pigs infected with KS06 
(AB_KS06) and AA genotype pigs infected with KS06 (AA_KS06) to identify the DEGs for 
WUR within KS06-infected pigs, and the same for DEGs for WUR within NVSL-infected pigs 
(AB_NVSL vs AA_NVSL), High-TVclass pigs (AB_High vs AA_High), and Low-TVclass pigs 
(AB_Low vs AA_High). Each of the comparison can be called as a simple effect of WUR. For 
these simple effects of WUR, we only considered DEGs that overlapped with DEGs for the 
interaction effect between WUR and Isolate or TVclass, which identifies genes for which the 
effect of WUR differs between the two isolates or between pigs with high and low tonsil viral 
level. 
Statistical Analysis of NanoString Data 
The raw NanoString nCounter data were analyzed using the NanoStringDiff package in R 
[63]. NanoStringDiff fully utilizes the normalization information provided by the nCounter 
system, including housekeeping genes, six positive controls, and eight negative controls [63]. 
The expression of housekeeping genes is expected to be stable across samples, but this is not 
always the case [63]. Therefore, we checked the expression of the 9 housekeeping genes that 
were included in the NanoString CodeSet in the RNA-seq data of these same samples and 
removed the five genes that were DEGs for any factors or covariates  in the model without CE  
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as housekeeping genes, leaving HPRT1, TBP, YWHAZ, and SDHA (for Isolate and/or RIN). 
Although the latter two genes were DEG in the model with CE, all four genes were maintained 
as housekeeping genes in our analyses because NanoString analysis requires at least three 
housekeeping genes. 
The model for DE analysis of the normalized NanoString data was the same as the model 
used for analysis of the RNA-seq data, including Isolate, TVclass, WUR, sex, and RIN, with or 
without considering PC’s for CE predicted by xCell based on the tonsil RNA-seq data. The 
simple effect of WUR was also tested. Genes with a q-value less than 0.1 were defined as DEGs.  
Biological Function and Pathway Enrichment Analyses 
To identify over-represented canonical pathways associated with DEGs, the p-values, q-
values, and estimates of log2(Fold Changes) (log2FC) of all genes for the effects of Isolate, 
TVclass, and WUR in the model for each gene were uploaded in the IPA software [64]. Because 
IPA does not recognize pig Ensembl gene ID’s, 12,876 of the 19,106 genes identified in our 
tonsil RNA-seq data were converted from Ensembl pig gene ID to pig gene names using 
BioMart in Ensembl, resulting in 11,841 pig gene names identified by “Gene symbol-human 
(Hugo/HGNC, Entrez Gene)” in IPA. For the NanoString results, log2FC values, p values, and q 
values of 228 of the 230 genes that were identified by IPA were entered into IPA. 
For IPA, the same settings were used for analysis of results from the RNA-seq and the 
NanoString data. After setting “Create Core Analysis” and 0.1 as the q-value cutoff, the “User 
Dataset” and “Direct and Indirect Relationships” were chosen as “Reference Set” and 
“Relationships to consider”, respectively. In the canonical pathway analysis, the cutoff of 
Fisher’s Exact Test p-value was set to less than 0.05 and the cutoff for the absolute value of the 
z-score was set to be greater than 2.0.  
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Comparison Between RNA-seq and NanoString 
In order to make a more reliable comparison between RNA-seq and NanoString data 
based on the 50 overlapping samples, we extracted the data from the 203 genes from the tonsil 
RNA-seq data that overlapped with the 230 genes in the NanoString data. Of the 27 NanoString 
genes that were not in the RNA-seq expressed data, 24 had low read counts in RNA-seq and 
were filtered out before DE analysis. The other three, OAS1, C3AR1, and IFNA, did not have 
corresponding Ensembl ID’s in the Ensembl database. Using the data on the 203 genes, we first 
compared the correlation of the normalized RNA-seq and NanoString read count data, separately 
for each gene. We used the same normalized methods as described above for DE analyses. For 
the RNA-seq data, we log-transformed read counts for DEG analysis using the 
voomWithQualityWeights method in the R limma package. For the NanoString data, we 
transformed read counts as log2(n+0.5), where n is the normalized count of a given gene 
extracted from NanoStringDiff. Second, we checked the DEGs among these 203 genes that 
overlapped between RNA-seq and NanoString for each factor (Isolate, TVclass, WUR). Third, 
the biological functions of DEGs were compared based on analysis of the RNA-seq versus 
NanoString data for these 203 genes by IPA.  
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Tables and Figures 
Table 3.1 Significant effects of Isolate, TVclass, and WUR genotype on xCell enrichment scores 
for lymphocytes and myeloid cells. 
 Full name dLSMa SE p-value Group 
   KS06-NVSL    
Isolate 
Class-switched memory B-cells 0.013 0.006 0.032 Lymphocytes 
CD4+ central memory T-cells 0.003 0.002 0.098 Lymphocytes 
Basophils 0.042 0.017 0.016 Myeloid cells 
Plasmacytoid dendritic cells -0.003 0.002 0.099 Myeloid cells 
   High-Low    
TVclass 
B-cells 0.021 0.012 0.081 Lymphocytes 
CD8+ T-cells 0.011 0.006 0.059 Lymphocytes 
Class-switched memory B-cells 0.017 0.005 0.004 Lymphocytes 
Memory B-cells 0.009 0.004 0.042 Lymphocytes 
naive B-cells -0.004 0.002 0.048 Lymphocytes 
Plasma cells 0.008 0.003 0.028 Lymphocytes 
Type 1 T-helper cells 0.007 0.003 0.027 Lymphocytes 
CD8+ naive T-cells 0.005 0.002 0.033 Lymphocytes 
CD8+ central memory T-cells 0.021 0.007 0.003 Lymphocytes 
Basophils 0.046 0.016 0.006 Myeloid cells 
Activated dendritic cells 0.016 0.008 0.048 Myeloid cells 
Plasmacytoid dendritic cells 0.005 0.002 0.020 Myeloid cells 
Immune scoreb 0.021 0.010 0.034  
   AA-AB    
WUR Type 1 T-helper cells 0.007 0.004 0.082 Lymphocytes 
Plasmacytoid dendritic cells 0.005 0.002 0.056 Myeloid cells 
aDifferences of Least squared mean (dLSM) for cell enrichment estimates associated with each comparison: LSM 
for KS06 minus LSM for NVSL isolates; High minus Low tonsil viral class; AA minus AB WUR genotypes. Only 
estimates of significance (p<0.1) for lymphocytes and myeloid cells and their subsets are shown based on the library 
size of the tonsil RNA-seq. 
bImmune score, as determined by the xCell software, is an aggregated score that considers B cells, CD4+ T cells, 
CD8+ T cells, dendritic cells (DC), eosinophils, macrophages, monocytes, mast-cells, neutrophils, and natural killer 
cells. 
The red font refers to the significant estimates after multiple test correction. 
 
 
 
 
 
 
 
 
70 
Table 3.2 Number of differentially expressed genes in tonsil for factors of interest based on the 
RNA-seq data, with or without accounting for cell enrichments. 
Factor Without accounting for cell composition 
With accounting for 
cell composition Overlap 
Isolate: KS06/NVSL 1074 204 162 
TVclass: High/Low 0 4 0 
WUR: AB/AA 0 0 0 
Isolate*WUR -a 107 -a 
TVclass*WUR -a 5 -a 
a This factor was not in the model so no differentially expressed genes were identified for it.  
 
 
Table 3.3. Comparison of the effect of WUR genotype on the number of genes that are 
differentially expressed in tonsil for Isolate and TVclass based on the RNA-seq and NanoString 
data. 
 RNA-seq NanoString 
 log2FC>0b log2FC<0c log2FC>0b log2FC<0c 
KS06 (AB vs AA) 74 3 14 37 
NVSL (AB vs AA) 0 0 26 12 
Low-TVclass (AB vs AA) 1 0 14 7 
High-TVclass (AB vs AA) 3 1 7 29 
aThe numbers of differentially expressed genes (q<0.1), comparing WUR genotypes within Isolate or TVclass, 
based on tonsil data from RNA-seq and NanoString analyses using the model with cell composition. 
bGene expression in tonsil at 42 dpi: AB>AA within Isolate or TVclass.  
cGene expression in tonsil at 42 dpi: AB<AA within Isolate or TVclass. 
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Table 3.4. Numbers of differentially expressed gene in tonsil based on NanoString with/without 
accounting for cell enrichments. 
 
Without accounting for 
cell enrichments 
With accounting for cell  
enrichments 
Overlap of 
differentially 
expressed 
genes log2FC<0
a log2FC>0b log2FC<0a log2FC>0b 
Isolate: KS06 vs NVSL 17 74 9 35 26 
TVclass: High vs Low 16 36 13 28 9 
WUR: AB vs AA 0 0 21 14 0 
(HighAB-HighAA) vs 
(LowAB-LowAA) -
c -c 6 36 -c 
(KS06AB-KS06AA) vs 
(NVSLAB-NVSLAA) -
c -c 64 20 -c 
a Gene expression in tonsil at 42 dpi: KS06>NVSL or Low>High or AB>AA or (High_AB-High_AA) > (Low_AB-
Low_AA) or (KS06_AB-KS06_AA)> (NVSL_AB-NVSL_AA)  
b Gene expression in tonsil at 42 dpi: KS06<NVSL or Low<High or AB<AA or (High_AB-High_AA) < (Low_AB-
Low_AA) or (KS06_AB-KS06_AA)< (NVSL_AB-NVSL_AA). 
c this factor/covariate was not in the model so no DEG was identified for it.  
 
 
Table 3.5. Numbers of differentially expressed genes among the 203 genes that were common to 
the NanoString and RNA-seq analyses.  
 Without cell enrichments With cell enrichments 
 RNA-seq NanoString Overlap RNA-seq NanoString Overlap 
Isolate 18 83 12 2 33 0 
TVclass 0 41 0 0 30 0 
WUR 0 0 0 0 25 0 
Isolate*WUR -a -a -a 1 69 1 
TVclass*WUR -a -a -a 0 32 0 
a this factor was not in the model so no differentially expressed genes were identified for it.  
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Table 3.6. Overlapping differentially expressed genes for isolate between the NanoString and 
RNA-seq analyses without accounting for cell enrichments.  
Gene 
name 
NanoString data RNA-seq data 
log2FCa  q-value  log2FC  q-value  
CDC25B 0.42 3.96E-03 0.48 0.03 
ETS1 0.28 0.08 0.45 0.05 
FN1 0.46 2.83E-04 0.43 0.01 
IFIT2 0.25 0.01 0.35 0.04 
IKBKE 0.25 0.02 0.35 0.02 
ITK 0.29 0.01 0.31 0.04 
JAK3 0.22 0.02 0.29 0.07 
LAT 0.37 1.43E-05 0.29 0.08 
LCP2 0.29 2.65E-06 0.25 0.03 
LYZ 0.36 2.43E-04 0.24 0.07 
PIK3CG -1.28 1.99E-03 -1.08 0.04 
TYK2 -0.59 0.04 -1.49 0.01 
a Log fold change of KS06/NVSL.  
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Table 3.S1. Cell types included in the significant group. 
Cell type Subgroup Parent/Child Final_model  
Neurons Epithelial Astrocytes Age 
Common lymphoid progenitors HSC HSC Isolate 
Multipotent progenitors HSC Parent Isolate 
Epithelial cells Epithelial Parent Isolate+RIN+Sex 
Mesangial cells Stroma Fibroblasts Isolate+TVclass+Isolate*TVclass 
Plasmacytoid dendritic cells Myeloid DC Isolate+TVclass+WUR 
Macrophages Myeloid Parent Isolate+TVclass+WUR+ 
Isolate*TVclass 
Endothelial cells Stroma Parent Isolate+TVclass+WUR+RIN+Sex+ 
Isolate*TVclass 
Microvascular endothelial cells Stroma Endothelial cells Isolate+TVclass+WUR+Sex+ 
Isolate*TVclass 
CD8+ T-cells Lymphoid Parent Isolate+WUR+Isolate*WUR 
Myocytes Stroma Skeletal muscle Isolate+WUR+RIN+Isolate*WUR 
B-cells Lymphoid Parent Sex 
Macrophages M2 Myeloid Macrophages Sex 
Neutrophils Myeloid Parent Sex 
naive B-cells Lymphoid B-cells Sex+Age 
CD8+ naive T-cells Lymphoid CD8+ T-cells TVclass 
Class-switched memory B-cells Lymphoid B-cells TVclass 
Keratinocytes Epithelial Epithelial cells TVclass 
Plasma cells Lymphoid B-cells TVclass 
Basophils Myeloid Parent TVclass+Age 
CD8+ central memory T-cells Lymphoid CD8+ T-cells TVclass+Sex 
Type 1 T-helper cells Lymphoid CD4+ T-cells TVclass+WUR 
Eosinophils Myeloid Parent TVclass+WUR+TVclass*WUR 
Lymphatic endothelial cells Stroma Endothelial cells TVclass+WUR+TVclass*WUR 
Mesenchymal stem cells Stroma Parent TVclass+WUR+TVclass*WUR 
Fibroblasts Stroma Parent WUR 
Hematopoietic stem cells HSC Parent WUR 
Megakaryocyte_erythroid 
progenitors 
HSC HSC WUR+Sex 
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Table 3.S2. Top three cell types explained by each principal component of enrichments of cell 
types in the significant and the nuisance groups. 
Principle component Top three cell types 
SigPC1a Epithelial cells, B cells, and microvascular endothelial cells 
SigPC2 Keratinocytes, mesangial cells, and myocytes 
SigPC3 Macrophages M2, neurons, and megakaryocytes 
NuiPC1b CD8+ central memory T-cells, CD4+ memory T-cells, CD4+ T-cells 
NuiPC2 Immature dendritic cells, chondrocytes, platelets 
NuiPC3 Common myeloid progenitors, mast cells, sebocytes 
a The first principle component of the significant cell group; 
b The first principle component of the nuisance cell group. 
 
 
Table 3.S3. Number of differentially expressed genes in tonsil based on the RNA-seq data 
(q<0.1) with or without accounting for cell enrichments. 
  Without accounting for cell enrichments 
With accounting for 
cell enrichments Overlap 
Isolate: KS06/NVSL 1074 204 162 
TVclass: Low/High 0 4 0 
WUR: AB/AA 0 0 0 
Isolate*WUR - 107 - 
TVclass*WUR - 5 - 
Sex 25 26 24 
RIN 3824 461 437 
SigPC1a - 1637 - 
SigPC2 - 10275 - 
SigPC3 - 238 - 
NuiPC1b - 4193 - 
a The first principle component of the significant cell group; 
b The first principle component of the nuisance cell group. 
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Figure 3.1 The relationship between tonsil and serum viral level in pigs infected with the NVSL 
or KS06 PRRS virus isolates. A. As a measure of serum viral load, calculated as area under the 
Wood’s curve from the day of infection until euthanasia at 42 days post infection (dpi), 
compared to viral level in tonsil at 42 dpi. Solid symbols indicate samples selected for RNA-seq 
and NanoString gene expression analyses (except one sample noted in red only for RNA-seq). B. 
The serum viremia level at 42 dpi compared to tonsil viral level at 42 dpi. 
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Figure 3.2. Differences in predicted biological functions and networks in tonsils of pigs infected 
with KS06 versus NVSL. A) and B) Ingenuity Pathway Analysis (IPA) was used to identify a 
subset of genes known to be regulated by six and two up-stream regulators, respectively, with 
significant differential expression (q-value <0.1) in tonsils using the model with cell 
enrichments. All eight and twelve genes were expressed more in tonsils of the KS06-infected 
pigs than the NVSL-infected pigs (intensity of red color indicates magnitude). Orange color (z-
score³2) and blue color (z-score £-2) indicate activation and inhibition of predicted relationships 
between these genes, potential up-stream regulator, and potential down-stream functions. Not 
conclusive indicated by grey color. C) A novel network that includes differentially expressed 
genes for isolate in tonsils at 42 dpi based on the model with cell enrichments. Dotted lines are 
indirect interactions and solid lines are direct interactions. Genes in red (green) were expressed 
more (less) in tonsils of the KS06-infected pigs than in tonsils of the NVSL-infected pigs. The 
grey genes were not differentially expressed and white genes were not expressed but predicted 
by IPA to be involved in the network. 
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Figure 3.3. Effects of PRRSV isolate, TVclass, and WUR on gene expression in tonsil based on 
the NanoString data. A) In the model with cell enrichments, the three significant biological 
functions in orange were predicted to be more activated, or less inhibited, in tonsils of the KS06-
infected pigs compared to the NVSL-infected pigs (magnitude indicated by intensity of red or 
green). B) In the model with cell enrichments, the regulators in blue were predicted to indirectly 
regulate (dashed line) their downstream differentially expressed genes for TVclass High/Low in 
red (expressed more in High TVclass) or green (expressed less in High TVclass), which were 
predicted to have effects on activating “formation of granuloma” or increasing  “Quantity of 
IFNG in blood” in orange of the High-TVclass pigs compared to the Low-TVclass pigs. C) In 
the model with cell enrichments, differentially expressed genes for WUR genotype have effects 
on five biological functions (orange color represents activation and blue color represent 
inhibition of the functions). The genes in red (green) were expressed more (less) in AB pigs than 
in AA pigs (magnitude indicated by intensity of red or green). The dashed lines represent indirect 
interactions; ‘‘ ’’indicates negative regulation and ‘‘à’’ positive regulation. The synonym of 
“Antibody-dependent cell-mediated cytotoxicity” is regulation of natural killer cell mediated 
cytotoxicity. 
78 
 
Figure 3.4. Comparison of immune response related pathways in tonsils at 42 days post infection 
between the NanoString and RNA-seq data. Comparison of the immune response related 
pathways that include differentially expressed genes for pigs infected with the KS06 compared to 
the NVSL isolate (K/N) based on the model without cell enrichments. The expression values of 
genes with a false discovery rate<0.1 were used to calculate -log(p-values) and z-scores for each 
pathway. Orange color (z-score³2) and blue color (z-score £-2) indicate activation and inhibition 
of predicted pathways, respectively. The more intense these colors, the higher the absolute z-
scores.  
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Figure 3.S1. PCA plots of each two of top three principle components (PC) of 28 significant cell 
types. The cell compositions in tonsils were predicted by xCell using tonsil RNA-seq data. The 
28 significant cell types were selected based on whether at least one of Isolate, TVclass, WUR, 
their interactions, Sex, or Age had significant effects for that cell type (p<0.1). Shapes indicate 
samples from NVSL or KS06-infected pigs. Colors indicate samples with high or low tonsil viral 
level. The cell composition is difficult to distinguished by PRRSV isolates or tonsil viral levels. 
PC1, PC2 and PC3 explained 31%, 22% and 18.4% of the variance of cell compositions of the 
28 cell types, respectively. 
 
 
 
Figure 3.S2. Hierarchical clustering of the 200 most variant based on the upper quartile 
normalized read counts. Fifty-one RNA-seq samples were clustered to identify any obvious 
outliers and potential clustering of samples by factors of interest using “euclidean” method to 
calculate the sample distance matrix, and the “average” agglomeration method to apply 
hierarchical clustering. The factors of Isolate (1=NVSL; 2=KS06), TVclass (1=High; 2=Low), 
WUR (1=AB; 0=AA), sex (3=Male, 2=Female), and RIN relate to the sample dendrogram were 
converted to a color representation. 
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Figure 3.S3. Significant immune response related canonical pathways that include differentially 
expressed genes for isolate in tonsils at 42 days post infection based on the model without cell 
enrichments. The expression values of genes with a false discovery rate <0.1 were used to 
calculate the z-scores and -log(p-values) for each pathway. Pathways shown in this figure have a 
-log(p-value)>1.3 and an absolute z-score > 2. The height of each bar corresponds to the -log(p-
value). Orange color (z-score³2) and blue color (z-score £-2) indicate activation and inhibition 
of predicted pathways, respectively. The intensity of these colors indicates the magnitude of the 
absolute z-score. 
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Figure 3.S4. Effect of PRRSV isolate on the pig tonsil RNA-seq transcriptome at 42 days post 
infection. Only one significant pathway, “GP6 Signaling Pathway”, was identified in the model 
without (A) and with (B) cell enrichments, which included the same 11 differentially expressed 
genes for both models. The genes that were expressed more (less) in tonsils of KS06-infected 
pigs than of NVSL-infected pigs are in red (green). The intensity of shading is proportional to 
the fold difference in gene expression. The solid lines between genes represent known direct 
interactions and dashed lines represent indirect interactions; ‘‘ ’’indicates negative regulation 
and ‘‘à’’ positive regulation. 
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Figure 3.S5. Effect of PRRSV isolate and TVclass on the expression of 230 immune related 
genes in tonsil at 42 days post infection based on the NanoString data without accounting for cell 
enrichments. A) The most significant signaling pathway, “iCOS-iCOSL Signaling in T Helper 
Cells”, that include differentially expressed genes for KS06/NVSL Isolate. Twenty-two genes 
were expressed more in tonsils of KS06-infected pigs than of NVSL-infected pigs (magnitude 
indicated by intensity of red color). Only one gene, PRKCQ, was expressed less in tonsils of 
KS06-infected pigs than of NVSL-infected pigs (magnitude indicated by intensity of green 
color). B) The most significant signaling pathway, “Interferon Signaling”, that included 
differentially expressed genes for High/Low TVclass. Eleven genes were expressed more in 
tonsils of High-TVclass pigs than of Low-TVclass pigs (magnitude indicated by intensity of red 
color).  
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Figure 3.S6. The GBP5 gene was predicted to be more activated or less inhibited in KS06-
infected pigs compared to NVSL-infected pigs based on the tonsil NanoString data when 
accounting for cell enrichments (p=0.009 and z=1.38). Orange color represents activation and 
blue color represent inhibition of the functions. The genes in red (green) were expressed more 
(less) in tonsil of pigs with the AB than the AA WUR genotype (magnitude indicated by 
intensity of red or green color). The dashed lines represent indirect interactions; ‘‘ ’’indicates 
negative regulation and ‘‘à’’ positive regulation. 
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Abstract 
Co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) and 
porcine circovirus type 2 (PCV2) is a useful model to study porcine reproductive and respiratory 
syndrome (PRRS) and porcine circovirus associated disease (PCVAD). Previous results from the 
infection trials used here have shown that pigs that were vaccinated (Vx) with a PRRS modified 
live virus (MLV) had lower PRRS viral load (VL) but higher porcine circovirus 2b (PCV2b) VL 
following co-infection with PRRSV and PVC2b than non-vaccinated (NonVx) pigs. The 
objectives of this study were to evaluate the effect of genotype at a marker WUR that is 
associated with PRRS resistance and of vaccination with a PRRS MLV (VxStatus) on the 
transcriptome response of blood in nursery pigs that were preselected to equally represent AA 
and AB WUR genotypes and experimentally co-infected with both PRRSV and PCV2b. In total, 
1078 blood samples collected from 169 piglets at 4, 7, 11, and 14 days post vaccination (dpv) 
and at 0 (=28 dpv), 4, 7, 11, 14, and 28 days post coinfection (dpi) were selected for 
transcriptome analysis using QuantSeq 3’mRNA sequencing (QuantSeq). The expression data 
were analyzed by linear models that did or did not account for cell enrichments in the blood 
samples, as predicted from the QuantSeq data by the xCell software. Differential expression 
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analysis was conducted separately for time points before and after co-infection (28 dpv/ 0 dpi 
was included in both analyses) using the Voom software, with weights to improve power and a 
covariance structure to account for the repeated measurements over time. With q-value < 0.1 as 
cutoff criteria for differentially expressed genes (DEGs), before co-infection, the predicted 
biological function of the identified DEGs for VxStatus based on Ingenuity Pathway Analysis 
(IPA) indicated that the PRRS MLV stimulated host innate immune response, especially by 
inducing larger enrichment scores of immune cells, upregulating innate immune related 
pathways, especially activating the interferon signaling pathway, in Vx pigs at 7/-21 dpv/dpi. 
After PRRSV/PCV2b co-infection, Vx pigs were predicted to stimulate stronger adaptive 
immune response than NonVx pigs, through pathways that involved T and B cells, and weaker 
innate immune response, such as less activation of the interferon signaling pathway. As 
expected, the GBP5 gene was significantly expressed more in AB pigs than in AA pigs across all 
trials and all time points. However, few DEGs were identified for WUR effect and its interaction 
with VxStatus, among which SEC61G. In Vx AA pigs, viruses may stimulate SEC61G gene 
expression to escape host immune response after co-infection. This study established a 
foundation and advanced our understanding for future research to investigate the effects of PPRS 
MLV and WUR genotype on host blood transcriptome response to co-infection with PRRSV and 
PCV2b, and contribute to design a rationale for PRRS and PCVAD control strategies. 
Keywords: PRRSV, PCV2b, vaccination, WUR10000125, co-infection, blood, QuantSeq, pigs.  
Introduction 
Pigs co-infected with PCV2 and PRRSV are commonly observed in the field 1. PCV2 is a 
non-enveloped, single-stranded, circular DNA virus from the family Circoviridae 2 and causes 
post-weaning multisystemic wasting syndrome (PMWS) 3, especially the type b strain of PCV2 
(PCV2b) 4. Porcine Circovirus Associated Disease (PCAD) refers to the different disease 
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manifestations associated with PCV2. The vaccine that is available for PCV2 has been effective 
to control PMWS 5–7 but novel PCV2 strains have been identified in PCV2 vaccinated pig herds 
8, which makes continued control of PCV2 by vaccination uncertain.  
PRRSV is an enveloped, positive-stranded RNA virus from the family Arteriviridae and 
causes is the most costly disease in pigs worldwide 9. Current PRRS vaccines are only partially 
effective because PRRSV has high genetic and antigenic heterogeneity, and effective immune 
evasion strategies 10–12. PRRSV can suppress host antiviral response 13 and potentiate PCV2 
pathogenesis and replication 14. PRRSV also has an effect on PMWS 15, as infection of pigs with 
either PRRSV and PCV2 alone induces less severe clinical symptoms than co-infection with 
both viruses 16. In addition, co-infection with PRRSV and PCV2b increases the rate of amino 
acid mutations of PRRSV in pigs compared to PRRSV-only infection 17. 
Several studies have shown a strong host genetic component to host response to PRRSV 
infection 18–20. In nursery pigs, a single nucleotide polymorphism (SNP) WUR10000125 (WUR) 
on SSC 4 was found to be strongly associated with serum viremia and weight gain after PRRSV 
infection 21. Allele B (A) at the WUR SNP is dominant and favorable to allele A (G) 18. The 
WUR SNP is in very high linkage disequilibrium (LD) with the putative causative mutation for 
this effect in the guanylate binding protein 5 (GBP5) gene 22. The alternate allele (A) at 
rs340943904 in the intron of the GBP5 gene induces a putative causative splice site acceptor that 
results in an early stop codon and truncation of 88 amino acids in AA pigs 22. GBP5 plays an 
important role in regulation of assembly of the NLRP3 (nucleotide-binding domain, leucine-rich-
containing family, pyrin domain-containing-3) inflammasome 23. In the blood transcriptome 
following experimental PRRSV infection, Schroyen et al. 24 identified a module of 506 genes, 
whose overall expression was significantly lower in pigs with the AB versus AA genotype at 
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WUR and in pigs with a higher weight gain. The GO terms of these 506 genes included the Toll-
like receptor signaling pathway, complement activation, and innate immune response 24. 
Schroyen et al. 25 identified another module consisting of 516 transcripts that are involved in “ion 
homeostasis”, “ion transport”, and the “GPCR signaling pathway”, with less expression in the 
AB than AA pigs at 4, 7, and 14 dpi. Based on the transcriptome results, Schroyen et al. 24 
proposed that AB pigs can inhibit viral entry and replication more quickly than AA pigs 
following PRRSV infection.  
Previous analyses of data from the same experiment as used here 26 have shown that pigs 
that were vaccinated with an MLV PRRS vaccine had lower PRRS viral load (VL, area under the 
curve from 0 to 21 dpi) but higher PCV2b VL (from 0 to 42 dpi), following PRRSV and PCV2 
co-infection than NonVx pigs. This indicates that the PRRS vaccine partially protected pigs 
against PRRS but enhanced PCV2 replication. Niederwerder et al. 27 found that the PRRS MVL 
vaccine had a protective effect early after co-infection in terms of increasing average daily gain 
and decreasing the number of pigs with PRRSV clinical sign. The enhancement of PCV2 
replication by PRRS vaccination may be due to the lymphoproliferation induced by PRRSV 
providing supports on PCV2 replication 27. However, in a later stage following co-infection, Vx 
pigs had greater PCV2b viremia, mortality, and PCVAD clinical signs, and decreased ADG 
compared to NonVx pigs 27. These results showed that the later PCVAD amplification 
outweighed the early benefits of PRRS vaccination 27. In addition, for the effect of WUR, AB 
pigs had lower PRRS VL than AA pigs after PRRSV/PCV2b co-infection regardless of 
vaccination status. AB pigs also had significantly lower PCV2b VL than AA pigs when pigs 
were vaccinated, but not among NonVx pigs 26. Dunkelberger et al. 28 identified several SNPs 
near the major histocompatibility complex that were significantly associated with PCV2b VL, 
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and multiple genomic regions associated with PRRS vaccination VL, PRRS VL, and PCV2b VL. 
Genes in and near these regions which were enriched for immune-related pathways 28.  
Although MLV PRRS vaccines have been used widely for 28 years, there are potential 
issues associated with its use, including transmission of the vaccine or of a mutated MLV, which 
can be more virulent to susceptible pigs 29. For the effect of MLV PRRS vaccination in vivo, 
transcriptome profiles for peripheral blood mononuclear cells (PBMCs) in Pietrain pigs showed 
that vaccination delayed the induction of innate anti-viral immune response to PRRSV based on 
the overexpression of IFNG at 28 dpv but not at 1 dpv 30. They also found that the PRRS 
vaccine-specific antibody response occurred at 14 dpv (42 days of age) and significantly 
increased in titer at 28 dpv and continued over 42 dpv 30. Additionally, their cell type enrichment 
analysis indicated that the cellular sub-population of PBMCs may play roles in PRRS vaccine 
immunity of pigs 30. Hence, it is important to consider cell composition in porcine blood 
transcriptome analyses following PRRSV infection or vaccination. A limitation of this study, 
however, was that only three piglets were involved in the transcriptome profiling 30. Previous 
RNA-seq analyses of PRRSV infected porcine tracheobronchial lymph nodes 31 and lung 32 
revealed that PRRSV induces proinflammatory response, which was consistent with results from 
the PBMC transcriptome study 30. 
To our knowledge, analyses of the transcriptome in pigs following co-infection with 
PRRSV and PCV2b has not been reported. Therefore, the objectives of this study were to 
evaluate the effect of WUR genotype and PRRS vaccination on the blood transcriptome response 
of nursery pigs from the co-infection experiments described by Dunkelberger et al. 26 and to 
identify mechanisms involved. Our hypotheses were: (1) before co-infection, the host response to 
PRRS vaccination is expected to be similar to host response to PRRSV infection, which induces 
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an immune response, including higher expression levels of antiviral response genes and 
enrichment of immune cells in blood of Vx pigs, compared to NonVx pigs, which can be treated 
as control groups at different time points after vaccination; (2) after co-infection, Vx pigs are 
expected to have a stronger adaptive immune response than NonVx pigs, including higher 
expression levels of adaptive immune response genes and greater enrichment of adaptive 
immune cells in blood, while NonVx pigs have a stronger innate immune response than Vx pigs, 
including higher expression of innate immune response genes and greater enrichment of innate 
immune cells in blood, because the co-infection represents their first exposure to PRRSV for 
NonVx pigs but second exposure for Vx pigs and 28 days after vaccination provides sufficient 
time to stimulate adaptive immune response; (3) before and after co-infection, pigs with the AB 
genotype for the WUR SNP, which have a putative functional GBP5, are expected to have a 
stronger innate immune response than AA pigs; (4) for Vx pigs, the effect of genotype at the 
WUR SNP is expected to be smaller after co-infection than for NonVx pigs, because GBP5 plays 
a role in the innate immune response, so an interaction between WUR genotype and VxStatus on 
the blood transcriptome or blood immune cell enrichment is expected. 
Results 
Viral Load and Weight Gain Before and After Co-infection  
For analysis of PRRS and PCV2b viremia, the Spatial Power structure fitted better than 
the other two structures for PCV2b viremia in the PRRS Host Genetics Consortium (PHGC) 
trials 16 and 20 (PHGC16+20) and for PRRS viremia in PHGC trial 22 (PHGC22), while the 
Toeplitz structure was chosen for PRRS viremia in PHGC16+20 and for PCV2b viremia in 
PHGC22. For the effect of PRRS vaccination, in PHGC16+20, Vx pigs had significant higher 
PRRS viremia at 7, 14, 21, and 28 dpv (= 0 dpi) but lower PRRS viremia at 4, 7, 11, 14, 21, and 
28 dpi than NonVx pigs (Figure 4.1A). In PHGC22, Vx pigs had significant higher PRRS 
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viremia at 28 dpv/ 0 dpi (no PRRS viremia data before 28 dpv for NonVx pigs) but lower PRRS 
viremia at 4, 7, 11, 14, 21, and 28 dpi (Figure 4.1B). However, in PHGC16+20, Vx pigs had 
higher PCV2b viremia at 7, 11 and 14 dpi (Figure 4.1C). In PHGC22, Vx pigs had higher 
PCV2b viremia at 7 dpi but no difference in PCV2b viremia between Vx and NonVx at any 
other time point after co-infection (Figure 4.1D). The average PCV2b viremia was lower in 
PHGC22 than in PHGC16+20 for all time points (Figure 4.1C and 1D).  
For the effect of WUR, in PHGC16+20, AB pigs had significantly lower PRRS viremia 
at 7 and 14 dpv, and 7, 11, 14, 28, and 35 dpi (Figure 4.1A). In PHGC22, AB pigs had 
significantly lower PRRS viremia at 7 and 21 dpi than AA pigs among vaccinated pigs (Figure 
4.1B). We only identified significant differences of PCV2b viremia at 28 dpi between AA and 
AB pigs, regardless of vaccination status, in PHGC16+20 (Figure 4.1C). We did not identify 
significant differences of PCV2b viremia between WUR genotypes at any time point after co-
infection in PHGC22 (Figure 4.1D). 
Blood Transcriptome Alignment and Mapping 
A summary of the alignment and mapping results for the QuantSeq data is in Table 4.2. 
Before excluding samples with small library size, more than 5.4 billion (5,443,917,017) 50-base 
paired-end reads were produced in total for the 1,078 RNA samples. The number of reads per 
sample ranged from 475 to 16,552,866 and averaged 2,728,509 (Table 4.2). On average, 97.5% 
of reads were mapped to the pig reference genome, of which 70.2% were unique mapping reads 
and 27.3% were multiple mapping reads (Table 4.2). For PHGC16.1, 16.2, and 20, 5, 3, and 2 
samples with 75th percentile read counts across all genes less than or equal to two were removed. 
In addition, 22,732 and 20,458 genes with average read counts less than or equal to two across 
the remaining samples were also excluded from further analysis for PHGC16+20 and PHGC22, 
respectively. In total, 15,343 and 17,617 genes were determined to be expressed in blood in 
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PHGC16+20 and PHGC22, respectively, of which 15,305 overlapped. For PHGC16+20 and 
PHGC22, 10,581 (on average) and 11,711 genes, respectively, were annotated in Ensembl 
(40.9% and 68.1% of the 25,880 genes in Ensembl), while 4,710 (on average) and 5,906 genes 
were novel genes from Iso-Seq (37.7% and 47.3% of the 12,491 novel genes from Iso-Seq), 
including the GBP5 gene (Table 4.S1). “Novel gene” in the manuscript refers to these genes that 
were first identified using Iso-Seq data by Beiki et al. 33. 
Model Selection for Cell Enrichment and Gene Expression Analyses 
Table 4.S2 shows the average and standard deviation of the cell enrichment values 
obtained from xCell 34 for each cell type across all samples, separately for PHGC16+20 and 
PHGC22. The top five cell types, excluding non-hematopoietic cell types, were natural killer T 
cells, immature dendritic cells, basophils, monocytes, and megakaryocytes in PHGC16+20, and 
natural killer T cells, basophils, CD4+ effector memory T cells, immature dendritic cells and 
class-switched memory B-cells in PHGC22. 
Based on AIC and for all data sets (PHGC16+20_BC, PHGC16+20_AC, PHGC22_BC 
and PHGC22_AC), heterogeneous compound symmetry without plate was chosen as the final 
residual covariance structure for analysis of cell enrichments, while compound symmetry 
without plate was chosen for analysis of gene expression with and without considering CE of cell 
enrichments. In the cell enrichment analyses, inferences were based on the full model described 
in methods. Based on FDR<0.1, cell-types were grouped into significant and nuisance groups for 
each dataset (Table 4.S3). The numbers of significant cell-types were 33 for PHGC22_BC, 35 
for PHGC22_AC, 25 for HGC16+20_BC, and 62 for PHGC16+20_AC (Table 4.S3). Then, PCA 
was done for each group of cell types; the percentage of variance explained by each PC is in 
Table 4.S4.  
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To test the effects of WUR, VxStatus, and dpv on CE, after deciding on the 
heterogeneous compound symmetry covariance structure, backward variable selection was done. 
The final models for PHGC22_AC and PHGC16+20_BC excluded the three-way interaction 
WUR*VxStatus*dpv and the two-way interactions WUR*dpv and WUR*VxStatus; for 
PHGC16+20_AC, RIN, WUR*VxStatus*dpv, WUR*dpv, and WUR*VxStatus were excluded in 
the final model; for PHGC22_BC, WUR*VxStatus*dpv, VxStatus*dpv, and WUR*VxStatus 
were excluded in the final model. 
For the gene expression analyses, all PCs were significant based on the number of genes 
with p-values less than 0.05, except for PC11 for the significant cell type group in 
PHGC16+20_BC. Based on backward selection, the final model excluded WUR*VxStatus*dpv, 
WUR*dpv and WUR*VxStatus for all data sets and with or without CE, except for 
PHGC16+20_AC with CE, for which only WUR*VxStatus*dpv and WUR*dpv were excluded. 
Effect of WUR and PRRS Vaccination on Cell Enrichments 
The effect of WUR genotype was significant only for plasma and CD8+ T cells in 
PHGC22_BC, with AB pigs having larger enrichment scores of plasma cells than AA pigs at 11 
dpv (log2FC(AB/AA)=0.024) and more CD8+ T cells at 28 dpv/ 0 dpi (log2FC(AB/AA)=0.044). 
Figure 4.2 summarizes the significant differences in estimated CE between Vx and NonVx pigs 
for each immune cell type in PHGC16+20 and PHGC22 after co-infection. Before co-infection, 
the only significance was for gamma delta T-cells (Tgd) cells in PHGC16+20 at 28 dpv/ 0 dpi, 
with Tgd cells more abundant in Vx pigs than in NonVx pigs (log2FC(Vx/NonVx) = 0.005 for 
both PHGC16+20_BC and AC, q<0.1). After co-infection, the CE scores of B cells were larger 
in Vx pigs than in NonVx pigs for both PHGC16+20 and PHGC22 at 4, 7, 11, and 14 dpi (for 
PHGC 22 only). Vx pigs had larger CE scores for adaptive immune cells than NonVx pigs, in 
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particular at 7 dpi, including B cells and T cells, and smaller enrichment scores for innate 
immune cells. 
Effect of PRRS Vaccination on the Blood Transcriptome Before Co-infection 
The numbers of DEGs identified at 7, 14, and 28 dpv (0 dpi), before co-infection, are 
shown in Figure 4.3 B, C, and D. At 7 dpv in PHGC16+20 with CE (i.e. considering CE by 
fitting their PCs), DDX60 and IFI6, which relate to activating antiviral response, were expressed 
more in Vx pigs. Similarly, at 7 dpv in PHGC22 with CE, 13 DEGs for VxStatus were involved 
in activating both antiviral response and innate immune response and all were expressed more in 
Vx pigs than in NonVx pigs (Figure 4.4A). Furthermore, at 7 dpv in PHGC22 with accounting 
for cell enrichment, IFNG, IRF1, IRF3, IRF7, and STAT1 were upstream regulators of 68, 21, 29, 
35 and 33 DEGs, respectively, for VxStatus and were expressed more in Vx pigs than in NonVx 
pigs; of these, only IRF7 and STAT1 were themselves DEGs and 23 of their downstream DEGs 
are expected to induce stronger innate immune response and/or antiviral response in Vx than 
NonVx pigs (results not shown). At 7 dpv in PHGC22, five significant immune related pathways 
were more activated in Vx pigs than in NonVx pigs, both with and without considering CE 
(Figure 4.S1A). The most significant pathway was the “interferon signaling pathway” with 
accounting for CE, for which all seven DEGs were significantly expressed more in Vx pigs than 
in NonVx pigs at 7 dpv (Figure 4.4B).  
At 14 dpv, we only identified DEGs for VxStatus in PHGC22 without CE (n=552, Figure 
4.3C), four of which were expressed less in Vx pigs and involved in activating “cytotoxic 
reaction of cells” (Figure 4.S1B). At 28 dpv/ 0 dpi, no DEG for VxStatus was identified for 
PHGC22, either with or without CE, and for PHGC16+20 without CE (Figure 4.3D and Figure 
4.3F). Only 3 and 2 DEGs were identified in PHGC16+20_BC with (CSF1R, MAFB, and a novel 
gene) and without CE (CSF1R and GZMK), respectively (Figure 4.3D). CSF1R and MAFB were 
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expressed more in Vx pigs. GZMK and the novel gene were expressed less in Vx pigs. All these 
four DEGs were also DEGs for VxStatus in PHGC16+20 with CE after coinfection analysis at 
28 dpv/ 0 dpi, with the same trend as the results in PHGC16+20_BC. 
Effect of PRRS Vaccination on the Blood Transcriptome After Co-infection 
Figure 4.5 shows an overview of the comparison of significant immune related pathways 
across time points after co-infection. No significant pathway was identified at 0 dpi in 
PHGC16+20 with CE, at 4, 7, and 11 dpi in PHGC22 with CE, and at 14 dpi in PHGC16+20 
with and without CE.  
At 28 dpv/ 0 dpi in PHGC16+20 with CE, the upstream regulators IFNG, IRF7, and IRF3 
of the DEGs for VxStatus in Figure 4.6 were expressed more in Vx than NonVx pigs, although 
not significantly (q=0.82, 0.15, and 0.85), while IL-4 (not identified in our blood transcriptome) 
was predicted by IPA to be expressed less in Vx pigs (Figure 4.6).  
At 4 dpi, in both PHGC22 and PHGC16+20 without CE, all pathways involving T and B 
cells were more activated, or less inhibited, in Vx pigs than in NonVx pigs, except the “Th2 
pathway” in PHGC22 and the “T cell exhaustion signaling pathway” in PHGC16+20 (Figure 
4.6). At 4 dpi for PHGC16+20 with CE, most adaptive immune response pathways were more 
activated, or less inhibited, in Vx pigs than in NonVx pigs (Figure 4.6). At 4 dpi for PHGC16+20 
with CE, NonVx pigs induced stronger innate immune response as an antiviral response to 
inhibit replication of virus (Figure 4.7). In Figure 4.7, all the DEGs, except FN1, IL18, and IRF1, 
were expressed less in Vx pigs than in NonVx pigs, and the upstream regulators IRF3, IRF5, 
IRF7, and PAF1 of the DEGs for VxStatus in Figure 4.7 were expressed less in Vx pigs than 
NonVx pigs but not significantly except IRF7 (q= 0.18, 0.23, 0.01, and 0.86). 
At 7 dpi for PHGC16+20 without CE, most pathways related to innate immune response 
were more inhibited, or less activated, in Vx pigs than in NonVx pigs (Figure 4.5), while with 
101 
CE, all immune response pathways, including both innate and adaptive immune response, were 
more activated, or less inhibited, in Vx pigs than in NonVx pigs (Figure 4.5). Of the DEG when 
accounting for CE, six were predicted by IPA to be regulated by SP1 and RETNLB and to induce 
activation of “binding of professional phagocytic cells” and “binding of myeloid cells” more in 
Vx than in NonVx pigs (Figure 4.8A). At 7 dpi in PHGC22, seven DEGs were expressed more in 
Vx than in NonVx pigs and were predicted by IPA to activate “chemotaxis of phagocytes” 
(Figure 4.8B). However, not all the DEGs involved in immune response were expressed more in 
Vx pigs. At 7 dpi, in PHGC16+20 with CE, 12 of the 13 DEGs for VxStatus were expressed less 
in Vx pigs. These DEGs were predicted by IPA to be regulated by IRF7, which was also 
expressed less in Vx pigs but not significantly (Figure 4.8C).  
At 11 dpi for PHGC16+20 without accounting for CE, most pathways related to innate 
immune response were less activated, or more inhibited, in Vx pigs than in NonVx pigs, except 
four pathways that involved T- and B- cells and the “role of NFAT in regulation of the immune 
response” pathway (Figure 4.6). At 11 dpi for PHGC16+20 with CE, half of the pathways were 
more activated, or less inhibited, in Vx pigs than in NonVx pigs (Figure 4.6) and IRF7, which is 
an upstream regulator of 13 DEGs that were expressed less in Vx pigs, except for ITGAM, was 
expressed less in Vx pigs but not significantly (q=0.31) (Figure 4.9A). IRF7 was significantly 
expressed less in Vx pigs than in NonVx pigs in PHGC16+20 at 4 dpi with and without CE and 
at 7 dpi without CE. At 11 dpi in PHGC22 with CE, IFNG, OSM and IL1B were upstream 
regulators of 14 DEGs for VxStatus; IFNG and OSM were expressed less in Vx pigs but not 
significantly (Figure 4.9B). At 4 dpi in PHGC16+20, OSM was significantly expressed less in 
Vx pigs but only without CE. 
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At 14 dpi in PHGC16+20 with CE, 20 DEGs were predicted to interact with IFN-γ, IFN-
β, IFN-α, MHCII, IL12, ERK1/2 and immunoglobulin, and play roles in “inflammatory 
response”, “antimicrobial response”, and “connective tissue disorders”. Sixteen of these DEGs 
were expressed less in Vx pigs than in NonVx pigs (Figure 4.10). 
Effect of WUR Genotype and Its Interaction with VxStatus on the Blood Transcriptome 
There was no interaction between WUR and dpv/dpi on the blood transcriptome, either 
before or after co-infection. The expression of GBP5 was significantly greater in AB pigs than in 
the AA pigs across all time points (only not significant in PHGC22 after co-infection without CE 
(q=0.14) but significant without multiple testing (p=4.0E-05)). Additionally, after co-infection, 
SLC41A2 was expressed more in AA pigs than in AB pigs in PHGC16+20, both with and 
without CE, but not in PHGC22. The other two DEG for WUR, ELL3 and KNOP1, were only 
significantly expressed more in AA pigs than in AB pigs in PHGC16+20 after co-infection with 
CE. All other WUR DEGs were novel genes (Figure 4.3E). Four DEGs, UBXN11, STXBP1, 
SEC61G, and a novel gene, were identified to have a significant interaction for WUR and 
VxStatus in PHGC16+20 after co-infection with CE.  
Because of evident interactions of WUR with VxStatus, differences in gene expression 
between AA and AB pigs were also tested separately for NonVx and Vx pigs. For NonVx pigs, 
GBP5 and ENSSSCG00000022701, and a novel gene were expressed significantly more in AB 
than AA pigs. For Vx pigs, 12 DEGs for WUR were identified, four of which, GBP5, RGS9BP, 
and two novel genes, were expressed more in AB than AA pigs and the other eight, AICDA, 
TTYH1, ELL3, SEC61G, TNFRSF13C, DUT, NUGGC, and one novel gene, were expressed less 
in AB pigs. AICDA and TNFRSF13C play a function in “class switching of B lymphocytes”.  
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Discussion 
Limitations of This Study 
The PHGC trials were designed to identify genomic regions associated with host 
response to PRRS vaccination and co-infections in nursery pigs. A limitation of the design for 
identification of DEGs after co-infection with PRRSV and PCV2b is that the data does not 
include gene expression in blood from age-matched uninfected pigs as a control group. 
Comparison of gene expression after co-infection with the baseline gene expression at 0 dpi is 
confounded with age. Thus, we cannot determine whether the expression of a gene was up- or 
down-regulated after co-infection. In addition, the biological function results from IPA are 
mostly based on information from human and mouse literature and the cell signatures used by 
xCell were also developed based on human transcriptome 34. However, pigs are more similar to 
human in anatomy, genetic composition and physiology than classic animal models are to human 
35-37. Because of this, pigs also play an important role as a biomedical research model such as 
genetically modified pigs. Based on this, IPA is expected to be a good source to identify 
biological functions of DEGs associated with factors of interest and xCell is a good source to 
predict cell enrichments comprehensively for 64 cell types 34. To interpret biological function, 
we also assumed that mRNA levels are highly correlated with protein expression, but this may 
not always be the case. Therefore, proteins expression should be investigated in order to confirm 
our hypotheses. Further experiments are needed to validate these hypotheses.  
Our studies on blood transcriptome highlight the importance of measuring cell 
composition for transcriptome analyses in multicellular tissues. Complete blood count data were 
not available for our samples. We used the xCell software, which was designed based on human 
data, to predict cell enrichments in porcine tonsils and blood. Most computational cell type 
quantification methods in multicellular tissues based on transcriptome data have been developed 
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based on human sequencing data and they have rarely been used in livestock studies 34, 38-42. 
CTen was also developed for human/mouse species to identify enriched cell types from 
heterogeneous microarray data 43 and it has been used in pig and chicken RNA-seq studies 25, 44. 
However, CTen does not provide estimates of cell enrichments for a given sample 43, which is 
what was required for our analyses. However, using xCell to estimate cell type enrichments in 
blood in pigs, we assumed that the gene signatures that xCell uses to characterize each cell type 
in human blood can be used in pigs. Compared to other computational cell type quantification 
methods, xCell provides comprehensive estimation of the relative abundance of 64 cell types 34 
and is a good choice to test presence or absence of a certain cell type 45. In contrast, 
CIBERSORT can only estimate 22 immune cell types, does not support between-sample 
comparisons 41, and is susceptible to background predictions as a deconvolution-based approach 
45. The other four methods from Becht et al. 38, Finotello et al. 39, Li et al. 40, and Racle et al. 42 
can only estimate 10 cell types or fewer. 
Although xCell does not provide cell proportions, the relative scores with arbitrary units 
provided by xCell are useful to infer fold changes of cell type enrichments between treatments 
and to account for overall cell enrichments in samples on differentially expression analysis using 
principal components. A limitation of xCell, however, is that a sample can obtain different scores 
if analyzed with different sets of other samples 45. Therefore, we analyzed all samples in a single 
run. 
To further justify the use of xCell, we used complete blood count data and QuantSeq data 
from healthy nursery pigs from another project (see appendix). We found that CE scores from 
xCell and cell proportions based on CBC for two of the main cell types in blood, lymphocytes 
and neutrophils, had correlation that were of similar magnitude as reported in the xCell paper 
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(reference) for corresponding human data. In addition, the PCs of CE from xCell explained ~ 
60% variance of the cell proportions for these two cell types based on CBC. Additional details 
are in the appendix. 
PRRS Vaccination Effect Before Co-infection 
After vaccination and before co-infection, the non-vaccinated group could be treated as a 
control without exposure to the virus. Compared to the control NonVx group before co-infection, 
for the CE in blood, only γδ T cells were significantly enriched in blood of Vx pigs at 28 dpv/ 0 
dpi in PHGC16+20 (BC and AC: log2FC(Vx/NonVx) = 0.01).  Following infection of germ-free 
piglets with PRRSV strain VR-2332, the proportion of CD2+CD8α+ γδ T cells subset gradually 
but significantly increased at 21 and 28 dpi 46, which is consistent with our results. This is also in 
line with previous finding that γδ T proliferated from 0 to 60 days post PRRSV infection in four-
month-old gilts 47. γδ T cells can produce large amounts of interleukin 17 (IL-17), which is a pro-
inflammatory cytokine that can attract neutrophils to promote antigen presentation and activate 
granuloma formation in inflammatory monocytes 48. Therefore, production of IL-17 by γδ T cells 
contributes as a first line of defense against infection in Vx pigs. However, the genes involved in 
IL-17 signaling pathway were not DEGs for VxStatus at 28 dpv/ 0 dpi, and some of these genes 
were significantly expressed more in NonVx pigs at 4, 7, and 11 dpi without accounting for CE 
for both PHGC16+20 and PHGC22, including TIMP1, CXCL10, and JAK1/2 (results not 
shown). In memory response to infection, γδ T cells can accumulate after primary infection as 
tissue-resident memory T cells to protect the host from secondary infection 49. Therefore, 
enrichment of γδ T cells in Vx pigs at 28 dpv/ 0 dpi, before co-infection with PRRSV and 
PCV2b, may induce strong pathogen-specific cell-mediated immune response, which may confer 
against the secondary infection.  
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When accounting for CE in blood at 7 dpv, in PHGC22, 13 DEGs were identified for 
VxStatus that were predicted by IPA to be involved in activating both the antiviral response and 
the innate immune response, and all of these were expressed more in Vx pigs than in NonVx pigs 
(Figure 4.4A). In the most significant pathway for VxStatus, the “interferon signaling pathway”, 
which is a well-known innate immunity upon virus infection or vaccination, all seven DEGs 
involved in that pathway were significantly expressed more in Vx than in NonVx pigs at 7 dpv 
(Figure 4.4B). This is consistent with the changes in the PBMC transcriptome response to PRRS 
vaccination in Pietrain pigs at 1 dpv, which revealed that the PRRS vaccine can induce pro-
inflammatory responses 30. In PHGC16+20, IFI6 was significantly expressed more in Vx pigs 
and was the only DEG involved in the “interferon signaling pathway” (results were not shown). 
In PHGC16+20, the number of DEGs was limited for IPA to output significant enrichment 
pathways.  
In PHGC16+20_AC with CE, at 28 dpv/ 0 dpi, IFNG (also named IFN-γ), IRF7, and 
IRF3 were predicted to be expressed more in Vx than NonVx pigs and IL-4 was predicted to be 
expressed less in Vx pigs based on their downstream DEG expressions (Figure 4.5). This finding 
is in line with previous studies, which reported that an MLV-PRRS vaccine induced increasing 
IFN-γ secreting cells among peripheral blood mononuclear cells (PBMC) gradually from 0 to 56 
dpv 50, and overexpression of IFN-γ at 28 dpv but not at 1 dpv in the PBMC transcriptome in 
pigs 30. Additionally, γδ T cells were shown to produce IFN-γ from 0 to 50 days after PRRSV 
challenge in four-month-old gilts 38. After a second exposure to PRRSV, at 14 days post 
challenge, both γδ T cells and CD4+ T cells were shown to increase IFN-γ production 
significantly while the number of γδ T cells and CD4+ T cells also increased but not significantly 
in four-month-old gilts 47. IFN-γ provides major contributions to the cell-mediated immune 
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system by inhibiting PRRSV replication in porcine macrophage 51. IRF3 and IRF7 are essential 
transcription factors of type I IFNs that are important for both innate and adaptive immunity to 
evoke antiviral responses. Therefore, the observed greater expression of IRF3, IRF7 and their 
downstream genes, CMPK2, ISG20, PARP14, PSMB9, and DHX58, at 28 dpv/ 0 dpi may induce 
stronger innate immunity in Vx pigs. IL-4 can inhibit IL-6 and antibody production in pigs and 
suppress transcription of inflammatory cytokine gene in porcine alveolar macrophages, as well 
as B cell proliferation in pigs 52,53. Therefore, the observed lower expression of IL-4 in Vx pigs at 
28 dpv/ 0 dpi could enhance adaptive immunity. In summary, the greater enrichment of γδ T 
cells and the greater expression of DEGs involved in innate immunity in Vx compared to NonVx 
pigs are consistent with our hypothesis that PRRS vaccination can induce immunity, by 
enrichment of immune cells and greater expression levels of antiviral response genes compared 
to pigs without vaccination. 
PRRS Vaccination Effect After Co-infection 
After co-infection, xCell predicted more B cells, especially memory B cells, class 
switched memory B cells (csmB) and naïve B cells, in Vx than in NonVx pigs at 4, 7, 11, and 14 
dpi (only B cells and csmB cells at 14 dpi) in both PHGC16+20 and PHGC22 (Figure 4.2), 
which suggests that the PRRS vaccination stimulated humoral immune response through 
proliferation and differentiation of B cells. Sinkora et al. 46 showed that with PRRSV strain VR-
2332 infection only in blood of germ free piglets, the proportion of naïve CD2+CD21+ B cells 
subset gradually decreased significantly at 21 and 28 dpi; the proportion of CD2-CD21- resting 
antibody-forming cells and plasma cells (AFC/PC) and CD2+CD21- effector AFC/PC subset 
gradually increased significantly at 21 and 28 dpi; and the proportion of primed CD2-CD21+ B 
cells subset did not change in blood comparing to controls. However, with PCV2a isolate 688 
infection only, the proportion of these B cells subset did not change 46. Therefore, Vx pigs may 
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produce B cells before co-infection at 28 dpv, which may result in more B cells in Vx pigs than 
NonVx pigs after co-infection. This also indicates that before 21 dpi, especially at the beginning 
of the infection, B cells may not be activated in NonVx pigs. xCell also predicted more Th2 cells 
in Vx than in NonVx pigs at 4 dpi but in PHGC16+20 only (the same trend was found in 
PHGC22 at 4 dpi, results were not shown), and at 7 dpi in both PHGC16+20 and PHGC22 
(Figure 4.2). Th2 cells can produce IL-10, which is a negative regulator of immune response by 
suppressing Th1 cell proliferation and dendritic cell function 54. It has been shown that PRRSV 
infection in dendritic cells derived from monocytes in the porcine peripheral blood stimulates IL-
10 production. Sinkora et al. 46 also showed that PRRSV polarizes the immune response from 
Th1 to Th2, which could result in immunosuppression 55. However, we still identified more Th1 
cells in Vx pigs at 7 dpi (Figure 4.2), which indicates that or PCV2a infection only in blood of 
germ free piglets, the proportion of effector/memory CD4+CD8α+ αβ T helper cells subset 
gradually increased significantly at 7 (PRRSV only), 14, 21 and 28 dpi. In our study, we also 
identified that Vx pigs had more CD8+ T cells and their subsets, Th1, γδ T cells, CD4+ memory 
T cells and NK cells than NonVx pigs at 7 dpi (Figure 4.2). Although the magnitude of the FC 
differences in CE scores between treatments or factors were small because of the large 
coefficient of variation of the CE scores (Table 4.S2), these results are consistent with our 
hypothesis and the significant pathways we identified after co-infection without considering cell 
enrichments (Figure 4.6) that after co-infection, Vx pigs can induce stronger adaptive immune 
response by increasing the number of adaptive immune cells than NonVx pigs. Meanwhile, we 
also identified larger enrichment scores for innate immune cells in the NonVx compared to the 
Vx pigs, such as macrophages, dendritic cells, neutrophils, eosinophils and mast cells after co-
infection in PHGC16+20 and/or PHGC22, especially at 7 dpi (Figure 4.2). This is also consistent 
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with our hypothesis and the significant pathways we identified after co-infection without 
accounting for CE (Figure 4.6) that, compared to Vx pigs, co-infection in NonVx pigs induces 
stronger innate immune response by stimulating more innate immune cells because for NonVx 
pigs, the co-infection was their first time to be exposed to virus resulting in initiation of innate 
immune response. 
When accounting for CE in PHGC16+20, most of the immune related pathways were 
more activated or less inhibited in Vx pigs than in NonVx pigs after co-infection (Figure 4.6). 
This is consistent with the observation that Vx pigs had lower PRRS VL than NonVx pigs after 
co-infection. However, at 4 dpi, some of the DEGs for VxStatus were related to enhancing 
antiviral response through innate immune response and all of them were expressed more in 
NonVx pigs except FN1, IL18 and LYST (Figure 4.7). This is consistent with results presented in 
Figure 4.6 that “interferon signaling” was less activated in Vx pigs at 4 dpi in PHGC16+20. 
However, in PHGC22, only one DEG, IRF1, was involved in the “interferon signaling” and 
expressed more in Vx pigs (q=0.096, log2FC= 0.54). Although all pathways at 7 dpi in 
PHGC16+20 in Figure 4.6 were activated more in Vx pigs with CE, 12 DEGs regulated by IRF7 
were expressed less in Vx pigs. IRF7 was significantly expressed more in NonVx pigs at 4 dpi 
with and without CE, and at 7 dpi without CE in PHGC16+20. At 14 dpi, a stronger 
inflammatory response was identified in NonVx pigs in PHGC16+20 based on the DEGs with 
CE (Figure 4.10). In summary, when accounting for cell enrichments in blood from 4 dpi, the 
adaptive immune response was more activated in Vx pigs but some of the innate immunity, 
especially regulated by IRF7, was less activated in Vx pigs. One possible interpretation of the 
stronger innate immunity in NonVx pigs at 4 dpi when accounting for CE in blood is that PCV2b 
can induce stronger innate immunity in NonVx pigs than in Vx pigs after co-infection. This is 
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also supported by the finding that PCV2b VL in was higher in Vx than NonVx pigs at 11 and 14 
dpi in PHGC16+20 (Figure 4.1C). In the same study (only PHGC16), Niederwerder et al. 27 also 
reported that Vx pigs showed not only greater PCV2b viremia than NonVx pigs but also lower 
ADG, more PCVAD clinical signs and higher mortality; For PHGC16+20, Dunkelberger et al. 26 
also showed that AA_Vx (WUR genotype_VxStatus combination) pigs had significantly higher 
PCV2b viral load (calculated as the area under the curve of log-transformed viremia between 0 
and 42 dpi) than the other three groups. 
Effect of WUR Genotype and Its Interaction with PRRS Vaccination Status 
The GBP5 gene was significantly expressed less in pigs with the AA genotype at WUR than AB 
pigs across all trials and all time points, except PHGC22_AC (q=0.14). GBP5 is known to be 
involved in innate immunity 23,56. WUR did not have significant interaction effects with dpv or 
dpi, which suggests that the effect of WUR on gene expression in blood is stable across all time 
points before and after coinfection. The SLC41A2 gene was expressed more in AA than AB pigs 
in PHGC16+20 with and without CE. The same but non-significant (q=0.86) trend was found in 
PHGC22_AC with CE but opposite trend without CE. SLC41A2 is a plasma-membrane Mg2+ 
transport 57. Mg2+ plays a potential role in activation of immune response because deletions of 
Mg2+ transporters in humans, such as TRPM6 and MAGT1, can induce Hypomagnesemia and 
X-chromosomal immunodeficiency, respectively 58. The function of SLC41A2 and its more 
expression in AA pigs suggests that AB pigs can induce a stronger innate immune response 
through GBP5 and may not need other cell-mediated immunity such as through SLC41A2 to 
enhance the immunity. This is consistent with our hypothesis that before and after co-infection, 
AB pigs, which have putative functional GBP5, can induce stronger innate immune response 
than AA pigs. 
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We only identified interactions of WUR genotype with PRRS vaccination status on the 
blood transcriptome after co-infection in PHGC16+20 with CE. Four DEGs, UBXN11, STXBP1, 
SEC61G, and a novel gene, were identified for the interaction effect between WUR and 
VxStatus, in PHGC16+20_AC with CE, which suggests the differences in expression of these 
genes between AA and AB were not the same for Vx and NonVx pigs. In order to interpret the 
biological meaning of the interaction, we tested the simple effect of WUR within the Vx and the 
NonVx pigs. Only one DEG, SEC61G, overlapped with the DEGs for the interaction. SEC61G 
was expressed significantly more in AA pigs than in AB pigs within the Vx group but was not a 
DEG within the NonVx group. The Sec61 channel plays a role in retro-translocation of 
misfolded MHC class I proteins from endoplasmic reticulum to cytosol for degradation by 
proteasome 59. Viruses can co-opt the retro-translocation pathway to degrade proteins that are 
involved in host anti-viral immune response 60. Mizuno et al. 61 found that an increase in the 
expression of SEG61G was significantly associated with the occurrence of structural variants that 
may contribute to immune escape of tumor cells. Therefore, in AA pigs with PRRS vaccination, 
viruses may stimulate SEC61G gene expression to escape host immune response. However, in 
PHGC22_AC with CE, the interaction between WUR and VxStatus was not significant. The 
SEC61G gene was not a DEG for WUR effect and the trend was different between AA and AB 
pigs across VxStatus in PHGC22.  
Conclusions 
To the authors’ knowledge, this is the first time the blood transcriptome has been 
analyzed using RNA-seq across multiple time points after co-infection with PRRSV and PCV2b, 
especially with PRRS MLV before co-infection. The blood of Vx and NonVx pigs showed very 
different responses to PRRS MLV at 7 dpv and to co-infection at 4, 7, 11 and 14 dpi in number 
of DEGs and the amount of detectable PRRSV. After vaccination and before co-infection, the 
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PRRS MLV stimulated host innate immune response, especially by inducing increasing 
enrichment of immune cells, up-regulation of IRF7, STAT1 and their down-stream genes, and of 
the interferon signaling pathway at 7 dpv, compared to pigs without vaccination. Comparison of 
significant immune related pathways that involved DEGs for VxStatus across time points after 
co-infection suggested that Vx pigs induced stronger adaptive immune response by generating 
more adaptive immune cells and higher expression levels of adaptive immune response genes 
than NonVx pigs, and that co-infection in NonVx pigs induced stronger innate immune response 
by stimulating more innate immune cells and more expression of innate immunity related genes 
than Vx pigs because for NonVx pigs, the co-infection represented the first exposure to virus. 
Some DEGs were identified for the effect of WUR genotype, including its putative causal 
candidate gene, GBP5, which was significantly expressed more in AB pigs than in AA pigs 
across all trials and all time points. These DEGs in blood, and their biological functions, can help 
us understand PRRS vaccination effects on host-response mechanisms to coinfection with 
PRRSV and PCV2b in nursery pigs, and contribute to design a rationale for PRRS and PCVAD 
control strategy. 
Methods 
Co-infection Trial Design 
Blood samples used in this study were from three trials of the PHGC, trials 16, 20, and 
22. A detailed description of these trials is in Dunkelberger et al. 26. Each trial had an identical 
2x2 factorial experimental design and used three-week-old Large White by Landrace crossbred 
barrows. PHGC16 (n=199) and PHGC20 (n=197) were from one genetic source and PHGC 22 
(n=189) from another genetic source. Pigs for each trial were preselected based on genotype at 
the WUR SNP (approximately 50% AA and 50% AB) and randomly assigned to one of 2 rooms 
after weaning. Pigs in one room were vaccinated 3-4 days after weaning (between 21 and 32 
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days of age) using a 2-ml dose of a commercial PRRS modified live vaccine (Ingelvac PRRS®, 
Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO; GenBank accession no. AF159149), 
which was administered intramuscularly. At 28 dpv/ 0 dpi, pigs in both rooms were challenged 
with a 2-ml dose of 105 TCID50 PRRSV (isolate KS62; GenBank accession no. KM035803) and 
103.6 TCID50 PCV2b (GenBank accession no. JQ692110), which were administered intranasally 
and intramuscularly. Pigs were then followed for 42 dpi. Blood samples were collected from all 
piglets at 0, 4, 7, 11, 14, 21, and 28 dpv (0 dpi), and 4, 7, 11, 14, 21, 28, and 35 dpi. Real Time 
PCR assays were used to evaluate serum PRRS and PCV2b viremia, as described in 
Niederwerder et al 27.  
Analyses of Viremia 
Comparisons of the level of PRRS and PCV2b viremia of pigs at each time point between 
each WUR genotype x VxStatus combination (AA_Vx, AB_Vx, AA_NonVx, AB_NonVx) were 
done separately for PHGC16+20 and PHGC22 and for data before and after co-infection. 
Analyses were performed using a mixed linear model in SAS 9.4 (SAS Institute, Cary, NC), with 
the fixed effects of trial (only for PHGC16+20), WUR, VxStatus, dpv, two-way interactions 
between WUR and VxStatus (WUR*VxStatus), between WUR and dpv (WUR*dpv), and 
between VxStatus and dpv (VxStatus*dpv), covariates of initial age and weight, and the random 
effects of pen within trial and litter to account for random environmental and common 
environmental effects, with a covariance structure on residuals to account for repeated 
measurements of the PRRS and PCV2b viremia over time. We selected the best covariance 
structure from among Compound Symmetry, Spatial Power, and Toeplitz (models did not 
converge for other more complicated structures) based on the Akaike information criterion 
(AIC). The type 3 ANOVA test was used to generate p-values of the main effects of WUR and 
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VxStatus and for the three two-way interactions across all time points before and after 
coinfection for PRRS viremia, and after coinfection for PCV2b viremia. 
QuantSeq Experimental Design 
We conducted QuantSeq of RNA samples from two sets of pigs from PHGC16. Library 
preparations for the first set were without globin block (not developed yet at that time) 
(PHGC16.1), but with globin block for the second set (PHGC16.2). For PHGC 16.1, 190 blood 
samples collected on 28 piglets from 7 litters that had one piglet for each Vac x WUR genotype 
combination (AA_Vx, AB_Vx, AA_NonVx, AB_NonVx) were selected for transcriptome 
analysis (Table 4.1). For PHGC 16.2, 288 blood samples on 49 piglets from 16 litters with at 
least two of the four VxStatus x WUR combinations were selected (Table 4.1). For PHGC 20, 
216 blood samples on 30 piglets from 9 litters with at least three of the four VxStatus x WUR 
combinations were selected (Table 4.1), and for PHGC 22, 384 blood samples on 62 piglets from 
18 litters with at least three of the four VxStatus x WUR combinations (Table 4.1).  
Total RNA was isolated from blood samples using Preserved Blood RNA Purification Kit 
I (Norgen, Canada) according to the manufacturer’s protocol. RNA concentration, purity and 
integrity were first measured with NanoDrop ND-1000 UV-vis Spectrophotometer (NanoDrop 
Technologies Inc., Wilmington, DE, USA) and then by the RNA Nano 6000 Assay kit on the 
Bioanalyzer 2100 system (Agilent Technologies, CA, USA). As a measurement of the quality of 
the RNA in a sample, the RNA integrity number (RIN) of the extracted RNA was determined for 
each sample by the 2100 Bioanalyzer (Agilent Technologies, USA) using Eukaryote total RNA 
6000 Nano kit. 
The QuantSeq 3' mRNA-Seq Library Prep Kit FWD for Illumina (Lexogen, Austria) was 
used to generate the RNA-seq libraries from ~500 ng of total RNA according to the 
manufacturer’s protocol. For PHGC 16.2, 20 and 22, the RNA Removal Solution-Globin Block 
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Sus scrofa (commercially available as RS-GBSs: Lexogen Cat. No. 071) was used to reduce the 
presence of HBA and HBB in the library. For PHGC 16.1, the regular Removal Solution without 
globin block was used 62. Libraries from piglets from the same litter were assigned to the same 
plate and multiplexed to 96 samples. Each plate was loaded on two lanes of the Illumina HiSeq 
3000 Sequencing System (Illumina, USA) and sequenced with single-end 50 bp. 
QuantSeq Pipeline 
The QuantSeq raw sequence data were processed using a pipeline with Bbduk 
(https://jgi.doe.gov/data-and-tools/bbtools/bb-tools-user-guide/bbduk-guide/) to remove poly-A 
tails, adapter sequences, and low-quality bases, FastQC (Version 0.11.3) for checking read 
quality before and after trimming 63, and STAR (Version 2.5.3) 64 for read alignment. To avoid 
multiple mapping issues of hemoglobin (HB) genes, the sequences in the following regions were 
masked from the reference genome sequence Sus Scrofa 11.1: one of two similar exon sequences 
within HBA (ENSSSCG00000007978), as well as HBB-like (ENSSSCG00000014727). For 
gene annotation, the Ensembl pig 11.1 gene annotation was combined with annotation for an 
additional 12,491 novel genes that were identified by Pacific Biosciences single-molecule long-
read isoform sequencing (Iso-Seq) of a cross-bred pig and RNA-seq data of nine pig tissues 
(brain, hypothalamus, liver, muscle, thymus, pituitary, small intestine, spleen and diaphragm) 33. 
“Novel gene” in the manuscript refers to these genes that were first identified using Iso-Seq data 
by Beiki et al. 33. In the current version of the Ensembl gene annotation (pig 11.1), the WUR 
SNP (rs80800372) and the putative causative intronic SNP in the GBP5 gene (rs340943904) are 
present in three different transcripts (ENSSSCT00000065307, ENSSSCT00000060466, 
ENSSSCT00000044130) that are all annotated as guanylate binding protein 1 (GBP1) and no 
transcripts have been annotated as the GBP5 gene in the 11.1 Ensemble annotation. However, 
blasting the cDNA sequence of GBP5 reported by Koltes et al. 22 to these three transcripts 
116 
identified them to be GBP5. Therefore, these three of the nine GBP1 transcripts in the 11.1 
annotation were separated and tagged to be recognized as a GBP5. BAM output files from STAR 
were used to build an index using Samtools (Version 1.3.1.1) 65 and HTSeq-count 66 was used for 
counting unique-mapping reads, using the merged IsoSeq novel gene annotation and version 11.1 
of the pig reference genome (Ensemble, http://www.ensembl.org/), with the GBP5 gene 
annotation included, as described above, as the gtf file. Reads from the HBA 
(ENSSSCG00000007978) and HBB (ENSSSCG00000014725) genes were filtered out before 
further analyses. Samples with 75th percentile read counts across all genes less than or equal to 
two were removed. Genes with average read counts across all remaining samples less than or 
equal to two were also excluded from further analysis. 
Cell Type Enrichment Estimation and Analysis 
Because blood consists of multiple cell types, any DEGs identified could be the result of 
differences in cell composition between blood samples. Because complete blood counts were not 
available on these samples, the cell type enrichment of each sample was estimated from the 
blood QuantSeq data with the xCell software 34. The xCell software uses expression levels of 
signature genes in each cell type in human to identify 64 cell types, including immune cells, 
stromal cells, stem cells, and other cells; similar protocols using signature genes in porcine cell 
types are not available. After filtering the samples and genes in the QuantSeq data as described 
above, the remaining genes in the blood transcriptome for which Sus Scrofa gene names from 
Ensembl had corresponding human gene names based on “ortholog_one2one” 
HumanHomologyType in Ensembl Biomart were inputted into the xCell software. For 
subsequent analyses, the log2 of cell type enrichment scores output by xCell after transformation 
of raw scores was used. The latter are the averages of single-sample gene set enrichment analysis 
scores of all gene signatures for a given cell type 34.  
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Because pigs in PHGC 16 and 20 were from one genetic background and pigs in PHGC 
22 were from the other genetic background, we analyzed the PHGC 22 data separately from the 
PHGC 16 and 20 (PHGC16+20) data. Also, because the cell composition in blood may be quite 
different before and after co-infection,  estimates of cell type enrichments before and after co-
infection were analyzed separately: data before co-infection included time points  4, 7, 11, 14, 
and 28 dpv (0 dpi) (PHGC16+20_BC; PHGC22_BC), while data after co-infection included time 
points 0, 4, 7, 11, 14, and 28 dpi (PHGC16+20_AC; PHGC22_AC). Note that the 28 dpv data 
are the same as the 28 dpv/ 0 dpi data, from blood samples that were collected on the day of co-
infection but just before co-infection. Data from this time point were also included in the after-
coinfection data set, as a baseline, just before co-infection. 
The xCell results for each cell type before and after the co-infection were analyzed 
separately using a mixed linear model in SAS 9.4 (SAS Institute, Cary, NC) with the fixed 
effects of WUR, VxStatus, dpv, RIN (covariate), and trial (PHGC16+20 only), the random effect 
of litter, and the 2-way and 3-way interactions among WUR, VxStatus, and dpv. For each data 
set (PHGC16+20_BC, PHGC22_BC, PHGC16+20_AC, PHGC22_AC), the best residual 
covariance structure for each cell type from the following six different covariance structures for 
repeated measures was selected based on AIC to account for the dependence of cell enrichments 
(CE) from the same pig across time points: Spatial Power, Compound Symmetry, Heterogeneous 
Compound Symmetry, Toeplitz, Heterogeneous Toeplitz, and Unstructured. To determine 
whether the plate of QuantSeq should be included as an additional effect, we also compared all 
six covariance structures with and without fitting plate as a random effect for each cell type 
based on AIC. The model used for final analysis of each cell type was the model selected as the 
best for the largest number of cell types. Then, based on False Discovery Rate (FDR), cell types 
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were assigned to a “significant cell type” group (Sig) if at least one of the factors of interest, i.e. 
WUR, VxStatus, dpv, or their interactions, was significant for that cell type (q<0.1); otherwise, it 
was assigned to the “nuisance cell type” group (Nui). The rationale for this was that effects of 
cell types in the Sig group were more important to account for in the differential expression (DE) 
analysis than the effects of cell types in the Nui group, because the former are expected to impact 
estimates of effects of factors of interest for DE. However, cell types in the Nui group may also 
be important to account for in DE analysis because, although there was no evidence of 
systematic differences between factors of interest for these cell types, they may explain part of 
the random variation in the gene expression data. After grouping the cell types, principal 
component analysis (PCA) was done for the two groups of cell types. Then, the top PCs that 
together explained more than 90% of the variance of CE within a group were included in the DE 
analysis model to account for CE, as described in the following.  
To test the effects of WUR, VxStatus, and dpv (or dpi) and their two-way and three-way 
interactions on gene expression in blood, we used the same two-stage backward selection method 
and methods for inferences and estimation as for the differential gene expression analysis 
described below but without Voom weight and PCs. We plotted the log2FC of the VxStatus 
simple effect (referring to the effect of one independent variable within one level of a second 
independent variable) at each time point after co-infection if FDR<0.1 using heatmap.2 function 
in R with the euclidean distance matrix and the complete agglomeration method for clustering, as 
by default. 
Differential Gene Expression Analysis  
The linear mixed-effects model used for each gene and, separately for PHGC 16/20 and 
PHGC 22 and for data before and after coinfection (PHGC16+20_BC, PHGC16+20_AC, 
PHGC22_BC, and PHGC22_AC), included all the variables described for analysis of CE, with 
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or without PCs of CE for the Sig and Nui groups of cell types. The differential expression 
analysis across time points was done using Voom 67. In order to improve power, Voom weights 
68 were generated to model sample and observational level variability in the models with and 
without PCs. Then, covariance structure selection was performed, as described for the CE 
analysis, except with Voom weights. Then, the following two-stage backward variable selection 
procedure was used to identify the best model across genes: in the first stage, a sequence of 
models was derived using a backward selection method in which, in each iteration, p-values were 
calculated for each effect in the model for each gene, from which a relevance measure was 
calculated for each effect as the number of genes with corresponding p-values less than 0.05. The 
effect with the lowest relevance measure was then removed from the model. To avoid removal of 
a lower order interaction term before its higher order interaction terms, we only considered the 
highest order terms involving WUR, the highest order terms involving VxStatus, the highest 
order terms involving dpv, and covariates as candidates to be removed in each iteration. Iteration 
was stopped when the least favorable effect was one of WUR, VxStatus and dpv main effect 
terms, which were kept in the model regardless of their level of significance. In the second stage, 
the final model was chosen from the sequence of models by computing the p-value for the type-3 
comparison of each model with its corresponding reduced model without any effects involving 
WUR, VxStatus, and dpv for each gene. Then, for each model in the sequence, the number of 
genes with significant p-values at 10% FDR was determined and the model with the maximum 
number of significant genes regarding WUR, VxStatus, and dpv, and their two-way and three-
way interaction, if present in the model was chosen as the final model. Type-3 tests were used to 
calculate p-values for each effect. When the two-way interaction effects between WUR and dpv 
or/and VxStatus and dpv were in the chosen model, p-values corresponding to the effects of 
120 
WUR and/or VxStatus for each dpv (also called “simple effects”) were calculated. Storey’s 
method 69 with an estimate of proportion of true null hypotheses based on the histogram-based 
method of Nettleton et al. 70 was applied to control FDR at less than 0.1 for identification of 
DEG. 
Ingenuity Pathway Analysis  
Pathway enrichment analysis of the identified DEGs was conducted using the Ingenuity 
Pathway Analysis software (IPA, 2019 release). Because IPA does not recognize pig Ensembl 
gene IDs, the IDs of 15,347 of 25,880 genes in Ensembl were converted from Ensembl pig gene 
ID to human gene names using BioMart in Ensembl with “ortholog_one2one” and “human 
orthology confidence” =1, and inputted into IPA identified by “Gene symbol-human 
(Hugo/HGNC, Entrez Gene)”. The cutoff for the log2(Fold Change) in IPA was set to 0 and the 
q-value cutoff was set to 0.1. In the canonical pathway analysis, the cutoff of Fisher’s Exact Test 
p-value was set to less than 0.05 and the cutoff for the absolute value of the z-score was set to be 
greater than 2.0. The comparison analysis of the pathway results between time points used 
Fisher’s Exact Test p<0.05 and |z|>1. 
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Tables and Figures 
Table 4.1. The number of RNA samples and pigs used for QuantSeq at each day post 
vaccination (dpv) or infection (dpi). 
Trial Vaccination 
status 
WUR 
genotype 
# 
pigs 
dpv      4   7 11 14 28 32 35 39 42 56 
dpi    -28 -21 -17 -14 0 4 7 11 14 28 
PHGC16.1 
Vx 
 
AA 7 5 3 6 6 6 4 6 5 6 6 
AB 7 4 4 6 4 7 7 7 7 7 7 
NonVx AA 7     7 7 5 6 6 4 
 AB 7     7 7 6 7 6 6 
PHGC16.2 
Vx 
 
AA 11     11 11 11 11 10 11 
AB 13     12 13 13 12 13 12 
NonVx 
 
AA 13     13 13 13 13 12 10 
AB 12     12 11 12 12 12 12 
PHGC20 
Vx 
 
AA 7 5 7   7 5 6 7 7 7 
AB 7 5 7 5  6 6 6 4 6 7 
NonVx 
 
AA 8  7 5  8 8 8 7 6 8 
AB 8  7   8 7 8 8 8 8 
PHGC22 
Vx 
 
AA 12 10 11 11 10 5 12 11 10 11  
AB 16 10 12 15 15 7 8 15 15 15  
NonVx 
 
AA 17  14  16 5 8 16 15 14  
AB 17  11  16 1 12 16 16 15  
 
 
Table 4.2. Summary mapping statistics for the QuantSeq reads. 
Trial Raw reads Mapping % Unique mapping % 
PHGC16 2,580,378 95.9 71.3 
PHGC20 3,309,625 98.5 71.2 
PHGC22 2,295,524 98.2 68.2 
Average 2,728,509 97.5 70.2 
 
 
Table 4.S1. The number of genes identified in the blood transcriptome with or without 
accounting for cell type enrichment. 
 Before co-infection After co-infection  
Trial Without cell 
enrichment 
With cell 
enrichment 
Without cell 
enrichment 
With cell 
enrichment 
Average 
PHGC16+20 15,297
1 
(10,585/4,712)2 
15,182 
(10,504/4,678) 
15,343 
(10,618/4,725) 
15,343 
(10,618/4,725) 
15,301 
(10,581/4,710) 
PHGC22 17,617 (11,711/5,906) 
17,617 
(11,711/5,906) 
17,617 
(11,711/5,906) 
17,617 
(11,711/5,906) 
17,617 
(11,711/5,906) 
1 The number of genes identified in total in the blood transcriptome. 
2 In the parentheses, the number of genes in version 11.1 of the pig Ensembl gene annotation followed by the 
number of novel genes identified in the IsoSeq novel gene annotation. 
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Table 4.S2. Mean and standard deviation (SD) of each cell type across all samples in each 
dataset. Enrichment scores generated by xCell cannot be interpreted as proportions or compared 
between different cell types. 
Cell type PHGC 22 PHGC 16+20 Mean SD Mean SD 
Activated dendritic cells 2.6E-02 4.2E-02 3.2E-02 5.1E-02 
Adipocytes 1.1E-03 6.9E-04 1.3E-03 9.7E-04 
Astrocytes 5.5E-03 4.2E-03 1.2E-02 7.5E-03 
B-cells 3.8E-02 1.6E-02 4.1E-02 1.6E-02 
Basophils 8.8E-02 3.7E-02 1.2E-01 4.5E-02 
CD4+ memory T-cells 6.5E-03 4.5E-03 6.9E-03 4.3E-03 
CD4+ naive T-cells 7.2E-03 4.6E-03 1.2E-02 6.0E-03 
CD4+ T-cells 6.0E-03 3.0E-03 1.0E-02 4.2E-03 
CD4+ central memory T-cells 1.8E-02 8.0E-03 2.1E-02 8.6E-03 
CD4+ effector memory T-cells 5.9E-02 1.7E-02 3.6E-02 1.8E-02 
CD8+ naive T-cells 8.9E-03 4.1E-03 4.5E-03 3.0E-03 
CD8+ T-cells 2.6E-02 1.4E-02 3.3E-02 1.3E-02 
CD8+ central memory T-cells 1.5E-02 1.0E-02 2.2E-02 1.2E-02 
CD8+ effector memory T-cells 1.5E-02 1.1E-02 2.6E-02 1.0E-02 
Xonventional dendritic cells 1.0E-02 8.4E-03 1.7E-02 1.3E-02 
Chondrocytes 1.0E-02 6.8E-03 1.2E-02 7.1E-03 
Class-switched memory B-cells 4.5E-02 1.9E-02 5.1E-02 1.7E-02 
Common lymphoid progenitors 1.5E-02 1.0E-02 2.1E-02 1.1E-02 
Common myeloid progenitors 3.9E-03 2.3E-03 7.7E-03 3.8E-03 
Dendritic cells 4.6E-03 4.0E-03 4.0E-03 4.5E-03 
Endothelial cells 1.2E-02 6.4E-03 1.0E-02 6.4E-03 
Eosinophils 1.0E-02 8.0E-03 2.6E-02 1.3E-02 
Epithelial cells 4.3E-03 5.0E-03 3.0E-03 2.7E-03 
Erythrocytes 8.7E-04 7.4E-04 4.6E-04 4.5E-04 
Fibroblasts 5.9E-02 2.1E-02 6.4E-02 2.3E-02 
Granulocyte-macrophage progenitors 7.7E-03 2.1E-02 6.9E-03 2.3E-02 
Hepatocytes 1.6E-04 4.1E-04 5.1E-04 3.7E-04 
Hematopoietic stem cells 2.8E-02 2.5E-02 3.8E-02 2.2E-02 
Immature dendritic cells 4.7E-02 3.0E-02 1.4E-01 5.4E-02 
Keratinocytes 7.3E-04 7.3E-04 1.7E-03 1.6E-03 
Lymphatic endothelial cells 4.0E-03 2.7E-03 7.1E-03 5.4E-03 
Macrophages 1.1E-02 5.5E-03 1.3E-02 7.2E-03 
Macrophages M1 7.6E-03 5.3E-03 6.8E-03 5.8E-03 
Macrophages M2 6.7E-03 2.7E-03 7.5E-03 3.3E-03 
Mast cells 2.4E-02 4.9E-03 1.2E-02 3.1E-03 
Megakaryocytes 1.1E-02 8.6E-03 5.6E-02 2.1E-02 
Melanocytes 6.0E-04 5.1E-04 2.0E-03 1.4E-03 
Memory B-cells 4.3E-02 1.5E-02 4.9E-02 1.6E-02 
Megakaryocyte_erythroid progenitors 2.5E-02 1.3E-02 3.0E-02 1.5E-02 
Mesangial cells 1.7E-02 6.1E-03 3.4E-02 9.8E-03 
Monocytes 3.8E-02 1.5E-02 1.0E-01 3.0E-02 
Multipotent progenitors 1.6E-03 2.3E-03 9.7E-04 1.2E-03 
Mesenchymal stem cells 1.0E-01 4.3E-02 1.6E-01 7.4E-02 
Microvascular endothelial cells 2.2E-02 6.9E-03 1.4E-02 5.8E-03 
Myocytes 3.5E-02 1.8E-02 2.1E-02 1.5E-02 
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Table 4.S2. (continued) 
Cell type PHGC 22 PHGC 16+20 Mean SD Mean SD 
naive B-cells 1.4E-02 6.2E-03 1.8E-02 6.9E-03 
Neurons 5.1E-04 1.5E-03 1.6E-03 6.9E-04 
Neutrophils 6.6E-03 4.5E-03 2.5E-02 1.2E-02 
NK cells 1.4E-02 9.7E-03 1.9E-02 9.2E-03 
Natural killer T-cells 1.1E-01 4.4E-02 2.6E-01 6.7E-02 
Osteoblasts 3.8E-02 1.6E-02 3.8E-02 1.9E-02 
Plasmacytoid dendritic cells 1.2E-02 1.3E-02 1.7E-02 1.5E-02 
Pericytes 7.0E-02 3.4E-02 7.3E-02 3.4E-02 
Plasma cells 1.7E-02 9.4E-03 1.7E-02 9.1E-03 
Platelets 1.4E-02 1.0E-02 5.1E-02 1.8E-02 
Preadipocytes 9.4E-02 3.0E-02 9.6E-02 3.7E-02 
pro B-cells 1.2E-02 1.9E-02 1.6E-02 2.0E-02 
Sebocytes 5.3E-04 7.1E-04 1.7E-03 2.2E-03 
Skeletal muscle cells 1.2E-02 8.2E-03 6.6E-03 7.9E-03 
Smooth muscle cells 1.4E-01 3.9E-02 1.7E-01 6.3E-02 
Gamma delta T-cells 4.5E-03 3.4E-03 3.7E-03 2.5E-03 
Type 1 T-helper cells 9.6E-03 8.2E-03 1.0E-02 8.6E-03 
Type 2 T-helper cells 2.6E-02 2.8E-02 3.6E-02 2.8E-02 
Regulatory T-cells 1.4E-02 6.5E-03 1.0E-02 6.7E-03 
 
 
Table 4.S3. Cell types grouped in the significant cell group (at least one of WUR genotype, 
PRRS vaccination, days post vaccination/infection had a significant effect on cell enrichment) 
for each dataset. 
Table 4.S3.1. Cell types grouped into the significant cell group for PHGC16+20 before co-
infection 
Cell type Abbreviation of cell type Group Subgroup Parent/Child 
Hepatocytes Hepatocytes Non-Hematopoietic Epithelial Parent 
Hematopoietic stem cells HSC HSC HSC Parent 
Megakaryocytes Megakary. HSC HSC HSC 
CD8+ naive T-cells CD8+ naiveT Lymphocytes Lymphoid CD8+ T-cells 
CD8+ T-cells CD8+ T Lymphocytes Lymphoid Parent 
CD8+ effector memory T-cells CD8+ Tem Lymphocytes Lymphoid CD8+ T-cells 
Gamma delta T-cells Tgd Lymphocytes Lymphoid CD4+ T-cells 
Macrophages M2 Macro. M2 Non-lymphocytes Myeloid Macrophages 
Adipocytes Adipocytes Non-Hematopoietic Stroma Parent 
Fibroblasts Fibroblasts Non-Hematopoietic Stroma Parent 
Osteoblasts Osteoblast Non-Hematopoietic Stroma Skeletal muscle 
Preadipocytes Preadipocytes Non-Hematopoietic Stroma Adipocytes 
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Table 4.S3.2. Cell types grouped into the significant cell group for PHGC16+20 after co-
infection 
Cell type Abbreviation of cell type Group Subgroup Parent/Child 
Astrocytes Astrocytes Non-Hematopoietic Epithelial Parent 
Epithelial cells Epithelial cells Non-Hematopoietic Epithelial Parent 
Hepatocytes Hepatocytes Non-Hematopoietic Epithelial Parent 
Keratinocytes Keratinocytes Non-Hematopoietic Epithelial Epithelial cells 
Melanocytes Melanocytes Non-Hematopoietic Epithelial Parent 
Neurons Neurons Non-Hematopoietic Epithelial Astrocytes 
Sebocytes Sebocytes Non-Hematopoietic Epithelial Epithelial cells 
Common lymphoid progenitors CLP HSC HSC HSC 
Common myeloid progenitors CMP HSC HSC HSC 
Erythrocytes Erythrocytes HSC HSC HSC 
Hematopoietic stem cells HSC HSC HSC Parent 
Megakaryocytes Megakaryocytes HSC HSC HSC 
Megakaryocyte_erythroid 
progenitors MEP HSC HSC HSC 
Multipotent progenitors MPP HSC HSC Parent 
Platelets Platelets Non-lymphocytes HSC Parent 
B-cells B Lymphocytes Lymphoid Parent 
CD4+ memory T-cells CD4+ mT Lymphocytes Lymphoid CD4+ memory T-cells 
CD4+ naive T-cells CD4+ naiveT Lymphocytes Lymphoid CD4+ T-cells 
CD4+ T-cells CD4+ T Lymphocytes Lymphoid Parent 
CD4+ central memory T-cells CD4+ Tcm Lymphocytes Lymphoid CD4+ T-cells 
CD4+ effector memory T-cells CD4+ Tem Lymphocytes Lymphoid CD4+ T-cells 
CD8+ naive T-cells CD8+ naiveT Lymphocytes Lymphoid CD8+ T-cells 
CD8+ T-cells CD8+ T Lymphocytes Lymphoid Parent 
CD8+ central memory T-cells CD8+ Tcm Lymphocytes Lymphoid CD8+ T-cells 
CD8+ effector memory T-cells CD8+ Tem Lymphocytes Lymphoid CD8+ T-cells 
Class-switched memory B-cells csmB Lymphocytes Lymphoid B-cells 
Memory B-cells mB Lymphocytes Lymphoid B-cells 
naive B-cells naive B Lymphocytes Lymphoid B-cells 
NK cells NK Lymphocytes Lymphoid Parent 
Natural killer T-cells NKT Lymphocytes Lymphoid Parent 
Plasma cells Plasma Lymphocytes Lymphoid B-cells 
pro B-cells pro B Lymphocytes Lymphoid B-cells 
Gamma delta T-cells Tgd Lymphocytes Lymphoid CD4+ T-cells 
Type 1 T-helper cells Th1 Lymphocytes Lymphoid CD4+ T-cells 
Type 2 T-helper cells Th2 Lymphocytes Lymphoid CD4+ T-cells 
Regulatory T-cells Tregs Lymphocytes Lymphoid CD4+ T-cells 
Activated dendritic cells aDC Non-lymphocytes Myeloid DC 
Basophils Basophils Non-lymphocytes Myeloid Parent 
Conventional dendritic cells cDC Non-lymphocytes Myeloid DC 
Dendritic cells DC Non-lymphocytes Myeloid Parent 
Immature dendritic cells iDC Non-lymphocytes Myeloid DC 
Macrophages Macro. Non-lymphocytes Myeloid Parent 
Macrophages M1 Macro. M1 Non-lymphocytes Myeloid Macrophages 
Macrophages M2 Macro. M2 Non-lymphocytes Myeloid Macrophages 
Mast cells Mast cells Non-lymphocytes Myeloid Parent 
Monocytes Monocytes Non-lymphocytes Myeloid Parent 
Neutrophils Neutrophils Non-lymphocytes Myeloid Parent 
Plasmacytoid dendritic cells pDC Non-lymphocytes Myeloid DC 
Adipocytes Adipocytes Non-Hematopoietic Stroma Parent 
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Table 4.S3.2. (continued) 
Cell type Abbreviation of cell type Group Subgroup Parent/Child 
Chondrocytes Chondrocytes Non-Hematopoietic Stroma Parent 
Endothelial cells Endothelial cells Non-Hematopoietic Stroma Parent 
Fibroblasts Fibroblasts Non-Hematopoietic Stroma Parent 
Lymphatic endothelial cells ly Endothelial cells Non-Hematopoietic Stroma Endothelial cells 
Mesangial cells Mesangial cells Non-Hematopoietic Stroma Fibroblasts 
Mesenchymal stem cells MSC Non-Hematopoietic Stroma Parent 
Microvascular endothelial cells mv Endothelial cells Non-Hematopoietic Stroma Endothelial cells 
Myocytes Myocytes Non-Hematopoietic Stroma Skeletal muscle 
Osteoblasts Osteoblast Non-Hematopoietic Stroma Skeletal muscle 
Pericytes Pericytes Non-Hematopoietic Stroma Fibroblasts 
Preadipocytes Preadipocytes Non-Hematopoietic Stroma Adipocytes 
 
Table 4.S3.3. Cell types grouped into the significant cell group for PHGC22 before co-infection 
Cell type Abbreviation of cell type Group Subgroup Parent/Child 
Adipocytes Adipocytes Non-Hematopoietic Stroma Parent 
Astrocytes Astrocytes Non-Hematopoietic Epithelial Parent 
CD4+ memory T-cells CD4+ mT Lymphocytes Lymphoid CD4+ memory T-cells 
CD4+ naive T-cells CD4+ naiveT Lymphocytes Lymphoid CD4+ T-cells 
CD4+ central memory T-cells CD4+ Tcm Lymphocytes Lymphoid CD4+ T-cells 
CD8+ T-cells CD8+ T Lymphocytes Lymphoid Parent 
CD8+ central memory T-cells CD8+ Tcm Lymphocytes Lymphoid CD8+ T-cells 
CD8+ effector memory T-
cells CD8+ Tem Lymphocytes Lymphoid CD8+ T-cells 
Chondrocytes Chondrocytes Non-Hematopoietic Stroma Parent 
Class-switched memory B-
cells csmB Lymphocytes Lymphoid B-cells 
Endothelial cells Endothelial cells Non-Hematopoietic Stroma Parent 
Erythrocytes Erythrocytes HSC HSC HSC 
Keratinocytes Keratinocytes Non-Hematopoietic Epithelial Epithelial cells 
Lymphatic endothelial cells ly Endothelial cells Non-Hematopoietic Stroma Endothelial cells 
Macrophages Macro. Non-lymphocytes Myeloid Parent 
Macrophages M1 Macro. M1 Non-lymphocytes Myeloid Macrophages 
Macrophages M2 Macro.M2 Non-lymphocytes Myeloid Macrophages 
Megakaryocytes Megakary. HSC HSC HSC 
Memory B-cells mB Lymphocytes Lymphoid B-cells 
Mesangial cells Mesangial cells Non-Hematopoietic Stroma Fibroblasts 
Monocytes Monocytes Non-lymphocytes Myeloid Parent 
Mesenchymal stem cells MSC Non-Hematopoietic Stroma Parent 
Myocytes Myocytes Non-Hematopoietic Stroma Skeletal muscle 
naive B-cells naive B Lymphocytes Lymphoid B-cells 
NK cells NK Lymphocytes Lymphoid Parent 
Osteoblasts Osteoblast Non-Hematopoietic Stroma Skeletal muscle 
Plasma cells Plasma Lymphocytes Lymphoid B-cells 
Platelets Platelets Non-lymphocytes HSC Parent 
Sebocytes Sebocytes Non-Hematopoietic Epithelial Epithelial cells 
Gamma delta T-cells Tgd Lymphocytes Lymphoid CD4+ T-cells 
Type 2 T-helper cells Th2 Lymphocytes Lymphoid CD4+ T-cells 
Regulatory T-cells Tregs Lymphocytes Lymphoid CD4+ T-cells 
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Table 4.S3.4. Cell types grouped into the significant cell group for PHGC22 after co-infection 
Cell type Abbreviation of cell type Group Subgroup Parent/Child 
Astrocytes Astrocytes Non-Hematopoietic Epithelial Parent 
B-cells B Lymphocytes Lymphoid Parent 
CD4+ naive T-cells CD4+ naiveT Lymphocytes Lymphoid CD4+ T-cells 
CD8+ naive T-cells CD8+ naiveT Lymphocytes Lymphoid CD8+ T-cells 
CD8+ T-cells CD8+ T Lymphocytes Lymphoid Parent 
CD8+ effector memory T-cells CD8+ Tem Lymphocytes Lymphoid CD8+ T-cells 
Chondrocytes Chondrocytes Non-Hematopoietic Stroma Parent 
Class-switched memory B-cells csmB Lymphocytes Lymphoid B-cells 
Common lymphoid progenitors CLP HSC HSC HSC 
Epithelial cells Epithelial cells Non-Hematopoietic Epithelial Parent 
Erythrocytes Erythrocytes HSC HSC HSC 
Fibroblasts Fibroblasts Non-Hematopoietic Stroma Parent 
Granulocyte-macrophage 
progenitors GMP HSC HSC HSC 
Macrophages Macro. Non-lymphocytes Myeloid Parent 
Macrophages M1 Macro. M1 Non-lymphocytes Myeloid Macrophages 
Mast cells Mast cells Non-lymphocytes Myeloid Parent 
Megakaryocytes Megakary. HSC HSC HSC 
Melanocytes Melanocytes Non-Hematopoietic Epithelial Parent 
Memory B-cells mB Lymphocytes Lymphoid B-cells 
Mesangial cells Mesangial cells Non-Hematopoietic Stroma Fibroblasts 
Monocytes Monocytes Non-lymphocytes Myeloid Parent 
Mesenchymal stem cells MSC Non-Hematopoietic Stroma Parent 
naive B-cells naive B Lymphocytes Lymphoid B-cells 
Neurons Neurons Non-Hematopoietic Epithelial Astrocytes 
Neutrophils Neutrophils Non-lymphocytes Myeloid Parent 
NK cells NK Lymphocytes Lymphoid Parent 
Natural killer T-cells NKT Lymphocytes Lymphoid Parent 
Osteoblasts Osteoblast Non-Hematopoietic Stroma Skeletal muscle 
Platelets Platelets Non-lymphocytes HSC Parent 
Preadipocytes Preadipocytes Non-Hematopoietic Stroma Adipocytes 
Gamma delta T-cells Tgd Lymphocytes Lymphoid CD4+ T-cells 
Type 1 T-helper cells Th1 Lymphocytes Lymphoid CD4+ T-cells 
Type 2 T-helper cells Th2 Lymphocytes Lymphoid CD4+ T-cells 
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Table 4.S4. Percentage of variance of cell enrichments in blood explained by principal 
components for cell types that are associated with factors of interest (Sig) and cell types that are 
not (Nui). 
 Trial Before or 
after co-
infection 
Cell 
type 
group 
PC1a PC2 PC3 PC4 PC5 PC6 PC7 PC8 PC9 PC10 PC11 PC12 
16+20 
 
Before Sigb 40.9 21.3 14.3 9.8 5.1 4.8 2.4 0.7 0.4 0.2 0.1  
Nuic 25.7 19.2 10.2 8.8 7.9 5.6 4.5 3.2 2.5 2.1 2.0 1.8 
After Sig 25.5 15.8 10.5 7.6 6.0 5.9 4.7 3.6 3.0 2.8 2.0 1.8 
Nui 78.3 21.7           
22 
 
Before Sig 31.5 17.7 13.7 9.8 6.7 5.8 3.4 2.7 2.2    
Nui 20.5 17.9 13.9 9.9 7.9 7.5 6.7 3.7 3.0    
After Sig 27.2 19.4 13.5 9.1 7.1 5.2 4.2 3.9 2.6    
Nui 26.8 22.1 15.0 10.3 6.4 5.0 3.6 3.1 1.8    
a Principal component; b significant cell type group; c nuisance cell type group. 
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Figure 4.1. Least square means ± standard errors for PRRSV and PCV2b viremia at each time 
point before (only PRRSV) and after co-infection for each WUR genotype by vaccination (Vx) 
status combination (AA_NonVx, AA_Vx, AB_NonVx, AB_Vx). A) PRRS viremia in 
PHGC16+20 before and after co-infection; B) PRRS viremia in PHGC22 before and after co-
infection; C) PCV2b viremia in PHGC16+20 after co-infection; D) PCV2b viremia in PHGC22 
after co-infection. * means significant PRRS vaccination effect on the phenotype at that time 
point across WUR genotypes; + means significant WUR effect on the phenotype at that time 
point across PRRS vaccination status. 
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Figure 4.2. Heatmap showing the log2(Fold Change) of predicted cell type enrichments that 
were significantly (FDR<0.1) different between vaccinated and non-vaccinated pigs. Sample 
names are designated as PHGC trial followed by the day post co-infection. The relative order of 
cell types was determined by hierarchical clustering based on the log2(Fold Change). The color 
key ranges from -0.04 to 0.04 by 0.01 increment. 
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Figure 4.3. The number of differentially expressed genes (DEGs) in blood using the model with 
(P) and without (NP) accounting for cell type enrichments in PHGC16+20 and PHGC22. A) 
Venn diagram of DEGs for the main effect of WUR genotype (AB and AA) across all time 
points before co-infection (BC) for PHGC16+20 and PHGC22 with and without cell 
enrichments. B) Venn diagram of DEGs for the main effect of WUR genotype (AB and AA) 
across all time points after co-infection (AC) for PHGC16+20 and PHGC22 with and without 
cell enrichments. C), D), and E) Venn diagrams of DEGs for the simple effect of vaccination 
status (Vx and NonVx) at 7, 14, and 28 days post vaccination (dpv), respectively, before co-
infection for PHGC16+20 and PHGC22 with and without cell enrichments. F), G), H), I) and J) 
Venn diagrams of DEGs for the simple effect of vaccination status (Vx and NonVx) at 0, 4, 7, 
11, and 14 days post infection (dpi) for PHGC16+20 and PHGC22 with and without cell 
enrichments. 
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Figure 4.4. Ingenuity Pathway Analysis results for PRRS vaccinated (Vx) pigs versus non-
vaccinated (NonVx) pigs at 7 days post vaccination in PHGC22 with considering cell 
enrichments in blood. Genes in red (green) were up- (down-)regulated in vaccinated pigs. ‘‘
’’indicates negative regulation and ‘‘à’’ positive regulation. A) Differentially expressed genes 
between vaccinated and non-vaccinated pigs have functions in activating antiviral response and 
innate immune response. Dotted lines are indirect interactions and solid lines are direct 
interactions. B) Interferon signaling pathway activation in blood of vaccinated pigs. Image of the 
canonical pathway of interferon signaling, highlighting genes found to be differentially 
expressed in blood of vaccinated versus non-vaccinated pigs.  
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Figure 4.5. Ingenuity Pathway Analysis (IPA) results for PRRS vaccinated (Vx) pigs versus 
non-vaccinated (NonVx) pigs at 28/0 days post vaccination/co-infection in PHGC 16+20 with 
considering cell enrichments in blood. Genes in red (green) were up- (down-)regulated in 
vaccinated pigs. Differentially expressed genes were predicted by IPA to be regulated by 
upstream regulator in orange and blue. Regulator in orange (blue) were predicted to be expressed 
more (less) in vaccinated pigs. Dotted lines are indirect interactions and solid lines are direct 
interactions; ‘‘ ’’indicates negative regulation and ‘‘à’’ positive regulation. 
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Figure 4.6. Heat map showing the immune related canonical pathways predicted by Ingenuity 
Pathway Analysis based on the differentially expressed genes in blood for vaccinated versus 
non-vaccinated pigs at 4, 7, 11, 14 and 28 days post co-infection, with and without considering 
cell enrichments (CE) in PHGC16+20 and PHGC22, respectively. The column names refers to 
with or without CE (P or NP), PHGC16+20 or PHGC22 (16 or 22), and days post vaccination 
(28, 32, 35, 39, 42, or 56). Prediction of more (less) activation of a canonical pathway in 
vaccinated than non-vaccinated pigs is represented by positive (negative) z-score and colored in 
orange (blue) in the heat map. The intensity of the color in the heat map indicates the magnitude 
of  the predicted difference based on |z-score|. P<0.05 and |z-score| >1 were set as the cutoffs for 
significant pathways. 
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Figure 4.7. Ingenuity Pathway Analysis results for PRRS vaccinated pigs versus non-vaccinated 
pigs at 4 days post co-infection in PHGC16+20 with considering cell enrichments in blood. 
Genes in red (green) were up- (down-)regulated in the blood of vaccinated pigs. Differentially 
expressed genes were predicted by IPA to be regulated by upstream regulators or play a role in 
biological functions in orange and blue. Regulators and functions in orange (blue) were predicted 
to be expressed and activated more (less) in vaccinated pigs. Dotted lines are indirect interactions 
and solid lines are direct interactions; ‘‘ ’’indicates negative regulation and ‘‘à’’ positive 
regulation. 
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Figure 4.8. Ingenuity Pathway Analysis results for PRRS vaccinated pigs versus non-vaccinated 
pigs at 7 days post co-infection. Genes in red (green) were expressed more (less) in the blood of 
Vx pigs. Dotted lines are indirect interactions and solid lines are direct interactions; ‘‘
’’indicates negative regulation and ‘‘à’’ positive regulation. (A) Differentially expressed genes 
(DEGs) for PRRS vaccinated pigs versus non-vaccinated pigs at 7 days post co-infection in 
PHGC16+20 with considering cell enrichments in blood were predicted by IPA to activate two 
biological functions in orange, which means that the functions were predicted by IPA to be more 
activated in vaccinated pigs. The DEGs were predicted to be regulated by the genes in orange, 
which were predicted to be more expressed in vaccinated pigs. (B) In PHGC22 with considering 
cell enrichments in blood, DEGs have functions in activating chemotaxis of phagocytes. (C) In 
PHGC22 with considering cell enrichments in blood, DEGs were predicted to be directly 
regulated by IRF7 (in blue) which were predicted to be expressed less in vaccinated pigs. 
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Figure 4.9. Ingenuity Pathway Analysis results for PRRS vaccinated pigs versus non-vaccinated 
pigs at 11 days post co-infection. Genes in red (green) were expressed more (less) in the blood of 
vaccinated pigs. Dotted lines are indirect interactions and solid lines are direct interactions; ‘‘
’’indicates negative regulation and ‘‘à’’ positive regulation. (A) In PHGC16+20 with 
considering cell enrichments in blood, differentially expressed genes (DEGs) were predicted to 
be directly regulated by IRF7 (in blue) which were predicted to be expressed less in vaccinated 
pigs. (B) In PHGC22 with considering cell enrichments in blood, DEGs were predicted to be 
indirectly regulated by IFNG, OSM, and IL1B (in blue) which were predicted to be expressed 
less in vaccinated pigs. 
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Figure 4.10. Network analysis for the differentially expressed genes (DEGs) for PRRS 
vaccinated pigs versus non-vaccinated pigs at 14 days post co-infection in PHGC16+20 with 
considering cell enrichments in blood. Dotted lines are indirect interactions and solid lines are 
direct interactions. ‘‘ ’’indicates negative regulation and ‘‘à’’ positive regulation. Genes in 
red (green) were expressed more (less) in the blood of vaccinated pigs. The grey genes were not 
DEGs and white genes were not expressed but predicted by Ingenuity Pathway Analysis to be 
involved in the network. The functions of these genes in the network are related to inflammatory 
response, antimicrobial response, and connective tissue disorders. 
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Figure 4.11. Network analysis for the differentially expressed genes (DEGs) for AA genotype at 
WUR and vaccinated (AA_Vx) pigs versus AB genotype at WUR and vaccinated (AB_Vx) pigs 
in PHGC16+20 with considering cell enrichments in blood. Dotted lines are indirect interactions 
and solid lines are direct interactions; ‘‘ ’’indicates negative regulation and ‘‘à’’ positive 
regulation. Genes in red (green) were expressed more (less) in the blood of vaccinated pigs. The 
grey genes were not DEGs and white genes were not expressed but predicted by IPA to be 
involved in the network.  
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Figure 4.S1. Ingenuity Pathway Analysis (IPA) results for PRRS vaccinated (Vx) pigs versus 
non-vaccinated (NonVx) pigs in PHGC22. (A) Heat map showing the immune related canonical 
pathways predicted by IPA based on the differentially expressed genes (DEGs) at 7 days post 
vaccination (dpv) with and without considering cell enrichments in blood. Prediction of more or 
less activation of a canonical pathway in Vx pigs than NonVx pigs is calculated as positive or 
negative z-score and colored in orange or blue, respectively, in the heat map. The intensity of the 
color in the heat map based on |z-score| indicates degree of the predicted difference. P<0.05 and 
|z-score| >1 were set as the cutoff for significant pathways. (B) DEGs at 14 dpv without 
considering cell enrichments in blood were predicted by IPA to activate cytotoxic reaction of 
cells. The red color indicates that the gene was up-regulated in Vx pigs whereas green color 
signifies downregulation. The four genes in green were predicted to be regulated by the genes in 
blue, which were predicted to be less expressed in Vx pigs. Dotted lines are indirect interactions 
and solid lines are direct interactions; ‘‘ ’’indicates negative regulation and ‘‘à’’ positive 
regulation. 
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Appendix: Justification of using xCell 
In order to justify the usage of xCell 1 in pigs, blood QuantSeq and complete blood count 
(CBC) data from 441 pigs were used to compare estimates of cell enrichments from xCell with 
CBC data. The CBC data were obtained using a flow cytometry-based hematology analyzer 2 to 
estimate the percentage of neutrophils, lymphocytes, monocytes, eosinophils, large unstained 
cells, and basophils. The blood samples were from 441 weaned barrows from healthy multiplier 
farms from PigGen Canada, which were moved to a research facility in Québec, Canada, as 
described in Putz et al. (2018). The blood samples were collected in Tempus Blood RNA Tubes 
(Thermo Fisher Scientific, USA) at approximately 27 days of age during acclimation in a 
quarantine nursery. Preserved Blood RNA Purification Kit I (Norgen, Canada) was used for the 
blood RNA extraction. 
QuantSeq raw data was processed as described in Chapter 4 Methods. We compared the 
transformed scores estimated from xCell using the blood QuantSeq data with the CBC data by 
calculating their correlations and plotting them in a scatter plot (Fig.1). Pearson correlations 
between estimates obtained from CBC and xCell for lymphocytes and neutrophils were 0.58 and 
0.73, respectively, (Fig.1) and Spearman correlations were 0.57 and 0.70. These were in the 
same range as correlations reported for human blood in the xCell paper 1: using data from two 
studies (n=61 and n=104), correlations of fractions of cell subsets from PBMCs obtained by 
mass spectrometry with cell type scores estimated by xCell from RNA-seq data of the 
corresponding whole blood samples ranged from 0.52 to 0.74. The mass spectrometry 
technology increases the number of simultaneously used probes in cytometry and the resolution 
of rare cell populations in complex samples 4. It also addresses the issues the spectral overlap 
issues of flow cytometry that limit fluorescence assay 4. However, for the other three cell types, 
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correlations between the percentage of CBC and the xCell estimated scores were very low 
(Fig.1). This may result from the gene signatures of these cell types may be not clearly defined in 
pigs but they are well known in neutrophils and lymphocytes. In blood, ~30% of cells are 
neutrophils and ~60% are lymphocytes, which are the two cell types with high correlation. So, 
the low correlation may also be due to the very small amount of these cell types in blood 
(monocytes: 1-10%; eosinophils: 0-7%; basophils: 0-0.5% in human).  
To justify our method of fitting principal components (PCs) of xCell estimated 
enrichment scores in the DEG model to account for cell composition, principal component 
analysis was conducted on the 441 blood QuantSeq data to generate PCs. To determine how 
much variation of each of the six cell types in the CBC data could be explained by the PCs of 
cell type enrichment scores, the percentage of each immune cell type based on the CBC data was 
analyzed with a linear model with the PCs as fixed effects. In total, 64 PCs were generated from 
the xCell transformed scores and the combination of largest PCs that explained more than 90% 
(91.3%) of the variance in enrichment scores were included in the linear model. The adjusted R-
square for lymphocytes and neutrophils was 0.60 and 0.61, which indicates that the PCs from 
xCell transformed scores explained ~60% variance of the CBC estimates of the percentages of 
lymphocytes and neutrophils. This suggests that our method to account for the cell enrichments 
using PCs from xCell scores captures enrichment of these two cell types. However, for the other 
three immune cells, the correlation and the adjusted R-square were low (monocytes%: 0.20; 
eosinophils%: 0.06; and basophils%: 0.07). This may be due to (1) the sampling of the blood for 
CBC measurement using the flow cytometry, which was not the whole tube of blood; (2) the 
quality of blood, which may have clotting, and the storage time of blood samples, which can 
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change the CBC counts because of degradation; (3) the gene signatures of these cells in xCell for 
humans are not appropriate for pigs. Therefore, future validation work is needed. 
Tables and Figures 
 
Figure 1. Scatter plots of the transformed enrichment scores estimated using blood QuantSeq 
data by xCell with the complete blood count results from flow cytometry. (A) lymphocytes, (B) 
neutrophils, (C) eosinophils, (D) monocytes, (E) basophils. 
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Abstract 
Pigs with complete resistance to porcine reproductive and respiratory syndrome (PRRS) 
virus have been produced by editing the CD163 gene, which serves as a receptor of the PRRS 
virus for entry into macrophages. In this study, we genotyped pigs from previously conducted 
experimental PRRS infection studies for several single nucleotide polymorphisms (SNPs) in the 
CD163 and other candidate genes (CD169, TRAF1, RGS16). SNPs in the CD163 gene were not 
included on SNP genotyping panels that were used for previous genome-wide association 
analyses in these studies. The objective of this study was to identify associations of natural 
variation in these candidate genes with host response to PRRS virus (PRRSV) infection and to 
co-infection with PRRSV and porcine circovirus type 2b (PCV2b) with or without prior 
vaccination with a PRRS modified live virus vaccine. Using data from PRRS-only infection 
trials and data following PRRS vaccination and PRRSV- PCV2b co-infection, several SNPs in 
the CD163, CD169, and RGS16 genes were significantly associated with PRRSV and/or PCV2b 
viral load, and/or growth rate after PRRSV-only infection, and/or with average daily gain post 
vaccination and post co-infection. The effects of some SNPs depended on genotype at a SNP 
151 
(WUR) with major effect on host response to PRRSV infection near the GBP5 gene or on PRRS 
vaccination status. Interestingly, one SNP in the 3’UTR of CD163 that was significantly 
associated with PRRSV viral load in the PRRSV-only infection trials may be targeted by a 
miRNA. The identified SNPs are potential genetic markers that can be used to select for 
increased natural resistance to PRRSV-only and/or PRRSV-PCV2b co-infection. 
Keywords: CD163, CD169, PRRSV, PCV2, pigs 
Introduction 
Porcine reproductive and respiratory syndrome (PRRS) has caused dramatic economic 
losses in the swine industry through worldwide spread since the 1990’s. The causative agent is 
an enveloped, positive, single-stranded RNA virus from the family Arteriviridae (Snijder et al., 
2013) and has a restricted tropism for host cells of monocyte/macrophage origin. Pigs are the 
only known natural host of the PRRS virus (PRRSV) (Lunney et al., 2016). The PRRS Host 
Genetics Consortium (PHGC) was established in 2007 in order to investigate the genetic basis of 
host response to PRRSV infection (Lunney et al., 2011). Results from the PHGC showed that the 
response of pigs to PRRSV infection is moderately heritable but highly polygenic (Waide et al., 
2017), except for genotype for the GBP5 gene or region (Koltes et al., 2015), which was shown 
to have a major effect on both viremia and weight gain following PRRSV infection (Boddicker 
et al., 2012; Boddicker et al., 2014a; Boddicker et al., 2014b). To our knowledge, no pigs with 
complete natural resistance to PRRS have been identified. In 2016, however, generation of 
CD163 gene knockout pigs that are completely resistant to infection with PRRSV isolate NVSL 
97-7895 was reported (Whitworth et al., 2016; Burkard et al., 2017), which was a breakthrough 
for modern pig breeding. The CD163 gene is a member of the scavenger receptor cysteine-rich 
(SRCR) superfamily and is a cellular receptor for the PRRSV (Calvert et al., 2007). The CD163 
knockout pigs have a non-functional SRCR domain 5 (SRCR5) from exon 7, which demonstrates 
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that SRCR5 in porcine CD163 is essential for PRRSV to infect macrophages. Ma et al. (2017) 
found that a single-site-mutation (not natural) at position 561 in CD163 SRCR5 causes an 
arginine to alanine substitution, which may be responsible for PRRSV to bind to the CD163 
receptor during virus invasion. The CD163 receptor consists of nine extracellular SRCR domains 
and two proline-serine-threonine-rich domains. Besides SRCR5, the other extracellular SRCR 
domains also participate in PRRSV infection (Gorp et al., 2010). After deletion of SRCR4-6 in 
CD163, the CD163 mutants were only expressed in HEK293T cells but not on the cell surface 
and none of the resulting HEK293T cells were infected by PRRSV (Gorp et al., 2010). After 
deletion of SRCR7-9 in CD163, although surface and intracellular expression of CD163 mutants 
were identified, none of the HEK293T cells were infected by PRRSV (Gorp et al., 2010).  
Johnson et al. (2018) used pooled sequencing of the exons of the CD163 gene of 35,000 
pigs with different genetic backgrounds and whole-genome sequencing of three pigs to identify 
natural mutations in the CD163 gene that may result in resistance of pigs to PRRSV infection, 
but no potential natural knockout variants of the CD163 gene were found. However, Ren et al. 
(2012) identified three SNPs in the CD163 gene and found one to be associated with risk of 
PRRSV infection in an outbreak population of 524 crossbred pigs (Duroc x (Landrace x Large 
White)) of approximately 1 year of age. In addition, using data from 47 Landrace x Yorkshire x 
Duroc pigs that were experimentally infected with the PRRSV JA142 strain, Lim et al. (2017) 
found significant associations of several SNPs in the CD163 gene with PRRSV viremia and 
weight gain at 21 days post infection (dpi) and with average viremia at 3, 14, 21, and 28 dpi, 
including the c.2509G>C, c.2638A>G and c.3534C>T polymorphisms. The latter SNP is located 
in the 3’-UTR region of the CD163 gene and was found by Wang et al. (2012) to be significantly 
associated with IgG content in blood in a population of 128 pigs from different breeds and 
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crosses without treatments. However, associations for the two SNPs in the CD163 gene that were 
identified by Ren et al. (2012), c.2592A>G (also named A2552G) and c.2740C>A (also named 
C2700A), were not found to be significant in the study of Lim et al. (2017). Interestingly, both 
the c.2509G>C and c.3534C>T SNPs had significant interaction effects with genotype at the 
WUR10000125 (WUR) SNP (Lim et al., 2017), which has previously been identified to have 
significant associations with PRRSV viral load (VL) and weight gain (WG) after PRRSV 
infection (Boddicker et al., 2012). The WUR SNP is in very high linkage disequilibrium with the 
putative causative mutation for this association in the GBP5 gene (Koltes et al., 2015). SNPs in 
the CD163 gene were not included on the SNP panel that was used to genotype the pigs in the 
PHGC trials, as the CD163 gene was not included in the porcine genome builds prior to the 
current 11.1 build (http://www.ensembl.org/Sus_scrofa/Info/Index). The same holds for several 
other candidate genes (although they were in the pig 10.2 genome) for host response to viral 
infection, including CD169, TRAF1, and RGS16. 
Initially, CD169 was postulated to be a required receptor on the surface of macrophages 
for PRRSV attachment and internalization into macrophages, based on binding with sialic acid 
on the PRRSV surface in vitro (Van Breedam et al., 2010). However, CD169 gene knockout pigs 
developed PRRSV viremia to a similar degree as wild-type pigs after PRRSV infection (Teson et 
al., 2013), which demonstrated that CD169 is not required for PRRSV infection. In addition to 
having a role in pathogen uptake into macrophages, CD169 also plays other roles in immune 
response. Specifically, CD169 can promote CD8+ cytotoxic T cell activity through cross-
presentation with CD8α+ dendritic cells (classical DC1, cDC1) (Dinther et al., 2018; Uchil et al., 
2019). The binding of CD169 to sialic acid ligands on other cells, such as cDC1 and B cells, also 
participates in anti-pathogen immune response by activating T and B cells (reviewed in Neill et 
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al., 2012). Ren et al. (2012) identified three SNPs in the CD169 gene and found two to be 
associated with risk of PRRSV infection in a population of 524 pigs (Duroc x (Landrace x Large 
White)).  Wang et al. (2012) found another non-synonymous SNP, c.878A>G, in exon 3 of the 
CD169 gene to be associated with white blood cell count in peripheral blood in a 128 mixed 
breed pig population. We evaluated these same four SNPs in the PHGC trials. 
The TNF receptor-associated factor (TRAF)1 can interact with the Toll/IL-1 receptor 
(TIR) domain-containing adaptor, inducing IFN-β (TRIF) to inhibit TRIF-induced NF-κB and 
IFN regulatory factor (IRF)3 activation and shutting down the TLR signaling pathway, which 
plays an essential role in mediating antiviral innate immune response (Xie et al., 2005). Although 
TRIF is involved in Toll-like receptor (TLR)3-mediated signaling and TLR3 can recognize 
double-strand (ds) RNA as a pathogen-associated molecular patterns, Guo et al. (2018) identified 
dsRNA in cells of pigs during the persistent stage of PRRSV infection. We also evaluate these 
SNPs in this study. 
Regulator of G protein signaling (RGS)16 is a GTPase-activating protein that can induce 
T cell migration and activation (Webster et al., 2014). RGS16 can interact with ORF3 of Porcine 
circovirus type 2 (PCV2) and plays a role in ORF3 translocation to the cell nucleus (Lovgren et 
al., 2009). ORF3 of PCV2 is involved in pathogenesis of PCV2 and contributes to the spread of 
PCV2 in cell culture through apoptosis (Karuppannan, 2011). PCV2 is a non-enveloped, single-
stranded, circular DNA virus (Todd et al., 1991) and is the causative agent of post-weaning 
multisystemic wasting syndrome (PMWS) (Harding and Clark, 1997). Lim et al. (2017) found 
two SNPs in the 5’ upstream region of the RGS16 gene to be associated with PCV2 viremia at 10 
weeks of age in 142 naturally infected pigs that were not vaccinated for PCV2. Therefore, we 
also set out to validate the effects of these two SNPs on PCV2 viral load (VL) in the PHGC 
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PRRSV/PCV2b co-infection trials reported on by Dunkelberger et al. (2017). Both PCV2 and 
PRRSV can suppress the host immune defense system and persist asymptomatically in pigs, 
which can cause secondary infections in affected susceptible pigs. Therefore, we also tested the 
effect of these two SNPs in the RGS16 gene on PRRSV VL in the PHGC PRRSV-only infection 
trials reported on by Boddicker et al. (2014a). 
Waide et al. (2017) conducted a genome-wide association study (GWAS) using data from 
13 PHGC PRRSV infection trials, including the 8 trials used in this study. She identified regions 
in the pig genome that were associated with PRRSV VL and WG to differ between the two 
different PRRSV isolates that were used in these trials, NVSL 97-7985 (NVSL) and KS2006-
72109 (KS06), except for the GBP5 region, which showed associations for both isolates. 
However, across these two PRRSV isolates, the genes near SNPs that were associated with host 
response at a less stringent level of significance were enriched for the same gene ontology (GO) 
terms, which suggested that many genes play roles in similar biological processes in pigs 
infected by either of these two PRRSV isolates (Waide et al., 2017). Consistent with this result, 
Hess et al. (2016) estimated the genetic correlation of host response between these two PRRSV 
isolates to be high for VL and WG in the PHGC trials.  
Dunkelberger et al. (2017) conducted a GWAS for host response in two PHGC PRRS-
PCV2b co-infection trials. SNPs that were significantly associated with PCV2b VL were near the 
major histocompatibility complex (MHC), while genes near SNPs that were significantly 
associated with PRRS vaccination VL and PRRS VL were involved in immune-related GO 
terms/pathways, and genes near SNPs significantly associated with growth rate were involved in 
metabolism GO terms/pathways, similar to results of the PRRSV-only infection studies by 
Waide et al. (2017). 
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Against this background, the objective of this study was to identify associations of natural 
variation in the CD163, CD169, TRAF1, and RGS16 genes on host response of nursery pigs to 
PRRSV-only infection and to co-infection with PRRSV and PCV2b following PRRS MLV 
vaccination.  
Materials and Methods 
Experimental Design 
Data and DNA used for this study were from the PRRSV and PRRSV-PCV2b co-
infection PHGC trials. A detailed description of animals and data from the PRRSV-only 
infection trials used for this study is in Boddicker et al. (2014a). Briefly, eight groups of ~200 
commercial crossbred piglets from one of six breeding companies were shipped to Kansas State 
University (KSU, Manhattan, KS) at weaning. After one week for acclimation, all pigs were 
inoculated with 105 tissue culture infectious dose (TCID50) of the NVSL PRRSV isolate, both 
intramuscularly and intranasally. Blood samples of each pig were collected at 0, 4, 7, 11, 14, 21, 
28, 35, and 42 dpi. Body weight was recorded weekly, starting at 0 dpi and all pigs were 
euthanized at 42 dpi. A detailed description of the two co-infection trials (PHGC16 (n=199) and 
PHGC20 (n=197)) is in Dunkelberger et al. (2017). Briefly, pigs were commercial Large White x 
Landrace crossbred barrows from the same high-health multiplier farm and the same genetic 
source. Piglets were pre-selected based on WUR genotype: approximately 50% AA and 50% 
AB. After shipping to Kansas State University, pigs were randomly assigned to one of two 
rooms. After 3-4 days to acclimate, pigs in one room were vaccinated with a 2-ml dose of a 
PRRS MLV vaccine (Ingelvac PRRS®, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO; 
GenBank accession no. AF159149). After 28 days post vaccination, all pigs in both rooms were 
co-infected with a 2-ml dose of 105 TCID50 PRRSV (isolate KS62; GenBank accession no. 
KM035803) and 103.6 TCID50 PCV2b (GenBank accession no. JQ692110), which were 
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administered both intranasally and intramuscularly (Niederwerder et al., 2015). All pigs were 
euthanized at 42 dpi. Blood samples were collected on vaccinated pigs at 0, 4, 7, 11, 14, and 21 
day post vaccination (dpv) and on all pigs at 0, 4, 7, 11, 14, and 28 dpi and then weekly until 42 
dpi. All pigs were weighed weekly, starting at 0 dpv. 
Genotypes 
All pigs from the PRRSV-infection only trials were genotyped using the Illumina Porcine 
SNP60 BeadChip (Ramos et al., 2009) and pigs from the co-infection trials were genotyped 
using the GeneSeek-Neogen PorcineSNP80 BeadChip (Dunkelberger et al., 2017). Fixed SNPs 
and SNPs with a genotyping call rate less than 0.85 were removed, while genotypes with a gene 
call score lower than 0.3 were set to missing. For the purposes of this study, DNA samples from 
all pigs were also genotyped by Geneseek Inc. using an Agena Mass Spec for an additional 29 
SNPs in the four candidate genes (19 in CD163, four in CD169, and two in both TRAF1 and 
RGS16). Most of these SNPs were previously identified to be associated with host response to 
PRRSV or PCV2 (RGS16 only) infection (Ren et al., 2012; Wang et al., 2012; B.L. Lim et al., 
2017; K.S. Lim et al., 2017). Using our previous tonsil RNA-seq data at 42 dpi from the PRRSV-
only infection trials (Qian et al. unpublished), we identified two SNPs in the TRAF1 gene, which 
were also included for genotyping in this study. Details on the genotyped SNPs are in Table 
5.S1. 
Phenotypes 
Previous studies have shown that viral load, calculated as the area under the curve for 
viremia post infection, is more heritable than viremia at individual time points or than specific 
parameters of the viremia curve (Boddicker et al., 2012; Hess et al., 2016). Viral load represents 
an overall measure of the immune response after infection. For the PRRSV-only infection trials, 
two phenotypes were analyzed: PRRS VL, which was calculated as the area under the curve of 
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log10 viral copies/ml of serum from 0 to 21 dpi, rather than to 42 dpi because viremia is lowly 
heritable after 28 dpi because of PRRSV rebound (Boddicker et al., 2012); and weight gain 
(WG) after infection, which was calculated as the difference in body weights between 42 and 0 
dpi. For the co-infection trials, the host response phenotypes described by Dunkelberger et al. 
(2017) were analyzed: PRRS VL post vaccination from 0 to 28 dpv (vaccination VL), PRRS VL 
post co-infection from 0 to 21 dpi (PRRS VL), and PCV2b VL post co-infection from 0 to 42 dpi 
(PCV2b VL), all calculated as area under the curve of the log10 of PRRSV RNA or PCV2b 
DNA copies in blood per reaction. Growth rate post vaccination (ADG Post Vx) and post co-
infection (ADG Post Co-X) were calculated as the regression of body weight from 0 to 28 dpv 
and from 0 to 42 dpi, respectively, on age. The same phenotypes recorded on Vx versus non-
vaccinated (NonVx) pigs were treated as separate genetic traits in the analyses. 
Linkage Disequilibrium Analyses 
Linkage disequilibrium (LD) between SNPs in each gene was quantified based on r-
squared using Haploview 4.2 (Barrett et al., 2005), both across trials and within each genetic 
source. If the SNPs were in complete LD within a gene across all trials in the PRRSV-only 
infection or in the co-infection trials, these SNPs were merged into one SNP.  
Association Analyses for PRRSV-only Infection Trials 
Single SNP analyses 
Single-SNP analyses to identify associations of the candidate gene SNPs with host 
response in the PRRSV-only infection trials were similar to those described by Waide et al. 
(2017), using ASReml 4 (Gilmour et al., 2015). Briefly, a linear mixed model was used to test 
the effect of SNP genotype on PRRSV VL and WG by fitting the genotypes of one SNP at a time 
as a fixed effect, along with the fixed effects of trial, parity of the sow within trial, sex, and 
genotype at the WUR SNP, covariates of initial age and weight, and the random effects of pen 
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within trial, litter, and animal to account for random environmental and common environmental 
effect, and genetic effect respectively: 
Model [1]       Yijklmnop = μ + Trialj + Parityk(j) + WURl +Sexm + SNPn + β1 * BegWti +                       
β2 * BegAgei + Animali + Littero + Penp(j) + eijklmnop,     
where Yijklmnop = the observed phenotype (PRRS VL or WG); Trialj = fixed effect of the 
jth trial (1-8); Parityk = fixed effect of parity of sow nested within trial; WURl = fixed effect of 
WUR SNP genotype (AA or AB); Sexm= fixed effect of sex (male or female); SNPn = fixed 
effect of the nth genotype (0, 1, or 2) at the fitted SNP; βP = partial regression coefficients for the 
covariate initial weight (BegWt) (P=1) and initial age (BegAge) (P=2); Animali = random animal 
genetic effect of the ith individual, assumed distributed ~ N(0, G "#$), with G equal to the 
genomic relationship matrix constructed using SNP genotypes from the Illumina Porcine SNP60 
BeadChip (Ramos et al., 2009) and the 29 SNPs in the four candidate genes, and "#$ is the 
additive genetic variance; Littero = random litter effect (20 levels), assumed to be distributed 
~N(0, I "%$); and Pen = random effect of pen nested within trial (97 levels), assumed to be 
distributed ~N(0, I "&$). Since the effect of trial (environmental effect) was confounded with 
genetic source in the experimental design, we assumed that pigs from different genetic sources 
were not related when constructing G. The Benjamini-Hochberg method (Benjamini and 
Hochberg, 1995) was used to control the false discovery rate (FDR).  
Haplotype analyses 
For the 19 genotyped SNPs in the CD163 gene, after merging SNPs in complete LD with 
each other, 16 SNPs were included for haplotype analyses. The software EAGLE (Loh et al., 
2016) was used for phasing the PRRSV-only infection trial data. In order to reduce the number 
of haplotypes to fit in the linear model to associate with VL and WG, the resulting 21 haplotypes 
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were analyzed with the MEGA7 software (Kumar et al., 2016) to establish a phylogenetic tree of 
the haplotypes based on the number of nucleotide substitutions per site between haplotype 
sequences. The neighbor-joining method with the p-distance option was used. After classifying 
the haplotypes into three groups (A, B, and C), the combination of two haplotypes in each 
individual, also called a diplotype, was fitted as a class variable in the single SNP association 
analysis Model [1] instead of SNP genotype. All other variables were the same as for Model [1]. 
Bayesian analyses 
The additional 29 genotyped SNPs were merged with genotypes from the Illumina 
Porcine SNP60 BeadChip. All SNPs were fitted simultaneously as random allele substitution 
effects using the Bayes-B method (Habier et al., 2011), as implemented in the JWAS software 
(Cheng et al., 2018). Missing SNP genotypes were replaced by the mean genotype code for that 
pig’s genetic background for that SNP. The linear mixed model was the same as used for the 
single SNP analysis (Model [1]) but without WUR genotype as a fixed effect and with the effects 
of SNP and animal replaced by ∑ ()*)+),)  , where zj = vector of the genotype covariate for SNPj 
(j = 1 to k) based on the number of B alleles using Illumina’s genotype calling (coded 0, 1, 2, or 
equal to the average for missing genotypes); *) = allele substitution effect for SNPj, and +) = 
indicator for whether SNP j was included (+) = 1) or excluded (+) = 0)  in the model for a given 
iteration of the Markov chain Monte Carlo (MCMC). A total of 50000 iterations were run for 
each analysis, with the first 5000 iterations discarded as burn-in. The probability of +) = 0 was 
set equal to p = 0.99. Genomic regions associated with traits were identified using non-
overlapping, 1 Mb windows using build 11.1 of the pig genome (Ensembl). 
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Bivariate Single-SNP Analyses for Co-infection Trials 
Associations of the candidate gene SNPs with phenotypes in the co-infection trial data 
were analyzed using the bivariate animal models described by Dunkelberger et al. (2017), to 
allow for differences in the genetic control of a trait depending on PRRS vaccination. The linear 
mixed models allowed estimation of the effect of each SNP, one at a time, averaged across PRRS 
vaccination status and the interaction effect between SNP genotype and vaccination status on 
PRRS/PCV2b VL and ADG Post Vx/Co-X. Additional effects the fixed effects of trial and WUR 
genotype, covariates of initial weight and age, and PCV2b viremia at 0 dpi, and the random 
effects of pen within trial, litter, and animal to account for random environmental, common 
environmental, and genetic effects, respectively, with bivariate distributions equivalent to the 
univariate distributions of Model 1 but allowing for covariances between the two traits analyzed 
(with and without vaccination). 
Prediction of miRNA that Target CD163 and SNP Associations with CD163 Expression 
We used the RNA22 software (Miranda et al. 2016) to detect potential microRNAs 
(miRNAs) that target the 3’UTR region of CD163 when it’s sequence includes alternative allele 
at each of the two significant SNPs (18 and 19). Expression of the CD163 gene was measured in 
the blood at multiple time points after vaccination and co-infection using QuantSeq, as described 
in Chapter 4. Association analyses of SNP19 with CD163 gene expression (in log2 scale) was 
done using a mixed linear model in SAS 9.4 (SAS Institute, Cary, NC), separately for time points 
before and after co-infection and separately for PHGC16+20 (same genetics) and PHGC22. The 
full model included the fixed effects of genotype at SNP 19, WUR genotype, PRRS vaccination 
status (VxStatus), dpv (or dpi), RNA integrity number (RIN, covariate), and trial (for 
PHGC16+20 only), the random effect of litter, and the 2-way interactions among SNP 19, WUR, 
VxStatus, and dpv (or dpi). For each data set (PHGC16+20, PHGC22, and before and after co-
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infection), the residual covariance structure for CD163 gene expression was Compound 
Symmetry, as determined by the differential gene expression analyses of Chapter 4. Backward 
selection of variables to obtain the final model was done by excluding the most non-significant 
(with the largest p value > 0.1) two-way interaction among SNP19, WUR, VxStatus, and dpv (or 
dpi), one by one.  
Results 
Linkage Disequilibrium 
The LD between pairs of SNPs genotyped on the CD163 gene, calculated by r-square, is 
shown in Figure 5.1, across the eight PRRSV-only infection trials (Fig 1A), and across the two 
co-infection trials (Fig 1B). SNPs 6, 16, and 17 were fixed in the PRRSV-only infection trials, 
while SNPs 2, 6, and 17 were fixed in the co-infection trials and are, therefore, not shown in 
Figure 5.1. In the PRRS-only trials, SNPs 4, 9, and 14 were in complete LD, so they were 
combined into one SNP called “SNP4_9_14”; similarly, SNPs 11 and 13 were merged into SNP 
11_13. In the co-infection trials, SNPs 1, 4, 9, and 14 were in complete LD and merged as SNP 
1_4_9_14, while SNPs 5, 11, 12, and 13 were combined into SNP 5_11_12_13. The LD within 
each of the six genetic sources within the PRRSV-only infection trials are shown in Figure 5.S1. 
The LD between the CD163 SNPs was highly consistent across the PRRSV-only trials and the 
co-infection trials, especially for the SNPs that were in high LD (in black in Figure 5.1). 
However, because there were some differences in LD between genetic sources, the interaction 
between genetic source and SNP genotype was tested in the association study in the PRRSV-
only infection trials. Pigs from the two co-infection trials were from the same genetic source. 
The LD between pairs of four SNPs genotyped on the CD169 gene was also calculated 
by r-square. The LD between SNPs 1 and 4 in CD169 was 0.6; between SNPs 3 and 4 was 0.4; 
SNP2 was in very low LD with other three SNPs in PRRSV-only infection and co-infection trials 
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in both PRRSV-only infection and co-infection trials; between SNPs 1 and 3 was 0.2 and 0.4 in 
PRRSV-only infection and co-infection trials, respectively. The two SNPs in the TRAF1 gene 
were in complete LD in both PRRSV-only infection and co-infection trials. The LD between two 
SNPs in the RGS16 gene were 0.3 and 0.8 in PRRSV-only infection and co-infection trials, 
respectively.  
SNPs and Haplotypes Associated with Host Response to PPRSV-only Infection 
In the PRRSV-only infection trials, six CD163 SNPs and one CD169 SNP were 
significantly associated with PRRS VL (q<0.1) (Table 5.1). None of the evaluated SNPs had 
significant associations with WG. The six significant CD163 SNPs clustered into two groups of 
SNPs that were in high LD with each other: 5, 11_13, 12, and 15, 18, 19. The LD between these 
two clusters ranged from 0.13 to 0.27 in the PRRSV-only infection trials (Figure 5.1A). SNPs 5, 
11_13, and 12 had significant interaction effects with genetic background and estimates of the 
effect of these three SNPs on PRRS VL for each genetic background are shown in Figure 5.2. 
Results show that, for most genetic backgrounds, the AB genotype was favorable and BB was 
not significantly different because of its low frequency but in Trial 7, the BB genotype was not 
the favorable (Figure 5.2). The interaction effect between SNP genotype and WUR genotype was 
also tested but this was only suggestive (p=0.08 but not significant after multiple test correction) 
for SNP 2 in the RGS16 gene in the PRRSV-only infection trials (Figure 5.3). 
In the PRRSV-only infection trials, a total of 21 unique haplotypes were identified for the 
16 SNPs in the CD163 gene across all eight trials. Figure 5.4 shows the phylogenetic tree for the 
21 haplotypes. Using the unique haplotypes, the tree clearly grouped the haplotypes in three 
groups based on phylogenetic distances (Figure 5.4). To relate the two clusters of the six 
significant SNPs in the CD163 gene (SNP5, 11_13, 12, 15, 18, and 19) to the three groups of 
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haplotypes, interestingly, all haplotypes in groups A and B had “TCG” at SNPs 5, 11_13, and 12, 
except one haplotype in group B, which was “TCA” (Table 5.S3). These three SNPs were 
“CTA” in group C, except for one haplotype that had “TTA” (Table 5.S3). For SNPs 15, 18, and 
19, only “CCG” was a specific combination in group C, although one haplotype had “CTG” 
(Table 5.S3). 
The haplotype association analyses results showed that after grouping, diplotype based on 
the three groups (Table 5.S2) was significantly associated with PRRS VL (Figure 5.5) but not 
with WG. The interaction of diplotype with WUR genotype was not significant for either PRRS 
VL or WG. Diplotype “AC” and “BC” were estimated to be the most favorable diplotype to 
reduce PRRS VL (Figure 5.5).  
The GWAS results from the Bayesian analyses are in Figure 5.6. The “GBP5” window in 
Figure 5.6 includes the WUR SNP, which explained the largest proportion of genetic variance 
for both PRRS VL and WG in the PRRSV-only infection trials, consistent with previous 
analyses of these data (Waide et al., 2017). The “CD163” and “TRAF1” windows in Figure 5.6 
were the top two windows after the “GBP5” window for PRRS VL, although they explained less 
than 2% of the genetic variance for PRRS VL. 
SNPs Associations for the Co-infection Trials 
In the PRRSV and PCV2b co-infection trials, none of the SNPs in the CD163 gene had a 
significant main effect associated with PRRS VL, even at q value threshold of 0.4. However, 
SNPs 5 and 8 showed suggestive (p=0.05 and 0.04 but not significant after multiple test 
correction) interaction effects with WUR genotype on PRRS VL following first exposure, i.e. 
based on vaccination (Vx pigs Post Vx) or co-infection without vaccination (NonVx pigs Post 
Co-X) (Figures 5.7A and B). In addition, SNP 7 in the CD163 gene was suggestively associated 
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with PCV2b VL (q=0.35, p=0.04), with ADG Post Vx (q=0.32, p=0.06), and with ADG Post Co-
X (q=0.38, p=0.11) (Table 5.2).  
For the CD169 gene, SNPs 1 and 3 were suggestively associated with PCV2b VL 
(q=0.35, p=0.03) and ADG Post Co-X (q=0.38, p=0.11), respectively. SNP 1 also showed a 
significant interaction effect with WUR genotype on ADG Post Vx and ADG Post Co-X (p=0.09 
and 0.03, Figure 5.7C and D). Finally, SNPs 2 and 4 in the CD169 gene had significant 
interactions with PRRS vaccination status on ADG Post Vx (p=0.07) and PCV2b VL (p=0.02), 
respectively (Figures 5.7E and F).  
For the RGS16 gene, SNP 2 had a significant interaction with WUR genotype for ADG 
Post Vx (p=0.01, Figure 5.7G). The genotyped SNPs in the TRAF1 gene were not significantly 
associated with any of the phenotypes in the co-infection trials. 
Predicted miRNA that Target the CD163 3’UTR and SNP Associations with CD163 
Expression 
No miRNA was predicted to target CD163 3’UTR sequences that include the alternative 
allele at SNP 18. However, ssc-mir-9819, ssc-mir-125b-2, and two novel miRNA 
(ENSSSCG00000031463 and ENSSSCG00000021878) in the ENSEMBL porcine miRNA 
database were predicted to target the CD163 3’UTR sequence that includes the alternative allele 
of SNP 19 (Figure 5.8).  
For the association analysis for CD163 expression, the two-way interactions between 
genotypes at SNP 19 and WUR (p=0.07) and between WUR genotype and dpi (p=0.02) were 
significantly associated with CD163 gene expression but only in PHGC22 after co-infection. The 
CD163 gene expression for each combination of genotypes for SNP 19 and WUR is shown in 
Figure 5.9. For pigs with the AA genotype for WUR, those with AA at SNP 19 had higher 
CD163 gene expression than the other two genotypes (Figure 5.8). For pigs with the AB 
166 
genotype for WUR, those with genotype GG at SNP 19 had higher CD163 gene expression than 
the other two genotypes (Figure 5.9). 
Discussion 
CD163 and WUR (GBP5) 
In the PRRSV-only infection trials, we found that six SNPs in the CD163 gene were 
significantly associated with PRRSV serum viremia (Table 5.1). The six significant CD163 
SNPs clustered into two groups of SNPs that were in high LD with each other (Figure 5.1): SNPs 
5, 11_13, 12 and 15, 18, 19; therefore, these groups likely represent two quantitative trait loci 
(QTL). In addition, SNPs 5, 11_13 and 12 had significant interaction effects with genetic 
background on PRRS VL (Figure 5.2), which suggests that different favorable allele can be 
selected based on different genetic backgrounds. In the results from the haplotype analyses, 
diplotypes based on the three groups of haplotypes were significantly associated with PRRS VL, 
and diplotypes “AC” and “BC” were estimated to be the top two favorable diplotypes to reduce 
PRRS VL (Figure 5.5). Interestingly, all haplotypes in groups A and B had “TCG” at SNPs 5, 
11_13 and 12, except one haplotype in group B, which was “TCA” (Table 5.S3). These three 
SNPs were “CTA” in group C, except for the single haplotype with “TTA” (Table 5.S3). For 
SNPs 15, 18 and 19, only “CCG” was a specific combination in group C, although one haplotype 
had “CTG” (Table 5.S3). Therefore, the combination of “CTA” at SNPs 5, 11_13 and 12 and 
“CCG” at SNPs 15, 18 and 19 as one allele with the other allele including “TCG” at SNPs 5, 
11_13 and 12 may be the most favorable diplotype as “AC” or “BC”.  
In the vaccination and co-infection trials, SNPs 5 and 8in the CD163 gene were 
associated with PRRSV serum viremia upon primary exposure to virus, and SNP 7 was 
associated with PCV2b serum viremia, and with growth rate before and after co-infection. The 
effects of SNPs 5 and 8 in the CD163 gene depended on WUR genotype in the co-infection trials 
167 
(Figure 5.7A and B). SNP 5 was also significant for PRRS VL in the PRRSV-only infection and 
the trend was similar to pigs with AA genotype at WUR for primary PRRS VL in the co-
infection trials (CC > CT at SNP 5). 
The “GBP5” window in Figure 5.6, which includes the WUR SNP, which is in high LD 
with the putative causative major quantitative trait nucleotide in the GBP5 gene (Koltes et al., 
2015), explained the largest proportion of genetic variance for both PRRS VL and WG in the 
PRRSV-only infection trials (Figure 5.6). This is consistent with the results in our previous 
studies (Boddicker et al., 2012; Boddicker et al., 2014b; Boddicker et al., 2014a). In the co-
infection trials, SNPs 5 and 8 in the CD163 gene, which were in linkage equilibrium (Figure 
5.1B), showed significant interactions with WUR genotype on Primary PRRS VL (Figure 5.7A 
and B). This suggests a potential biological interaction between GBP5 and CD163. SNP 8 is 
non-synonymous c.2592A>G in exon11, causing a change of Lys851Arg. SNP 8 was not 
significantly associated with co-infection PRRS VL across Vx and NonVx pigs. However, upon 
primary exposure to PRRSV, the AA genotype at SNP 8 decreased PRRS VL for pigs with the 
AA genotype at WUR but increased it for AB pigs (Figure 5.7B). The result within pigs with AA 
genotype at WUR is consistent with the previous finding that the AA genotype of SNP8 in the 
CD163 gene decreases the relative risk of PRRS incidence (Ren et al., 2012). A possible reason 
why the effect of SNP8 was detected as a main effect by Ren et al. (2012) but only through an 
interaction with WUR genotype in our studies may be because most of the pigs in the study of 
Ren et al. (2012) may have been AA for WUR, while n our co-infection trials, the number of AA 
and AB at WUR were balanced by design. 
In the co-infection trials, pigs with the AB genotype at WUR had lower primary VL than 
pigs with the AA genotype at WUR, which is consistent with the findings of Dunkelberger et al. 
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(2017). However, the effect of WUR was greater for pigs with the AG compared to the AA 
genotype at SNP 8 in the CD163 gene. WUR AB pigs are expected to produce a functional 
GBP5 protein to induce innate immunity for anti-viral response (Koltes et al., 2015). When 
GBP5 is functional, it may have a positive effect on suppressing the receptor function of CD163. 
In addition, at SNP 8 in the CD163 gene, the AA genotype was found to reduce PRRS VL upon 
primary exposure to PRRSV in our study, and decrease the relative risk of PRRS incidence in the 
study of  Ren et al. (2012), which suggests that the AG genotype at this SNP may cause CD163 
to be more functional to allow PRRSV to enter macrophages, which may stimulate functional 
GBP5 to induce stronger innate immunity for viral clearance. However, in the PRRSV-only 
infection trials, the AA genotype at SNP 8 tended to have higher PRRS VL and lower WG than 
the other two genotypes, although these effects were not significant (p=0.75 and 0.88), which is 
consistent with the trend of primary PRRS VL for pigs with AA genotype at WUR but not for 
pigs with the AB genotype at WUR in the co-infection trials. This may be because most pigs in 
the PRRSV-only trials are AA for WUR. Note that the main effect of SNP 8 was also not 
significant in the co-infection trials. So, more work is needed to understand why the AA 
genotype at SNP 8 in the CD163 gene had a different effect with PRRSV-only infection versus 
co-infection. 
For SNP 5 in the CD163 gene, in the co-infection trials, pigs with the CT genotype had 
lower primary PRRS VL than CC pigs among pigs with the AA genotype at WUR (Figure 5.1D), 
which was in agreement with results from the PRRSV-only infection trials that CT tended to 
have lower PRRS VL (p<0.001) and higher WG than CC, although the result was not significant 
for WG (p=0.98, results not shown). Additionally, in the co-infection trials, among pigs with the 
AA genotype for WUR, pigs with the CT genotype at SNP 5 had higher primary PRRS VL than 
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pigs with the CC genotype, which was opposite for pigs with the AB genotype at WUR (Figure 
5.7A). This also suggests a potential interaction between CD163 and GBP5.  
Macrophages have been broadly classified into classically activated macrophages (M1) 
and alternatively activated macrophages (M2). In humans, monocyte-derived macrophages can 
be differentiated into M1, M2a, M2b and M2c subtypes following stimulation by different 
cytokines (Fujiwara et al., 2016). M1 can be induced by interferon-γ (IFN-γ) and express 
proinflammatory molecules, including interleukin-12 (IL-12), CXCL9, CXCL10, CXCL11, 
nitric oxide and reactive oxygen species. GBP5 is a candidate marker of the phenotype of the 
INF-γ-induced classically activated macrophages (Fujiwara et al., 2016). However, M2a, M2b, 
and M2c can be induced by IL-4, IL-1β and IL-10, respectively, and M2 cells produce anti-
inflammatory molecules, including ornithine, IL-10, CCL17, CCL18, CCL22, and scavenger 
receptors (Goerdt and Orfanos, 1999; Gordon, 2003; Mosser, 2003; Mantovani et al., 2004; 
Martinez et al., 2006). CD163 is a marker for the M2c phenotype (Fujiwara et al., 2016). 
Therefore, an immature macrophage can have at least these two fates: (1) become M1 expressing 
GBP5 or (2) become M2c expressing CD163. If immature macrophages become M1, they will 
produce GBP5 and there will be relatively low CD163 production because M2c does not exist. 
This may represent the potential interaction effect between CD163 and GBP5 that was observed 
in Chapter 4, where it was found that the interaction between CD163_SNP19 and WUR had a 
significant effect on CD163 gene expression. 
Two other SNPs in the CD163 gene, 18 and 19, were significantly associated with PRRS 
VL in the PRRSV-only infection trials, with homozygotes for the minor allele at both SNPs 
having lower PRRS VL than the other two genotypes (Table 5.1). Our results for SNP 18 are a 
validation of the results of Lim et al. (B.L. Lim et al., 2017), with the same direction of effects. 
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However, in the co-infection trials, homozygotes for the minor allele had higher PRRS and 
PCV2b VL (and higher primary PRRS VL even not significant) at both SNPs, in addition to 
tending to have higher ADG before and after co-infection, although none of these results were 
significant (p=0.50 and 0.64). In the PRRSV-only infection trials, pigs that were homozygotes fir 
the minor allele for SNP 18 and 19 had larger WG than the other two genotypes but not 
significant. Taking all these results together, selecting for the minor allele at both SNPs 18 and 
19 in the CD163 gene may improve disease resistance of pigs, but this needs future validation.  
SNPs 18 and 19 are located in the 3’UTR of exon 15 of the CD163 gene. The sequence in 
this region with the alternative and minor allele at SNP 19 was predicted to be a target region of 
four miRNA, ssc-mir-9819, ssc-mir-125b-2, and two novel miRNA (ENSSSCG00000031463 
and ENSSSCG00000021878) from the ENSEMBL porcine miRNA database (Figure 5.8). 
Binding of miRNA to the 3’UTR of the CD163 mRNA can result in mRNA degradation or 
translation inhibition of CD163. Because CD163 is a receptor for the PRRSV on the membrane 
of macrophages, a non-functional CD163 could reduce PRRS VL in pigs, as demonstrated by 
CD163 knockouts (Whitworth et al. 2017). However, we did not identify a significant effect of 
SNP 19 genotype on expression of the CD163 gene, but the interaction between genotype at SNP 
19 and at WUR was significant in PHGC22 after co-infection with PRRSV and PCV2b (Figure 
5.9). This points to an interaction between GBP5 and CD163, either directly or indirectly. 
However, we did not find this interaction to be significant in PHGC16+20 or in the PRRSV-only 
infection trials. Hence, more work is needed to validate these interactions. 
CD169 
SNP 1 in the CD169 gene is non-synonymous c.878A>G in exon 4, causing a change of 
Arg293His. In the PRRSV/PCV2b co-infection trials, SNP 1 was significantly associated with 
PCV2b VL, with genotype GA showing lower PCV2b VL than the other two genotypes, and GG 
171 
pigs having lower PCV2b VL than AA pigs (Table 5.2). This indicates that pigs with the GA and 
GG genotypes may have an improved immune response to PCV2b compared to AA pigs. This is 
in agreement with results of Wang et al. (2012) who showed that, without infection, the white 
blood cell (WBC) content in peripheral blood of pigs with the GG genotype at this SNP was 
significantly higher than that of AA pigs but differences between AG and each of the other two 
genotypes were not significant. In our data, SNP 1 also showed a significant interaction with 
WUR genotype on ADG Post Vx and ADG Post Co-X (Figure 5.7C and D). For pigs with the 
AA genotype for WUR, pigs with the AG genotype at SNP 1 had higher ADG Post Vx than the 
other two genotypes, but the opposite occurred for pigs with the AB genotype at WUR (Figure 
5.7C). Within WUR AB and AA pigs, pigs with the AA genotype at SNP1 had lower ADG Post 
Co-X than pigs with the other two genotypes but had a different magnitude of differences, 
although these differences were not significant; while AG pigs had similar ADG Post Co-X to 
GG pigs (Figure 5.7D). This trend for the effect of SNP 1 on ADG Post Co-X is in line with the 
results of Wang et al. (2012), which showed that the GG genotype at SNP 1 was favorable 
compared to the AA genotype. This suggests that CD169 may also interact with GBP5 indirectly.  
For PRRS VL in the co-infection trials, pigs with genotype AA at SNP 1 tended to have lower 
PRRS VL than pigs with the other two genotypes, regardless of WUR genotype, although these 
results were not significant (p=0.71, results not shown). This trend for the effect of SNP 1 on 
PRRS VL among pigs with the AB genotype agrees with the findings for ADG Post Co-X that 
AA at SNP1 induced lower PRRS VL and ADG Post Co-X than the other two genotypes among 
pigs with the AB genotype at WUR, which may be because AA pigs direct more energy to fight 
the pathogens, thereby limiting energy for growth. In the PRRSV-only infection trials, pigs with 
the AA genotype at SNP 1 had higher PRRS VL than pigs with the other two genotypes, while 
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GG pigs tended to have higher WG than pigs with the other two genotypes, although these 
effects were not significant (p=0.21 and 0.24, results not shown). These trends are in line with 
results for the co-infection trials on PCV2b VL and results of Wang et al. (2012) that the G allele 
at SNP 1was the favorable allele for PRRSV resistance. 
The non-synonymous SNPs 2 (G1640T in exon 6) and 3 (C1654A in exon 6) in the 
CD169 gene result in Arg547Leu and Leu552Ile substitutions in the CD169 protein, 
respectively. Both these SNPs are located in the Immunoglobulin C-2 Type domain encoding 
region of CD169 (Ren et al., 2012), which is associated with the formation of a disulfide bond 
and plays an important role in the native conformation and stability of the CD169 protein (Ren et 
al., 2012). Consequently, SNPs 2 and 3 may influence PRRSV entering into macrophages 
through adhesion and endocytosis because they are located in an essential functional region. In 
the PRRSV-only infection trials, SNP 2 was significantly associated with PRRS VL, with TT 
pigs having lower PRRS VL than pigs with the other two genotypes (Table 5.1). However, in the 
study by Ren et al. (2012), pigs with the TT genotype for this SNP showed significantly higher 
relative risk of PRRS incidence than GG pigs, and GT pigs tended to have a lower relative risk 
than GG pigs but not significantly. This inconsistency may be due to the different ages of the 
pigs in the two studies (approximately 1 year versus 28 days). In the co-infection trials, the effect 
of this SNP on ADG before co-infection depended on PRRS vaccination status; among NonVx 
pigs, pigs with the GT genotype had lower ADG before co-infection than the other two 
genotypes (Figure 5.7E), while no significant difference between GG and GT  genotype for Vx 
pigs. In the PHGC16+20 co-infection trials, GT pigs tended to have higher primary PRRS VL 
than GG pigs (there were no TT pigs) but not significantly (p=0.91). 
173 
In the co-infection trials, SNP 3 in the CD169 gene had a significant effect on ADG Post 
Co-X, with the CC genotype showing higher ADG Post Co-X than the other two genotypes 
(Table 5.2). For the other traits in the co-infection trials, the CC genotype tended to have higher 
PRRS VL and primary PRRS VL than the other two genotypes but not significantly (p=0.71 and 
0.73, results not shown). In the PRRSV-only infection trials, the AC genotype at this SNP tended 
to have lower PRRS VL and WG than the other two genotypes but this result was not statistically 
significant (p=0.84 and 0.94, results not shown). Ren et al. (2012) found that pigs with the AA 
genotype at this SNP had lower relative risk to PRRS than pigs with the other two genotypes, 
and CC pigs tended to have higher relative risk than AC pigs but not significantly. The 
inconsistency may result from this SNP having different effects for the PRRSV-only challenge 
versus co-infection with PRRSV and PCV2b, as well as differences in genetic backgrounds and 
potential differences in LD between the SNP and the causative mutation between the trials. 
Future work is needed to validate the effect of SNPs 2 and 3 in the CD169 gene.  
The non-synonymous SNP 4 in the CD169 gene is C4175T in exon 15, causing a change 
of Ala1392Val and occurring in an Immunoglobulin-like region. In the PRRSV/PCV2b co-
infection trials, this SNP had a significant interaction effect with PRRS vaccination status on 
PCV2b VL (Figure 5.7F). Ren et al. (2012) showed that CT pigs at this SNP had lower relative 
risk of PRRS incidence than the other two genotypes, which is consistent with our results for 
PCV2b VL among the NonVx pigs. However, for the Vx pigs, CT pigs had lower PCV2b VL 
than CC pigs but had higher PCV2b VL than TT pigs. Furthermore, in the co-infection trials, TT 
pigs tended to have higher PRRS VL and lower primary PRRS VL than the other two genotypes 
(p=0.4 and 0.8, results not shown). In our PRRSV-only infection trials, CT pigs tended to have 
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lower PRRS VL but also lower WG than the other two genotypes, although these results were 
also not significant (p=0.4 and 0.6, results not shown). 
RGS16 and TRAF1 
In the PRRSV-only infection trials, SNP 2 in the RGS16 gene had a significant effect on 
WG depending upon WUR genotype (Figure 5.3). In the co-infection trials, this SNP also had a 
significant interaction effect with WUR genotype on ADG Post Vx (Figure 5.7G). This SNP is 
located in the 5’upstream region of the RGS16 gene, which may be a transcription factor binding 
site and a mutation in this site may prevent binding of the transcription factor to the promoter 
region of the RGS16 gene, resulting in inhibition of RGS16 transcription. RGS16 is known to 
interact directly with ORF3 of PCV2 and may play an important role in translocation of the 
ORF3 protein of PCV2 into the cell nucleus (Timmusk et al., 2009) to harbor PCV2 proteins in 
infected cells (Vincent et al., 2003, 2005, 2007). Additionally, the RGS16 gene is up-regulated in 
immature dendritic cells (Shi et al., 2004), which PCV2 can persist in (Vincent et al., 2003), and 
inhibits maturation of dendritic cells through TLR9 (Vincent et al., 2005). Therefore, a non-
functional RGS16 may inhibit PCV2 infection and increase growth rate. However, the effect of 
these two SNPs 1 and 2 in the RGS16 gene on PCV2b VL were not significant (p=0.51 and 
0.13). The trends of PCV2b VL were different for SNPs 1 and 2 in the RGS16 gene: at SNP1, 
GG>GA>AA; at SNP2: TT>CC>CT (results not shown). 
Interestingly, for both the PRRSV-only infection trials and for the PRRSV/PCV2b co-
infection trials, SNP 2 showed a significant interaction with WUR genotype on WG (Figure 5.3) 
and ADG Post Vx (Figure 5.7G), which indicates that RGS16 may interact with GBP5. In RAW 
264.7 macrophages, both single treatment of IFN- β and dual treatment of IFN-β and KDO (2-
keto-3-deoxyoctonate, a ligand that binds with TLR4), increased GBP5 gene expression and 
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decreased RGS16 gene expression (dual treatment only) in the macrophages (Krishnan and Choi, 
2012).  
No SNP in the TRAF1 gene, which is a negative regulator of TNF signaling in T 
lymphocytes (Tsitsikov et al., 2001), was significantly associated with any trait in either the 
PRRSV-only or the co-infection trials. 
Conclusions 
We identified and evaluated natural mutations in four candidate genes for host response 
to PRRSV and/or PCV2b, CD163, CD169, TRAF1, and RGS16. Several SNPs in the CD163, 
CD169, and RGS16 genes showed significant associations with PRRSV and/or PCV2b VL, 
and/or growth rate following PRRSV-only infection or PRRSV/PCV2b co-infection and PRRS 
vaccination. Some SNPs that were significant in the PRRSV-only infection trials showed similar 
trend in the co-infection trials, and vice versa. In general, the number of significant SNPs was 
lower in the co-infection trials than the PRRSV-only infection trials, which may be due to the 
smaller number of observations. Therefore, further validation is needed. Several direct or indirect 
interactions of SNPs in these candidate genes with GBP5 and were identified. We also found that 
sometimes the genotype that was favorable for PRRSV or PCV2b VL was unfavorable for 
growth rate following (co-)infection. This may suggest that pigs with these genotypes used their 
energy to fight the pathogen, leaving limited energy for growth. A SNP in the 3’UTR of CD163 
and with significant effects on PRRS VL was identified as a possible target for a miRNA, which 
can decrease the CD163 protein level to inhibit PRRSV enter into the cells in pigs. The identified 
SNPs can serve as genetic markers to select for increased natural resistance to PRRSV and/or 
PCV2. In order to validate these findings and understand and validate the mechanism how these 
SNPs affect PRRS and/or PCV2 VL, and/or growth rate following (co-)infection, additional 
work is needed. 
 
176 
Tables and Figures 
Table 5.1. SNPs associated with host response to PRRSV-only infection (FDR<0.1). 
1 The second letter indicates the minor allele; 2 PRRS VL, PRRS viral load, calculated as the area under the curve from 0 to 21 dpi; 3 Homozygotes for the minor 
allele 
Abbreviations: FDR, false discovery rate; SE, standard error. 
 
 
 
 
 
 
 
Gene 
 
SNP 
 
Alleles1 
 
# of 
animals 
with 
genotype 
 
Minor 
allele 
frequency 
Least square means (SE) for PRRS VL2 by genotype 
FDR 
0 1 23 
CD163 
5 T/C 1415 0.10 105.7 (1.0) 102.8 (1.1) 108.0 (2.5) 2.6E-05 
11_13 C_C/T_A 1414 0.12 105.7 (1.0) 103.3 (1.1) 108.1 (2.2) 5.0E-05 
12 G/A 1417 0.12 105.7 (1.0) 103.4 (1.1) 109.5 (2.2) 3.2E-05 
15 T/C 1406 0.32 106.0 (1.0) 104.8 (1.0) 104.7 (1.2) 4.6E-02 
18 T/C 1408 0.42 106.3 (1.0)  104. 8 (1.0) 104.9 (1.1) 2.9E-02 
19 A/G 1409 0.32 106.0 (1.0) 104.8 (1.0) 104.8 (1.2) 4.6E-02 
CD169 2 G/T 1386 0.08 105.6 (1.0) 104.0 (1.1) 103.1 (2.4) 6.9E-02 
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Table 5.2. SNPs associated with host response to PRRS vaccination and PRRSV/PCV2b co-infection (FDR<0.4) 
1 The second letter indicates the minor allele 
2 PCV2b VL, PCV2b viral load: calculated as the area under the curve from 0 to 42 dpi 
3 Homozygote of the minor allele 
4 ADG Post Vx: calculated as the regression of body weight on dpi between PRRS vaccination and PRRSV/PCV2b co-infection 
5 ADG Post Co-X: calculated as the regression of body weight on dpi post PRRSV/PCV2b co-infection 
Abbreviations: FDR, false discovery rate; MAF, minor allele frequency; LSM, least squares mean; SE, standard error. 
 
Gene 
 
SNP 
 
Allele1 
# of 
animals 
with 
genotype 
 
Minor 
allele 
frequency 
 
 
Trait 
 
 
Least square means (SE) by genotype            FDR      P value 
0 1 23   
CD163 7 C/G 349 0.05 
PCV2b VL 
129.4 (4.1) 147.0 (9.1) - 0.35 0.04 
CD169 1 G/A 322 0.27 133.0 (5.0) 124.9 (5.0) 186.2 (28.6) 0.35 0.03 
CD163 7 C/G 349 0.05 ADG Post Vx 0.44 (0.01) 0.47 (0.02) - 0.32 0.06 
CD163 7 C/G 349 0.05 
ADG Post Co-X 
0.85 (0.01) 0.78 (0.04) - 0.38 0.11 
CD169 3 A/C 346 0.4 0.81 (0.02) 0.85 (0.01) 0.88 (0.03) 0.38 0.11 
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Table 5.S1. Information on selected SNPs. 
SNP ID Position dbSNP SNP alternative name Allele 1 Allele 2 Location Consequence 
TRAF1_SNP1 260949633 rs323032063  C G Exon 9 3' UTR 
TRAF1_SNP2 260955554 rs81504659  C T Exon 7 synonymous 
CD163_SNP1 63306373 rs1111878725 c.781 T C Exon 4 synonymous 
CD163_SNP2 63323121 rs793440145 c.1562 C A Exon 7 missense 
CD163_SNP3 63323697 rs1112082621 c.2041 C T Exon 8 synonymous 
CD163_SNP4 63324829 . G2277A A G Exon 10 synonymous 
CD163_SNP5 63324931 rs698342267 c.2419 T C Exon 10 synonymous 
CD163_SNP6 63325006 rs1107556229 c.2494 G A Exon 10 synonymous 
CD163_SNP7 63326686 . c.2509G>C G C Exon 11 synonymous 
CD163_SNP8 63326769 . c.2592A>G; A2552G A G Exon 11 missense 
CD163_SNP9 63326815 . c.2638G>A A G Exon 11 synonymous 
CD163_SNP10 63326917 . c.2740; C2700A A C Exon 11 synonymous 
CD163_SNP11 63327860 rs81215635 c.2902 C T Exon 12 synonymous 
CD163_SNP12 63327893 rs81215636 c.2935 G A Exon 12 synonymous 
CD163_SNP13 63327941 rs81215637 c.2983 C A Exon 12 synonymous 
CD163_SNP14 63328040 rs81215638 c.3082 T C Exon 12 synonymous 
CD163_SNP15 63328079 rs1111118836 c.3121 T C Exon 12 synonymous 
CD163_SNP16 63330243 . c.3346 G A Exon 14 3' UTR 
CD163_SNP17 63334309 . c.3436 C A Exon 15 3' UTR 
CD163_SNP18 63334407 . c.3534C>T C T Exon 15 3' UTR 
CD163_SNP19 63334420 . c.3547 A G Exon 15 3' UTR 
RGS16_SNP1 123920503 rs326071195  A G 5'upstream upstream 
RGS16_SNP2 123921385 rs332913874 - C T 5'upstream upstream 
CD169_SNP1 32003653 rs345830287 c.878A>G G A Exon 3 missense 
CD169_SNP2 32007147 rs328951928 G1640T G T Exon 6 missense 
CD169_SNP3 32007161 rs342517982 C1654A C A Exon 6 missense 
CD169_SNP4 32015498 rs323502146 C4175T C T Exon 15 missense 
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Table 5.S2. Haplotype information of 16 SNPs in the CD163 gene in PRRSV-only infection 
trials 1 through 8. 
ID Haplotype 
Number of 
Haplotype 
Frequency of 
Haplotype 
Group 
H1 CACGCGCACTACGCCG 17 6.0E-03 C 
H2 CATGTGCACTACGCCG 58 2.0E-02 C 
H3 CCCATGGAACGTGCCA 5 1.8E-03 A 
H4 CCCGCGCACTACGCCG 237 8.3E-02 C 
H5 CCCGCGCACTACGCTG 4 1.4E-03 C 
H6 CCCGTAGGACGCGCCG 6 2.1E-03 A 
H7 CCCGTGCACCATGCTA 2 7.0E-04 B 
H8 CCCGTGCACCGCGCTA 1 3.5E-04 B 
H9 CCCGTGCACCGCGCTG 2 7.0E-04 B 
H10 CCCGTGCACCGTGATA 1 3.5E-04 B 
H11 CCCGTGCACCGTGCCA 4 1.4E-03 B 
H12 CCCGTGCACCGTGCCG 1 3.5E-04 B 
H13 CCCGTGCACCGTGCTA 1634 5.7E-01 B 
H14 CCCGTGGACCGTACCA 38 1.3E-02 A 
H15 CCCGTGGGACGCGCCG 535 1.9E-01 A 
H16 CCCGTGGGACGCGCTG 1 3.5E-04 A 
H17 CCTGCGCACTACGCCG 18 6.3E-03 C 
H18 CCTGTGGACCGTACCA 113 4.0E-02 A 
H19 CCTGTGGGACGCACCG 38 1.3E-02 A 
H20 CCTGTGGGACGCGCCG 4 1.4E-03 A 
H21 TCCATGGAACGTGCCA 123 4.3E-02 A 
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Table 5.S3. Haplotype information of six significant SNPs associated with PRRS viral load in 
PRRSV-only infection trials 1 through 8. 
Group Haplotype SNP5 SNP111 SNP12 SNP15 SNP18 SNP19 
(5.11.12). 
(15.18.19) 
A CCCATGGAACGTGCCA T C G T C A TCGTCA 
A CCCGTAGGACGCGCCG T C G C C G TCGCCG 
A CCCGTGGACCGTACCA T C G T C A TCGTCA 
A CCCGTGGGACGCGCCG T C G C C G TCGCCG 
A CCCGTGGGACGCGCTG T C G C T G TCGCTG 
A CCTGTGGACCGTACCA T C G T C A TCGTCA 
A CCTGTGGGACGCACCG T C G C C G TCGCCG 
A CCTGTGGGACGCGCCG T C G C C G TCGCCG 
A TCCATGGAACGTGCCA T C G T C A TCGTCA 
B CCCGTGCACCATGCTA T C A T T A TCATTA 
B CCCGTGCACCGCGCTA T C G C T A TCGCTA 
B CCCGTGCACCGCGCTG T C G C T G TCGCTG 
B CCCGTGCACCGTGATA T C G T T A TCGTTA 
B CCCGTGCACCGTGCCA T C G T C A TCGTCA 
B CCCGTGCACCGTGCCG T C G T C G TCGTCG 
B CCCGTGCACCGTGCTA T C G T T A TCGTTA 
C CACGCGCACTACGCCG C T A C C G CTACCG 
C CATGTGCACTACGCCG T T A C C G TTACCG 
C CCCGCGCACTACGCCG C T A C C G CTACCG 
C CCCGCGCACTACGCTG C T A C T G CTACTG 
C CCTGCGCACTACGCCG C T A C C G CTACCG 
1 SNP11 was in complete linkage disequilibrium with SNP13 in the CD163 gene. 
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Figure 5.1. Linkage disequilibrium (r2) plot of the genotyped SNPs in the CD163 gene across 
trials 1 through 8 (A) and across trial 16 and 20 (B). Black squares signify r2=100% and white 
squares signify r2=0%. 
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Figure 5.2. Estimates (and SE) of the effects of genotype at SNPs 5, 12, and 11+13 (in very high 
LD within trials 1 through 3 and within trials 4, 5, 6, 7, and 8) in the CD163 gene on PRRS viral 
load by genetic background (interaction was significant at p<0.1). Viral load was calculated as 
area under the curve of log-transformed viremia from 0 to 21 days post infection.  
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Figure 5.3. Estimates (and SE) of the effects of SNPs in the RGS16 gene that had significant 
interaction effects with WUR genotype on weight gain (WG) in the PRRSV-only infection trials 
across 1 through 8. 
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Figure 5.4. Phylogenetic tree of the 21 haplotypes present across trials 1 through 8 for the 
genotyped SNPs in the CD163 gene with the frequency of each haplotype. The trees were 
created using the neighbor-joining, p-distance method in the MEGA 7 software. Haplotypes were 
grouped into the three clusters circled and labeled with A, B, and C. 
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Figure 5.5. Least square means for PRRS VL of diplotypes of haplotype group A, B, and C 
based on genotyped SNPs in the CD163 gene across trials 1 through 8. Values are least square 
means ± standard error. Diplotypes with non-overlapping letters are significantly different at 
p<0.1 
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Figure 5.6. Genome-wide association results for PRRS viral load and weight gain using Bayes-B 
analyses. Results show the percent of genetic variance explained by 1-Mb nonoverlapping 
windows of SNPs across chromosomes for PRRS viral load (A) and weight gain (B). Viral load 
was calculated as area under the curve of log-transformed viremia from 0 to 21 days post 
infection. Weight gain was calculated as the difference between body weight at 42 and 0 days 
post infection. The windows including genotyped SNPs in the TRAF1, CD163, RGS16, CD169, 
and GBP5 genes are in orange, tagged by the gene name. 
A
B
GBP5
GBP5
TRAF1 CD163
CD169
RGS16
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CD169
RGS16
187 
 
 
Figure 5.7. Estimates (and SE) of the effects of SNPs in CD163 and CD169 that had significant 
interaction effects with WUR genotype on vaccination viral load (VL) of Vx pigs and PRRS VL 
of Non-Vx pigs (primary PRRS VL) (A, B), ADG post PRRS vaccination (ADG Post Vx) (C), 
post co-infection on PRRSV and PCV2b (ADG Post Co-X) (D) in the co-infection trials 16 and 
20. Estimates (and SE) of the effects of two SNPs in CD169 that had a significant interaction 
effects with PRRS vaccination status on ADG Post Vx (E) and PCV2b VL (F). Estimates (and 
SE) of the effects of one SNP in RGS16 that had significant interaction effects with WUR 
genotype on ADG Post Vx (G). ADG was calculated as the regression of body weight on dpi 
using body weight data from -28 to 0 and 0 to 42 days post co-infection for ADG Post Vx and 
Post Co-X, respectively. Vaccination VL, PRRS VL, and PCV2b VL were calculated for each 
individual as the area under the curve of log-transformed viremia from -28 to 0, 0 to 21, and 0 to 
42 days post co-infection, respectively. 
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Figure 5.8. Predicted miRNA that targets the CD163 3’UTR region that includes the alternative 
allele G at CD163_SNP19. 
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Figure 5.9. Least square means for CD163 gene expression after co-infection for combinations 
of genotypes at CD163_SNP19 and WUR in PHGC22. Values are least square means ± standard 
error. 
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Figure 5.S1.1. Linkage disequilibrium (r2) plot of the genotyped SNP in the CD163 gene across 
trials 1 through 3 (A) and within trials 4 (B), 5 (C), 6 (D), 7 (E), and 8 (F). Black squares signify 
r2=100% and white squares signify r2=0%. 
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Figure 5.S1.2. Linkage disequilibrium (r2) plot of the genotyped SNP in the CD163 gene across 
trials 1 through 3 (A) and within trials 4 (B), 5 (C), 6 (D), 7 (E), and 8 (F). Black squares signify 
r2=100% and white squares signify r2=0%. 
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Figure 5.S1.3. Linkage disequilibrium (r2) plot of the genotyped SNP in the CD163 gene across 
trials 1 through 3 (A) and within trials 4 (B), 5 (C), 6 (D), 7 (E), and 8 (F). Black squares signify 
r2=100% and white squares signify r2=0%. 
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CHAPTER 6.    GENERAL DISCUSSION 
Porcine respiratory and reproductive syndrome (PRRS) is the economically most 
significant porcine disease and can affect pigs during all stages of production. The focus of this 
dissertation was to investigate the genetics and transcriptomics of host response to PRRSV in 
nursery pigs. Two chapters of this dissertation also investigated host genetic and transcriptomic 
response to co-infection with PRRS and porcine circovirus type 2b (PCV2b), which is commonly 
observed in pig production. 
The study presented in Chapter 3 investigates gene expression in tonsils of pigs following 
infection with one of two PRRSV isolates in order to better understand mechanisms of 
persistence of PRRSV in tonsil, which can improve measures of PRRS prevention and control. 
The study described in Chapter 4 investigated the effects of PRRS vaccination and genotype at a 
marker (WUR) that has been shown to be associated with host response to PRRSV, on blood 
gene expression response to co-infection with PRRSV and PCV2b in pigs. The final chapter 
sought to evaluate associations of natural polymorphisms in the CD163 and CD169 genes, along 
with several other candidate genes for viral disease resistance, with host response to PRRSV-
only infection and co-infection with PRRSV and PCV2b. 
The objectives of this discussion are (1) to summarize the key results and integrate these 
results across Chapter 3, 4, and 5; (2) to discuss the implications and potential implementations 
of the findings; (3) to discuss the important limitations of these studies and their findings, and 
additional questions raised; (4) to discuss future directions and research to address these 
limitations and questions.  
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Summary of Key Results and Implementation of the findings 
The PRRS Host Genetics Consortium (PHGC) was established in 2007, with the goal to 
investigate the genetic basis of host response to PRRSV infection in nursery pigs. Results of the 
PHGC showed that host response to PRRS is moderately heritable but highly polygenic, beyond 
a putative causative mutation in the GBP5 gene on SSC4, the effect of which was confirmed for 
host response to two different PRRSV strains and to PRRS vaccination and PRRS-PCV2b co-
infection through associations with a linked genetic marker, WUR (Boddicker et al. 2012; 
Boddicker et al. 2014a; Boddicker et al. 2014b; Dunkelberger et al. 2017; Hess et al. 2016; 
Koltes et al. 2015; Waide et al. 2017). 
Our studies on tonsil and blood transcriptome also highlighted the importance of 
measuring cell composition for transcriptome analyses in multicellular tissues because 
differences in cell composition in tissues that consist of multiple cell types can play a big role in 
observed differences in gene expression. We used the xCell software, which was designed based 
on human data, to predict cell enrichments in porcine tonsils and blood. The limitation of xCell is 
that the estimated scores have arbitrary units and are not “cell proportions”. However, we still 
can use the scores to infer the changes of cell type enrichments between treatments and to 
account for relative cell enrichments in samples for gene expression analysis using principle 
components. 
Previous studies have investigated the genetic basis of host response during the acute 
stage of PRRSV infection but little is known about the genetic basis of PRRSV persistence in 
pigs. Although tonsils play roles in protecting the host through an efficient immune response, 
some pathogens such as PRRSV can evade host anti-viral immune response and “hide” in tonsil 
to survive in the host-pathogen battle. Therefore, we need to know more about the genes 
associated with host response to PRRSV persistence in lymphoid tissues, especially in tonsils, 
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and how these genes work together in a network. Therefore, in the Chapter 3, we compared host 
tonsil transcriptome responses to infection with two genetically distinct North American PRRSV 
isolates (KS06 and NVSL), between pigs with high and low tonsil viral levels at 42 days post 
infection (dpi) (High-TVclass and Low-TVclass), and between pigs with different genotypes at 
WUR, using two approaches: RNA-seq and NanoString. To our knowledge, this is the first study 
of the tonsil transcriptome following PRRSV infection. In summary, we found higher immune 
response in tonsils of KS06-infected pigs and with High-TVclass than in tonsils of NVSL-
infected pigs and in pigs with Low-TVclass. We hypothesized that the NVSL PRRSV can 
weaken immune response in tonsils more than the KS06 PRRSV, such that NVSL can persist in 
tonsils longer than KS06, and that a high tonsil viral level can induce a stronger immune 
response, especially innate immune response. The 107 genes whose expressions were 
significantly impacted by the interaction between WUR genotype and PRRSV isolate, when 
accounting for differences in cell type enrichment in the tonsils, were suggested to play a critical 
role in cell movement and invasion based on Ingenuity Pathway Analysis (IPA), especially 
chemotaxis of phagocytes. This indicates that the putative causative mutation in the GBP5 gene 
may have different effects on immune response in tonsils of pigs infected by different PRRSV 
isolates during the persistent stage of infection, beyond potential changes in cell enrichments. 
Seventy-four of the 107 differentially expressed genes (DEGs) had greater expression and three 
DEGs had lower expression in pigs with the AB genotype at WUR than pigs with the AA 
genotype for KS06 infection. However, none of these 107 genes were DEGs for WUR for pigs 
infected with NVSL when accounting for cell enrichment in tonsils.  
Results from this study on the tonsil transcriptome provides a more comprehensively 
understanding of the mechanisms of PRRSV persistence in pigs in order to improve strategies to 
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reduce the risk of a second break resulting from PRRSV persistence. The DEGs for TVclass 
identified in Chapter 3 can be biomarker candidates as an early sign of PRRSV persistence in 
tonsils, which can help to identify these pigs and then separate them from the healthy population 
to avoid a second break. 
In the blood transcriptome study (in Chapter 4), the identified DEGs and pathways 
related to PRRS MLV vaccine response not only provided a better understanding of mechanisms 
of host response to viral pathogens but can also help to improve vaccination strategies. To the 
authors’ knowledge, this is the first time that the blood transcriptome of nursery pigs has been 
analyzed after co-infection with PRRSV and PCV2b, especially with vaccination with a PRRS 
MLV before co-infection. Before co-infection, the PRRS MLV stimulated host innate immune 
response, especially by inducing larger enrichment scores of immune cells, up-regulation of 
IRF7 and STAT1 and their down-stream genes, and of the interferon signaling pathway at 7 days 
post vaccination (dpv). After PRRSV and PCV2b co-infection, vaccinated (Vx) pigs were shown 
to stimulate a stronger adaptive immune response than non-vaccinated (NonVx) pigs through 
pathways that involved T and B cells, but to have a weaker innate immune response, including 
less activation of the interferon signaling pathway. Some DEGs for the effect of WUR genotype 
on gene expression were identified, including of its putative causal candidate gene, GBP5, which 
was significantly expressed more in AB pigs than in AA pigs across all trials and all time points.  
The PRRS MLV vaccine is only partially effective against PRRSV infection and previous 
studies have shown that co-administration of IL-12 or IL-2 enhanced the protective efficacy of 
PRRS vaccines (Charerntantanakul et al. 2005; Charerntantanakul 2008). Although these two 
genes were not identified in our blood QuantSeq data, their receptors were DEGs for VxStatus at 
7 dpv (IL2RA with or without accounting for cell enrichment in PHGC22) and at 7 dpi 
203 
 
(IL12RB1 with cell enrichments in PHGC16+20; IL2RB without cell enrichments in PHGC22). 
In addition, the IL2RB gene was significantly expressed more in Vx pigs at 7 dpi in PHGC22 
without accounting for cell enrichment.  
The identified DEGs for PRRS MLV vaccination are potential blood biomarkers for host 
response to PRRS vaccination, which can help to identify pigs that have better responses to the 
vaccine. If we want to compare two vaccines, e.g. subunit versus MLV, or the same vaccine with 
different adjuvants, the expression of these biomarkers can be an early sign of response to the 
vaccine. Furthermore, our study can also help identify or develop stimulants that could cause the 
identified pathways that enhance host anti-viral immune response to be activated, or to block the 
identified pathways that inhibit host anti-viral immune response, resulting in a better vaccine. In 
addition, some of the DEGs can be candidates for development of adjuvants. Finally, knowledge 
of mechanisms of host resistance and PRRSV persistence can help to prevent genetic selection 
for host response to PRRSV from having unforeseen negative impacts on other economically 
important traits or on host response to infection with other pathogens because some of the genes 
involved in host response to PRRSV or PRRSV persistence may also play roles in other traits or 
in response to other pathogens.  
Another potential implementation of findings from the differential expression analyses of 
both the tonsil and the blood transcriptome is to provide evidence of candidate genes in or near 
genomic regions with SNPs that have significant associations with host response to PRRSV 
infection or vaccination. This may also facilitate detection of additional loci associated with host 
response to PRRSV infection. If a significant SNP is located in or near a DEG for a treatment or 
factor of interest and this SNP is associated with host resistance to PRRSV or PRRSV 
persistence and/or with the expression level of this DEG, this suggests that this SNP and DEG 
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are strong candidate biomarkers for host resistance to PRRSV or PRRSV persistence. For 
example, the MX1 gene was DEG for VxStatus at 4 and 14 dpi in PHGC16+20 with cell 
enrichments, at 4 and 7 dpi in PHGC16+20 without cell enrichments, at 7 dpv in PHGC22 with 
and without cell enrichments, and at 7, 11, and 14 dpi in PHGC22 without cell enrichments. The 
MX1 gene was expressed more in blood of NonVx pigs than in blood of Vx pigs at all these time 
points after coinfection with PRRSV and PCV2b (results not shown). The MX1 protein is known 
to protect again viruses (Verhelst et al. 2013). Waide et al. (2017) found a one 1-Mb genomic 
region near the MX1 gene on Sus Scrofa chromosome (SSC) 13 to be significantly associated 
with weight gain in the KS06 PHGC trials. Thus, the identified 1-Mb genomic region near the 
MX1 gene could include a SNP as a biomarker to indicate the level of expression of the MX1 
gene to enhance host resistance to PRRSV and PCV2b. As another example, the C4 gene was a 
DEG at 4 dpi in PHGC16+20 with and without cell enrichments, at 7 and 28 dpi in PHGC16+20 
without cell enrichments, and at 7 dpi in PHGC22 without cell enrichments, and was expressed 
more in NonVx pigs than in Vx pigs (results not shown). Dunkelberger et al. (2017) found 
several SNPs in the vicinity of the swine leukocyte antigen genes (SLA) on SSC7 that were 
significantly associated with PCV2b VL following PRRSV and PCV2 co-infection. The SLA is 
one of the most gene-dense regions in the pig genome, including the C4 gene, and is known to 
influence immune response, vaccine response, and disease resistance (Lunney et al. 2009). So, 
the significant SNPs near SLA may be potential biomarkers, which may affect C4 gene 
expression, which may play a role in reducing PCV2b VL. As a final example, the CD34 gene 
was significantly expressed less in the blood of Vx pigs than in NonVx pigs at 7 dpv in PHGC22 
with and without cell enrichments. Hess et al. (2018) found a genomic region on SSC9 near the 
CD34 gene to be significantly associated with tonsil viral level. The CD34 protein is essential in 
205 
 
inflammation and is required for T cells to entry lymph nodes. Therefore, the SNP near the CD34 
gene may influence the expression of the CD34 gene, which may be an indicator of host 
response to PRRSV infection.  
Sometimes, a SNP may not have a significant effect on the expression level of just one 
gene but on the expression of a group of genes as a module, which indicates pleiotropic effects of 
that genomic region. For example, Schroyen et al. (2015 and 2016) found that WUR had 
significant effects on the overall expression of the two modules that included 506 genes and 384 
genes, respectively. This clarifies the precise molecular mechanisms of host response to PRRSV 
infection. Therefore, the analysis of modules and networks based on the RNA-seq data is one of 
our future works.  
Breeders can predict the effect of selection on the biomarkers such as the WUR SNP on 
host response PRRSV better if the causal mutation or gene is known, which can improve rates of 
genetic progress in the pig industry. The potential candidate DNA, RNA or protein biomarkers 
identified in this study, such as the significant SNPs in the CD163, CD169, and RGS16 genes, 
and the MX1, C4 and CD34 transcripts for the effect of PRRS vaccination can be easily 
measured directly by collecting ear for DNA or blood for gene expression after vaccination, 
without having to euthanize the pig.  
In addition, identification of not previously annotated genes obtained by Beiki et al. 
(2019) in the tonsil RNA-seq analyses provided information on the expression of these novel 
genes in tonsils because these genes were originally identified by Beiki et al. (2019) using Iso-
Seq data from nine pig tissues (brain, hypothalamus, liver, muscle, thymus, pituitary, small 
intestine, spleen and diaphragm). In this study, we assumed that mRNA levels were highly 
correlated with protein expression, but this may not always be the case. Therefore, abundance of 
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proteins, post-translational modifications, and cellular localization should be investigated under 
PRRSV infection in pigs in order to confirm our hypotheses. 
The use of gene editing technology, CRISP-Cas9, to generate pigs that lack functional 
CD163 showed that these animals are resistant to PRRSV and affirmed that CD163 is the major 
receptor that mediates viral internalization and disassembly (Burkard et al. 2017; Wells et al. 
2017; Whitworth et al. 2016). However, there are still some issues about gene-editing 
technology, such as the possibility of off-target effects, unknown new mutated PRRSV strains 
being capable to enter host cells in other ways, CD163 having effects on biological processes 
under non-challenged conditions or on infection with other pathogens, and how food products 
from gene-edited animals will be regulated or accepted by society. Therefore, we still need to 
know more about the mechanism of host response to PRRSV infection in pigs in terms of both 
genetics and transcriptomics to combat this disease, and to identify natural mutations associated 
with host response to PRRSV infection and co-infection with PCV2b. The identified SNPs in the 
final study, such as CD163_SNP19, can serve as natural genetic markers to select for increased 
natural resistance to PRRSV and/or PCV2. Additional research is needed to understand the 
mechanism of how these SNPs reduce PRRS and/or PCV2 VL, and/or increase growth rate 
following infection. 
Limitations of This Study and Future Directions 
Because xCell was developed based on human data, one of the future works needed is to 
adapt the xCell software or cells signature data to pigs. This can be based on porcine gene 
signatures for each cell type, as identified by single cell RNA-seq or, as used to develop xCell 
for humans (Aran et al. 2017), using the transcriptome of specific cell lines of pigs. The 
information used by IPA for functional genomics analyses in this study was also based on 
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human/mouse/rat literature and, therefore, confirmation of the functional genomic interpretations 
of our results in pigs is needed.  
The DEGs identified in the tonsil and blood transcriptome that are novel genes obtained 
by Beiki et al. (2019) are potential newly identified genes for the pig. Future work is needed to 
validate their existence and function. In addition, because DEG identification is at the 
transcriptional level, future studies should examine the impact of these genes on host response by 
investigating protein expression levels. Furthermore, we can use single cell sequencing to 
identify porcine gene signatures of each specific cell type in pigs and use gene knockout 
technology to validate the function of candidate genes such as the MX1 gene for decreasing 
PRRSV persistence and enhancing host resistance to co-infection. Gene editing can also generate 
new variation to improve resistance to PRRSV, even at the single nucleotide level. Therefore, 
this technology can be an ideal tool to mutate putative causative genes. Potential candidates are 
the SNPs we identified to be significantly associated with PRRS VL or other traits or with gene 
expression, e.g. CD163_SNP19, in order to provide definitive evidence for their function on 
improving PRRSV resistance. Disease resistance as well as disease persistence are complex 
quantitative traits that depend on the cumulative actions of multiple genes and environment 
factors. Therefore, it is still necessary for us to have a wider and deeper understanding about the 
molecular mechanisms involved in these traits related to immune response during PRRSV 
infection.  
In multicellular organisms, tissues operate together as a system, which means that there 
are interactions between tissues at the molecular level. For example, previous research in mice 
found that megakaryocytes in lungs, which can release platelets and account for about 50% of 
total platelet productions in the whole body, originate from other tissues, such as bone marrow. If 
208 
 
the bone marrow has low levels of platelets or relative stem cell deficiency, the megakaryocytes 
and haematopoietic progenitors in the extravascular spaces of the lung can move from the lung to 
bone marrow to regenerate blood platelets and play a role in multiple haematopoietic lineages 
(Lefrançais et al. 2017). We studied the transcriptome of two important tissues using RNA-seq 
profiling, tonsils and blood, however, these tissues were taken from different pigs in different 
studies. Future studies need to include more tissues from the same animals to better understand 
resistance mechanisms, including not only blood and tonsil but also lung, which is the first tissue 
that is infected by PRRSV through naturally challenge, and lymph nodes, which take on 
importance in the maturity of T and B cells.  
Multi-tissue analyses can be conducted through expression quantitative trait locus 
(eQTL) analysis. Deist et al. (2018) used weighted gene co-expression network analysis 
(WGCNA) to identify modules of co-expressed genes that are associated with traits of interest. 
In addition, in order to identify molecular inter-tissue interactions, Long et al. (2016) developed 
inter-tissue co-expression network analysis for human multi-tissue networks. This analysis aims 
at distinguishing three factors that contribute to inter-tissue interaction, including a common 
genetic basis, the same environmental variation, and biological signal exchanges between two 
tissues. The method then generates modules of genes involved in inter-tissue interactions that are 
driven by biological signal exchanges.  
To date, the majority of the multi-tissue analyses have been conducted in humans because 
the most popular example of multi-tissue genomics data is the Genotype-Tissue Expression 
(GTEx) consortium (2015), which includes expression measurements on about 20,000 genes in 
1641 samples from 43 tissues across 175 humans. However, very few multi-tissue studies have 
been conducted in pigs, likely due to the cost of creating the sequencing data using standard 
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RNA-seq of hundreds of individuals across multi-tissues. Recently, however, the “QuantSeq” or 
“3’RNA-seq” technology was developed (Moll et al. 2014), which is a robust and simple mRNA 
sequencing method that facilitates efficient and cost-effective expression profiling by increasing 
the precision in gene expression measurements by generating only one read per transcript and 
reducing the major cost areas, including sample preparation, sequencing and data processing in 
high-throughput sequencings. Furthermore, with the decreasing cost of next generation 
sequencing technologies, whole genome sequencing and whole exome sequencing can be used to 
capture both small and large variants that might otherwise be missed, such as SNP and copy 
number variants. These advanced new technologies can also be utilized to identify potential 
causative variants on gene expression and/or regulation mechanisms such as chromatin 
accessibility through ATAC-seq, chromatin interaction through Hi-C (3C-seq), and transcription 
factor binding site identification through ChIP-seq. 
During infection of pigs with PRRSV, antiviral immune response is very complex, 
including inter-tissue communication of a myriad biomolecules such as transcripts, miRNAs, 
long non-coding RNAs, proteins, and metabolites in different tissues that interact with each other 
and regulate each other. In the future, we can focus on building multi-tissue networks to identify 
modules of biomolecules in different tissues that communicate with each other and regulate each 
other, aiming at improving our understanding of host response to PRRS in relation to the 
immune system, especially sterilizing immunity, which is helpful to develop strategies to control 
the disease and eliminate it completely.  
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